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Abbreviations 
 
3’-UTR  3’-untranslated region 
Ago Argonaute 
ALS Amyotrophic lateral sclerosis 
AMPA α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
ASD Autism spectrum disorders 
CDS Coding sequence 
CLIP Crosslinking and immunoprecipitation 
E Excitation 
EPSC Excitatory postsynaptic current 
FDA Food & Drug Administration 
FMRP Fragile X mental retardation protein 
FTD Frontotemporal dementia 
GABA γ-aminobutyric acid 
I Inhibition 
IPSC Inhibitory postsynaptic current 
LTP Long-term potentiation 
LTD Long-term depression 
miRNA microRNA 
mRNA messenger RNA 
NOR Novel object recognition 
NMDA N-Methyl-D-aspartate 
Pum2 Pumilio2 
RBP RNA-binding protein 
RNP Ribonucleoprotein particle 
SMA Spinal muscle atrophy 
SMN1 Survival motor neuron 1 
Stau2 Staufen2 
tRNA transfer RNA 
WT Wildtype 
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Summary 
 
Neuronal activity and network excitability crucially rely on the balance between excitation (E) 
and inhibition (I). Dysregulation of this tightly controlled E/I ratio is thought to be the molecular 
cause of many neurological and neuropsychiatric diseases such as epilepsy and autism spectrum 
disorders (ASD). Elucidating the control mechanisms guiding this balance is a prerequisite to 
understand these diseases. Therefore, upstream regulators of the E/I ratio need to be identified 
and characterized. RNA-binding proteins (RBPs) are promising candidates since (i) depletion 
of certain RBPs causes severe pathological deficits such as ASD or epilepsy, (ii) RBPs bind to 
and control the expression of numerous mRNAs and (iii) they are able to bind transcripts coding 
for both excitatory and inhibitory synaptic signaling molecules. 
The aim of this PhD thesis is to unravel the impact of two different RBPs, i.e. Pumilio2 (Pum2) 
and Staufen2 (Stau2), on balancing neuronal activity. I exploited complementary approaches 
consisting of transcriptome/proteome analysis, microscopy, electrophysiology and behavioral 
assays using primary neuronal cell cultures, brain tissues and transgenic mouse lines. 
Altogether, my data strongly suggest that Pum2 and Stau2 control different aspects of neuronal 
activity. 
Pum2 has a dual role in regulating neuronal excitability. It is known to repress the expression 
of voltage-gated sodium channels such as Nav1.2 (Scn2a) and Nav1.6 (Scn8a) to inhibit 
neuronal excitation. In my work, I have identified that Pum2 regulates several key proteins for 
neuronal inhibition such as Gephyrin (Gphn) and the α2 subunit of the GABAA receptor 
(Gabra2). Thereby, Pum2 enhances Gphn, but represses Gabra2 expression. Gphn is the 
postsynaptic scaffolding protein of glycine and GABAA receptors. Interestingly, Gphn 
expression drops in dendrites, but not in the soma of Pum2 deficient neurons. Accordingly, 
spontaneous synaptic miniature inhibitory postsynaptic currents (mIPSCs) are significantly 
reduced while general (IPSCs) are unaffected. Together, these findings argue for a crucial role 
of Pum2 in GABAergic transmission. In the case of the α2 subunit of the GABAA receptor 
(Gabra2), Pum2 selectively represses Gabra2 expression both in cultured neurons and in mouse 
brain. Importantly, double knock-down of Gabra2 and Pum2 leads to enhanced excitatory 
synaptic transmission. These findings suggest that Gabra2 upregulation serves as a 
compensatory effect to counterbalance increased neuronal excitability in Pum2 depleted 
neurons. Together, these results establish Pum2 as a key regulator to balance neuronal activity. 
Supportive for this notion is the finding that Pum2 knock-down (KD) mice show a 
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predisposition to develop epileptic seizures, a neurological disease characterized by an 
imbalance in neuronal network activity. 
To evaluate whether the effect of Pum2 on GABAergic transmission was selective for this 
specific RBP, I also investigated the RBP Stau2. Stau2 is a crucial regulator of gene expression. 
Upon depletion of Stau2 in cortical neurons, GABAergic proteins remain mostly unaffected. 
Proteins involved in neurotransmitter release, however, such as Complexin1 (Cplx1) and the 
ionotropic glutamate receptor AMPA1 (Gria1), are significantly downregulated. Cplx1 and 
Gria1 are both essential for synaptic transmission and plasticity. Strikingly, a recently 
established Stau2 KD rat model in the lab shows an imbalance in the long-term potentiation 
(LTP) to long-term depression (LTD) ratio suggesting that Stau2 acts as a regulatory hub to 
balance plasticity. In line with this, Stau2 KD mice show spatial memory deficits and impaired 
novelty response. Moreover, another neurotransmitter receptor, the glutamate receptor 
ionotropic delta subunit 2 (GluD2 or Grid2), shows enhanced expression upon physical training 
of Stau2 KD animals, when compared to control mice. GluD2 is essential for synaptic 
transmission in the cerebellum and important for motor learning. Strikingly, Stau2 KD animals 
exhibit a delay in motor learning indicating an impact on synaptic plasticity in the cerebellum.  
Together, my PhD thesis establishes the RBPs Pum2 and Stau2 as crucial regulators to balance 
neuronal activity in the brain. While Pum2 fine-tunes GABAergic inhibition and voltage-gated 
sodium channel mediated excitation, Stau2 controls the balance in synaptic plasticity. 
Understanding the underlying mechanisms controlling synaptic balancing is key to develop new 
therapies for treating neurological and neuropsychiatric disorders such as epilepsy and ASD.
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Zusammenfassung 
 
Neuronale Aktivität und Netzwerk-Erregbarkeit hängen im besonderen Maße von einem 
Gleichgewicht zwischen Erregung (E) und Inhibition (I), dem sogenannten E/I Quotienten, ab. 
Ein Verschieben dieses Gleichgewichts wurde bisher mit verschiedenen neurologischen und 
neuropsychiatrischen Krankheiten wie Epilepsie und Autismus in Verbindung gebracht. Ein 
Verständnis der molekularen Mechanismen, die diese Balance etablieren, ist Voraussetzung um 
diese Krankheiten verstehen zu können. Dabei ist es besonders wichtig, Schlüsselregulatoren 
zu identifizieren, die das E/I Verhältnis beeinflussen. Hierfür sind RNA-Bindeproteine (RBP) 
aus mehreren Gründen vielversprechende Kandidaten. Erstens, genetische Deletion von 
bestimmten RBPs verursacht schwere neurologische und neuropsychiatrische Krankheiten wie 
Epilepsie und Autismus. Zweitens, RBPs binden und regulieren zahlreiche verschiedene 
Transkripte. Und drittens, sie sind in der Lage, sowohl mRNAs kodierend für erregende als 
auch hemmende Rezeptoren zu binden. 
Das Ziel dieser Doktorarbeit war es zu klären, ob und wie die beiden RBPs Pumilio2 (Pum2) 
und Staufen2 (Stau2) das E/I Verhältnis regulieren. Um diese Fragestellung zu beantworten, 
verwendete ich einen komplementären experimentellen Ansatz, der sowohl Transkriptom- und 
Proteom-Analysen, sowie Mikroskopie und Elektrophysiologie, als auch Verhaltenstests an 
verschiedenen Mauslinien enthielt. Meine Daten zeigen deutlich, dass Pum2 und Stau2 
unterschiedliche Aspekte der neuronalen Aktivität regulieren können. 
Pum2 hat eine Doppelfunktion in dieser Regulation. Aus anderen Studien ist bekannt, dass es 
die Expression von spannungsabhängigen Natriumkanälen wie Nav1.2 (Scn2a) und Nav1.6 
(Scn8a) inhibiert. Damit unterdrückt Pum2 indirekt die neuronale Erregbarkeit. Meine Arbeit 
zeigt nun, dass verschiedene Schlüsselmoleküle, lokalisiert an inhibitorischen Synapsen, wie 
z.B. Gephyrin (Gphn) und die α2 Untereinheit des GABAA Rezeptors (Gabra2), von Pum2 
reguliert werden. Hierbei fördert Pum2 die Expression von Gphn, inhibiert jedoch die von 
Gabra2. 
Gphn ist ein Verankerungsmolekül, das Glyzin- und GABAA-Rezeptoren in der Membran 
fixiert. Interessanterweise sinkt das Gphn Proteinlevel nur in den Dendriten, aber nicht im Soma 
von Pum2-defizienten Neuronen. Als Konsequenz zeigen spontane inhibitorische synaptische 
Ströme eine reduzierte Amplitude. Diese Daten belegen eindeutig, dass Pum2 die GABAerge 
synaptische Übertragung steuert. Ein weiteres Zielmolekül von Pum2 ist die α2 Untereinheit 
des GABAA Rezeptors (Gabra2). Hierbei unterdrückt Pum2 die Expression von Gabra2 in 
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kultivierten kortikalen Neuronen und im Mausgehirn. Dieser Effekt ist hochselektiv. Die 
Runterregulation von Pum2 und Gabra2 führt zu einer Erhöhung der neuronalen Aktivität. 
Basierend auf diesen Daten lässt sich folgendes Modell herleiten: die Hochregulation von 
Gabra2 in Pum2-defizienten Neuronen inhibiert die neuronale Aktivität und puffert somit die 
erhöhte Erregbarkeit dieser Neurone ab. Das bedeutet, die Pum2-abhängige translationelle 
Kontrolle von Gabra2 repräsentiert einen kompensatorischen Effekt. Zusammenfassend lassen 
meine Daten den Schluss zu, dass Pum2 ein wichtiger Regulator ist, um neuronale Aktivität 
auszubalancieren. Im Einklang mit diesem Modell sind in vivo Daten von Pum2-defizienten 
Mäusen. Diese Tiere zeigen spontane epileptische Anfälle, welche durch ein Ungleichgewicht 
der neuronalen Aktivität gekennzeichnet sind. 
Um die Selektivität der Pum2 vermittelten Kontrolle der GABAergen Inhibition einschätzen zu 
können, habe ich diesbezüglich auch Stau2 untersucht. Stau2 ist ein weiteres RBP sowie ein 
wichtiger Regulator der Genexpression. Nach der Depletion von Stau2 in kortikalen Neuronen 
sind Proteine für die GABAerge Transmission weitergehend unverändert. Jedoch zeigen 
Proteine, die für die Freisetzung von Neurotransmittern wichtig sind, wie z.B. Complexin1 
(Cplx1), als auch der AMPA1 Rezeptor eine Verminderung der Expression. Beide Proteine sind 
essentiell für die synaptische Übertragung und Plastizität. Von besonderer Bedeutung sind in 
diesem Zusammenhang in vivo Daten aus einer Stau2 KD Rattenlinie. Diese Ratte zeigt ein 
Ungleichgewicht zwischen LTP und LTD. Diese Daten deuten darauf hin, dass Stau2 ein 
zentraler Regulator der synaptischen Plastizität ist. Übereinstimmend mit diesen molekularen 
Daten sind Verhaltenstests mit einer Stau2-defizienten Maus. Diese zeigt Defizite im 
räumlichen Gedächtnis und in ihrer kognitiven Flexibilität. Des Weiteren zeigt ein anderer 
Neurotransmitterrezeptor, die Untereinheit Delta 2 des ionotropen Glutamatrezeptors (GluD2), 
nach körperlichem Training eine erhöhte Expression in Stau2-defizienten Mäusen. GluD2 ist 
essentiell für die synaptische Übertragung im Kleinhirn und wichtig für das Motorlernen. 
Interessanterweise zeigen Stau2 KD Mäuse eine Verzögerung im Motorlernen, was auf eine 
gestörte synaptische Plastizität hindeutet. 
Zusammenfassend hat meine Doktorarbeit gezeigt, dass Pum2 und Stau2 entscheidend 
neuronale Aktivität regulieren. Während Pum2 die GABAerge Inhibition als auch die 
Natriumkanal-abhängige Erregbarkeit steuert, balanciert Stau2 synaptische Plastizität. Das 
Verständnis über die zugrundeliegenden Mechanismen, die das Gleichgewicht der neuronalen 
Aktivität regulieren, ist Voraussetzung, um zukünftig neue Therapiestrategien gegen 
neurologische und neuropsychiatrische Krankheiten wie Autismus und Epilepsie entwickeln zu 
können.
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1. Introduction 
 
1.1 Synaptic transmission and plasticity 
 
Neuronal communication relies on the transmission of currents through chemical synapses. 
Intense research in the last decades has unraveled the principles of synaptic transmission at 
inhibitory and excitatory contact sites. This effort has been awarded by 17 Nobel prizes so far. 
It is generally accepted that sufficient dendritic (but also somatic) stimulation generates an 
action potential in the presynaptic neuron. This action potential moves along its axon and 
induces calcium dependent exocytosis of neurotransmitters at presynaptic buttons (1). These 
transmitters diffuse through the synaptic cleft to activate synaptic receptors in the postsynaptic 
neuron. Importantly, the action of a certain neurotransmitter on neuronal activity depends on 
both the nature of the neurotransmitter and the composition of the postsynaptic receptors. The 
activation of postsynaptic receptors can either stimulate a neuron or dampen its activity (1, 2). 
The two main opponent neurotransmitters in the brain are glutamate for excitation and GABA 
(γ-aminobutyric acid) for inhibition. The fine-tuned ratio of excitation (E) and inhibition (I) is 
the basis for both proper neuronal development and neuronal circuit homeostasis in the adult 
brain (3). 
Importantly, the Cl- ion concentration gradient conveys neuronal inhibition. Thus, intracellular 
Cl- concentration ([Cl-]i) determines whether GABA is excitatory or inhibitory (4, 5). For 
instance, early postnatal neurons highly express the Cl- ion intruder Solute carrier family 12 
member 2, also called Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2 
(Slc12a2 or NKCC1). NKCC1 imports Cl- from the extracellular environment. Thus, in 
immature neurons, activation of the GABAA receptor, which is a Cl- channel itself, leads to a 
net efflux of Cl- ions and thereby to neuronal depolarization. However, during postnatal 
maturation, the main Cl- ion extruder Solute carrier family 12 member 5, also called K/Cl 
cotransporter 2 (Slc12a5 or KCC2) is expressed. KCC2 exports Cl- ions and establishes the 
gradient that is necessary for neuronal hyperpolarization upon GABA stimulation (6). The 
opposing expression profiles of KCC2 and NKCC1 are essential to drive neuronal maturation 
through the establishment of GABA as neuronal inhibitor: the so-called GABA switch (4, 5). 
It has been shown that excitatory GABA enhances calcium influx through the NMDA receptor 
during development (7). Complementary, the NMDA receptor enhances inhibitory synapse 
formation in immature neurons (8). Hence, the balance between the glutamatergic and 
9 
 
GABAergic systems during development is essential for proper neuronal functioning in the 
adult brain. In line with this notion are findings showing that the imbalance between NKCC1 
and KCC2 causes ASD and schizophrenia (9, 10). 
In the adult brain, the E/I ratio determines net synaptic currents. In general, the strength of 
synaptic transmission is defined by its frequency and the corresponding amplitude. As an 
approximation, the frequency is determined by the number of presynaptic vesicles and their 
probability to release neurotransmitters. In contrast, the amplitude is crucially influenced by the 
activation of postsynaptic receptors. These two parameters crucially influence both excitatory 
and inhibitory postsynaptic currents (EPSCs and IPSCs, respectively). Hence, the interplay 
between pre- and postsynaptic activity as well as the E/I ratio decide about the stimulation 
efficiency of the target neuron. In addition to its role as receptor ligands, the downstream 
signaling induced by the neurotransmitters, such as serotonin, has the capacity to 
posttranslationally modify proteins. This process crucially regulates histone proteins and 
thereby transcription (11), linking synaptic stimulation with transcriptional activity. 
Synaptic activity induces different downstream signaling pathways in the postsynaptic neuron 
that can strengthen or weaken the transmission. This phenomenon is called ‘synaptic plasticity’ 
(12). Intense research in the last decades has identified numerous molecules that control 
synaptic plasticity (12–14). The two main types of synaptic plasticity are long-term potentiation 
(LTP) and long-term depression (LTD). It is generally accepted that LTP enhances transmission 
efficiency while LTD decreases it. Together, they provide the basis for learning, memory 
formation and cognitive flexibility (12, 13, 15, 16). Importantly, both LTP and LTD depend, at 
least partly, on translation (17, 18) (see also section 1.3 Translation as regulatory hub for 
neuronal homeostasis and synaptic transmission). Similar to the E/I ratio, LTP and LTD need 
to be balanced to allow flexibility of the neuronal network. Of note, both forms of plasticity are 
conveyed by changes in the synaptic actin cytoskeleton network. These changes are equally 
important for the decay of memory, a process that has been termed forgetting (19).  
In summary, the molecular basis for balancing neuronal activity and plasticity is already being 
established during development. Moreover, it is the basis for neuronal circuit homeostasis (20). 
This homeostasis is a prerequisite for adjusting and fine-tuning memory acquisition and decay. 
Therefore, identification of key regulators is crucial to understand these fundamental processes. 
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1.2 RNA-binding proteins as critical regulators of synaptic functioning 
 
Research in the last decades has clearly established that certain RBPs are crucial for synaptic 
function (21). RBPs bind their target mRNAs preferentially in the 3’-untranslated region (3’-
UTR) (22). Thereby, they control different aspects of the RNA life cycle such as splicing, RNA 
stability and localization as well as translation (23, 24). Importantly, mRNAs can be bound by 
several RBPs (25) indicating a certain degree of cooperativity or competition between RBPs to 
control gene expression. This cooperativity is thought to be a complex interplay between RBPs 
and might account for compensatory (or indirect) effects observed upon knocking out a single 
RBP (Schieweck et al., Physiol. Rev. under revision). To date, several hundred RBPs have been 
identified exploiting different experimental approaches such as UV crosslinking of RBPs to 
RNA and immunoprecipitation (CLIP) or density gradient centrifugation (26, 27). The ever-
growing list of RBPs raises the question about their manifold functional implications in 
neurons. 
In this context, RBPs might play a pivotal role in regulating the synaptic balance for several 
reasons. First, knock-out (KO) or KD of certain RBPs such as the Fragile X Mental Retardation 
Protein (FMRP), Rbfox1 or Pumilio2 (Pum2) in mice lead to severe alterations in neuronal 
network activity resulting in mental retardation and epilepsy (28–31). Second, RBPs have the 
ability to regulate numerous steps in the RNA life cycle such as RNA decay, transport and 
translation (23, 24). Thereby, in the absence of a certain functional RBP, multiple transcripts 
are affected, which is characteristic for complex multigenic disorders. Third, different mRNAs 
coding for subunits of GABAA (32) and glutamatergic receptors are bound by several RBPs 
(Schieweck et al., Physiol. Rev. under revision). Fourth, RBPs such as FMRP and Rbfox1 
regulate GABAergic transmission through different mechanisms, including receptor transport 
(33, 34), indicating distinct effects on excitability regulation.  
To date, only few RBPs have been tested for their in vivo role in neuronal transmission and 
synaptic plasticity. One of the best characterized RBPs regarding its impact on excitatory and 
inhibitory synaptic transmission is Rbfox1 (28, 34, 35). The absence of Rbfox1 in mouse brain 
increases excitatory synaptic transmission efficiency (28). Moreover, it is essential for 
development and required for establishing the connectivity of inhibitory interneurons. 
Therefore, interneuron specific KO of Rbfox1 leads to a decrease in frequency and amplitude 
of inhibitory synaptic currents (35). In line with this notion is the finding that brain-wide KO 
of Rbfox1 increases the E/I ratio (34), which might be a molecular explanation for the epileptic 
seizures observed in Rbfox1 KO mice (28). Another example for an RBP regulating the E/I 
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ratio is TAR-DNA binding protein 43, also known as TDP-43. Mutant TDP-43 is well-known 
to cause neurodegeneration as observed in amyotrophic lateral sclerosis (ALS) and 
frontotemporal dementia (FTD) (36, 37). Interestingly, presymptomatic mice carrying mutant 
TDP-43 show increased frequency of EPSCs, while IPSCs remain unaffected, leading to an 
increase in the E/I ratio (38) similar to Rbfox1 KO mice. In contrast to Rbfox1 and TDP-43, 
FMRP KO mice exhibit a reduction in both frequency and amplitude of EPSCs (39). This 
finding might be the molecular basis for mental retardation observed in fragile X mental 
retardation patients (40).  
 
 
Figure 1: RBPs regulate synaptic transmission through different mechanisms. 
(A) Transcripts coding for synaptic receptors or components of their downstream signaling cascade such as 
CaMKIIα are transported in RNA granules, also termed RNPs. Synaptic activation leads to disassembly of these 
RNA granules. Localized mRNAs are subsequently translated near and/or at synapses. Locally, newly synthesized 
proteins modify synaptic transmission efficiency. mRNAs might be degraded locally or repacked into RNPs in 
order to limit the protein supply. 
(B) Remodeling the synaptic actin network is necessary for synaptic plasticity. RBPs can regulate the actin 
organization through delivery and translational control of ß-actin (Actb) or essential actin remodelers such as 
Cofilin-1. 
(C) In addition to its role in RNA transport, degradation and translation, RBPs might regulate receptor trafficking 
to postsynaptic densities through direct protein-protein interactions. 
 
In the cerebellum, however, FMRP KO leads to enhanced release of GABA from the basket 
cells to inhibit Purkinje cells (33), suggesting a role for FMRP in balancing neuronal excitation 
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and inhibition. Moreover, FMRP also regulates the GABA switch during development. 
Depletion of FMRP leads to a delay of the inhibitory action of GABA due to the accumulation 
of NKCC1 (41) suggesting a complex impact of FMRP on neuronal activity. 
The three mentioned examples, i.e. Rbfox1, TDP-43 and FMRP, clearly show that RBPs might 
be essential to balance neuronal activity. Even though the underlying mechanisms of 
posttranscriptional gene regulation might be different (Fig. 1), some aspects are commonly 
shared between different RBPs. First, RBPs control neuronal excitation by regulating 
expression of synaptic proteins, cytoskeleton or receptor organization. Rbfox1 for example 
regulates the expression of the presynaptic vSNARE protein Vamp1 through antagonizing 
miRNA mediated repression (34). In brief, Rbfox1 binds the 3’-UTR of Vamp1 and thereby 
blocks binding of miRNA-9 that would otherwise induce Vamp1 mRNA degradation through 
the Ago pathway (42). Vamp1 is expressed in inhibitory interneurons and it is important for 
GABA release (34). Another example is FMRP. This RBP regulates the activity-dependent 
expression of Cofilin-1 (43), a protein that regulates the dynamics of the actin cytoskeleton, 
essential for dendritic spine maturity (44). Upon chemical induction of LTP, Cofilin-1 mRNA 
is decreased in dendrites. In FMRP KO neurons, the effect is absent, which might explain the 
impaired dynamics of dendritic spine morphology observed upon LTP induction (43). In 
addition to its ability to bind mRNAs, FMRP can directly control transmitter release through 
the interaction with ion channels such as the potassium channel Kv1.2 (33) (Fig. 1C). Second, 
in the brain RBPs can be expressed both in pyramidal cells and inhibitory interneurons (45) 
suggesting cell type specific roles and mRNA targets (Fig. 2). This might explain their distinct 
impact on excitation and inhibition as discussed above. And third, different RBPs share some 
of their mRNA targets such as the glutamate and the GABA receptors as well as additional ion 
channels (Schieweck et al., Physiol. Rev. under revision) (Fig. 3). Together, this provides the 
platform to either synergistically or antagonistically regulate their expression. 
 
13 
 
 
 
1.3 Translation as regulatory hub for neuronal homeostasis and synaptic transmission 
 
Numerous studies have unraveled by now that translation is a central regulatory hub for protein 
homeostasis (proteostasis) in cells (47). The classical view of translation as a biochemical 
process to synthesize proteins is certainly too simplistic. This process not only regulates protein 
levels, but also protein and mRNA stability as well as protein folding (48, 49). By exploiting 
different technologies such as ribosome profiling (50), polysome profiling (51) or translating 
ribosome affinity purification (TRAP) (52), different aspects of neuronal translation dynamics 
have been elucidated. To date, distinct sequences and structure elements embedded in an 
mRNA have been identified as regulators of translation. In particular for localized mRNAs, the 
3’-UTR is of utmost importance for translation control (22) and protein localization (53). For 
instance, it has been shown that the median 3’-UTR length of localized mRNAs that are targets 
of the RBP Stau2 is significantly longer compared to the median length of the 3’-UTRs of the 
transcriptome (54). A possible explanation for this expansion is the evolutive addition of 
regulatory elements, such as different RBP binding motifs (Fig. 3) as well as miRNA binding 
sites (22, 55). The collectivity of these elements decides whether, where and how much a 
transcript is translated. Moreover, some transcripts contain retained introns in their 3’-UTR. 
These introns are necessary for mRNA localization (56) and translation control through the 
induction of the non-sense mediated decay pathway (NMD) (57). Importantly, one of the 
Figure 2: Neuronal cell type specific expression of 
RBPs. 
Excitatory pyramidal cells (PC) are inhibited by 
different types of inhibitory interneurons. Thereby, 
somatostatin positive (SST+) interneurons target 
dendrites, parvalbumin positive (PV+) interneurons 
form synapses with the soma and chandelier cells 
(CH) with the axon initial segment (46). Importantly, 
within a negative feedback loop, vasointestinal 
peptide positive (Vip) interneurons inhibit SST+ 
cells. The coordinated interplay between PCs and 
interneurons is essential for homeostatic excitability. 
Interestingly, RBPs such as Pum2 and Stau2 show 
distinct expression profiles in different neuronal cell 
types (45). 
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transcripts that contain a retained intron in the 3’-UTR and is targeted for NMD is the activity-
regulated cytoskeleton associated protein (Arc). Arc is needed for the actin cytoskeleton 
remodeling, which occurs during LTP (58). Neuronal stimulation enhances Arc mRNA 
localization to dendrites (59) and increases Arc protein levels (57) suggesting a complex role 
of NMD in regulating protein expression. Of note, pioneer studies suggest that the 3’-UTR 
holds a certain coding capacity. This conclusion is based on a significant ribosome density 
found in the 3’-UTR (60) and the detection of translated 3’-UTR sequences separated from the 
mRNA body in aging neurons (61). The encoded peptides might convey important regulations. 
Future studies are clearly necessary to unravel their potential role in cells. Together, these 
findings clearly show that the 3’-UTR harbors an immense regulatory potential to control 
different aspects of the RNA life cycle. 
Similar to the 3’-UTR, the 5’-end of a transcript also contains regulatory elements. In addition 
to 5’-UTR length and structure (55), upstream open reading frames (uORF) tightly regulate 
translation of the main open reading frame (mORF) (62). The presence of uORFs leads to 
accumulation of ribosomes in the 5’-UTR. Interestingly, a redistribution of ribosomes from the 
5’-UTR to the mORF is observed during neuronal differentiation indicating an important 
functional role of uORFs in development (51). The translation rate of the mORF is critically 
regulated by the phosphorylation of initiation factor 2α (eIF2α). eIF2α is a component of the 
ternary complex that delivers GTP and the initiator tRNA to initiating ribosomes to start 
translation. Upon eIF2α phosphorylation, the GDP to GTP exchange by eIF2b is impaired. This 
mechanism inhibits global translation. uORF containing transcripts, however, show a higher 
ribosome occupancy of the mORF (62), even though this theory was challenged by a recent 
finding demonstrating that there is no dependency translatome-wide between translational 
activity of uORF and mORF (63). Interestingly, eIF2α phosphorylation is needed to regulate 
synaptic plasticity and long-term memory (64). At the molecular level, activation of the 
metabotropic glutamate receptor induces phosphorylation of eIF2α. In turn, global translation 
rate is decreased while the synthesis rate of uORF containing transcripts increases. This 
pathway is essential for learning and memory formation (65).  
In addition to 5’- and 3’-UTRs, the coding sequence (CDS) itself harbors regulatory elements 
that influence protein synthesis and folding rate. Thereby, the codon usage frequency that 
reflects tRNA levels crucially determines the speed of elongating ribosomes (66). Rare codons 
correspond to low-abundant tRNAs. Variations in the elongation speed promote or impair co-
translational folding (48, 49), indicating that finely adapted tRNA levels are essential for 
proteostasis (47). In line with this notion is the finding that deficiencies in tRNA homeostasis 
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lead to neurodegeneration probably through the accumulation of misfolded proteins (67, 68). 
In addition to co-translational folding, ribosomes can influence protein folding and identity 
through frameshifting. Frameshifting can be caused by depletion of cognate tRNAs during 
translation. Higher abundant tRNAs recognizing codons in the +1 and/or -1 frame enhance the 
frameshifting frequency of the ribosome. This has been observed for Huntingtin (Htt). 
Expansion of the CAG codon stretch in the Htt gene causes long poly-glutamine stretches that 
induce Htt aggregation and leads to Chorea Huntington, a neurodegenerative disease (47). 
Translation of the CAG stretch depletes cognate tRNAs. Consequently, the ribosome shifts to 
the +1 or -1 frame of Htt resulting in a poly-serine or poly-alanine stretch containing proteins, 
respectively, that influence the aggregation of Htt (69, 70). Another example for CDS mediated 
translational aberrations is FMRP and its contribution to the neurodegenerative disorder fragile 
X tremor ataxia syndrome (FXAS) (71). Unlike fragile X syndrome, the expansion of a CGG 
stretch within the 5’-UTR of Fmr1 (the mRNA coding for FMRP) does not cause complete 
transcriptional shutdown in FXAS patients. Instead, mutant Fmr1 mRNA is expressed (71). 
Interestingly, repeat associated non-AUG-initiated translation (RAN) is induced by the mutant 
Fmr1 mRNA leading to the production of a poly-glycine containing FMRP protein found in 
inclusion bodies (72–74). These examples show that translational homeostasis is critically 
needed to ensure neuronal function and survival. 
In addition to its molecular complexity, the spatial organization of the translational apparatus 
provides an elegant possibility to control protein expression in a spatially defined manner. From 
the first evidence (75) to transcriptome-wide screenings for locally translated mRNAs (76), 
different studies experimentally addressed how localized translation contribute to cellular 
functioning in developing and mature neurons. Importantly, localized translation depends on 
mRNA localization. According to the RNA granule hypothesis, transcripts are transported 
embedded in RNA granules (also known as RNPs) that contain a certain subset of RBPs (21). 
These granules are diverse in their mRNA and protein composition (21). It is generally accepted 
that translation is repressed during transport (77). This model, however, has been challenged 
by recent studies (78, 79). RNA granules deliver mRNAs that are translated at synapses. This 
theory, in turn, raises the question, which synapses are provided with mRNAs for translation. 
According to the synaptic tagging theory, activation of a single synapse creates a labile synaptic 
tag that subsequently recruits proteins needed for remodeling (80). This theory can be applied 
to RNA granules. Hence, synaptic activation leads to recruitment of RNA granules to the 
synapse (81, 82) that are then unpacked thereby releasing their embedded mRNAs for 
translation (Schieweck et al., Physiol. Rev., under revision). Arguably, one of the best 
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characterized localized and locally translated transcripts is β-actin (Actb). Actb mRNA is bound 
by the RBP Zipcode-binding protein 1 (ZBP1) (83, 84). Studies published by the Singer lab 
clearly show that Actb mRNA is transported to synapses and locally translated upon activation 
of NMDA receptors (81, 85, 86). Thereby, phosphorylation of ZBP1 might serve as a molecular 
switch to release Actb mRNA from binding and translational repression (84). Actin 
cytoskeleton remodeling is needed to establish synaptic long-term changes such as LTP and 
LTD (20). Thus, it is plausible to propose that activity-dependent delivery of Actb mRNA and 
its local translation support synaptic remodeling. In line with this notion are pioneer 
experiments showing that translation inhibitors impair both LTP and LTD in the hippocampus 
(87). LTP can be divided into an early and late LTP (e- and l-LTP), respectively. Only l-LTP 
depends on protein synthesis while e-LTP does not require newly synthesized proteins, but a 
rearrangement of existing receptors in the plasma membrane (88). Similarly, LTD also requires 
translation (89). In line with this finding, chemical induction of LTD causes phosphorylation 
of eIF2α and a global shutdown of translation. In turn, this effect leads to translational 
upregulation of uORF containing transcripts (65). Of note, translation and protein degradation 
need to be balanced for synaptic changes to occur. This has been shown for LTP as well as LTD 
(89–91). Even though it has not been experimentally shown that local translation is indeed 
needed for LTP and LTD, it is plausible that locally made proteins modify synaptic transmission 
to allow long-term synaptic changes. Supportive for this idea is the finding that the mRNA of 
essential regulators and components of the signaling cascade are localized at post- and 
presynaptic sites (92, 93). Importantly, most studies on RNA localization and translation to date 
focused on the impact of glutamatergic stimulation (56, 81, 82, 85). According to a pioneer 
study, however, it is plausible that GABAA receptor activation drives mRNA localization as 
well (94). In addition, ribosomes in axon terminals of inhibitory interneurons are able to 
translate localized mRNAs, although the number of translationally active compartments is 
significantly smaller for inhibitory presynaptic terminals than postsynaptic dendritic spines 
(93). Functionally speaking, translation is necessary for plasticity of GABA release at inhibitory 
presynaptic terminals (95). Together, these pioneer studies suggest that (localized) translation 
is equally important for inhibitory synapses as for excitatory synapses. Supportive for this 
notion is a recent study showing that deletion of the translation repressor eIF4E-binding protein 
2 (4E-BP2) in inhibitory GABAergic interneurons causes autism-associated behavior in mice 
(96). Even though it is unknown, which transcripts are affected by 4E-BP2 KO, this finding 
clearly shows that translational homeostasis in inhibitory interneurons is essential for normal 
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circuit functioning. How translation is regulated at inhibitory postsynaptic sites and how it 
impacts GABAergic transmission is, however, basically unknown (see also Discussion). 
 
 
Figure 3: RBPs share mRNA targets coding for ‘excitatory’ and ‘inhibitory’ proteins. 
Published CLIP and RIPseq datasets (54, 56, 97–108) reveal that RBPs show a certain degree of convergence in 
their target mRNA binding. Additionally, they interact with transcripts coding for proteins involved both in 
neuronal excitation and inhibition suggesting a role in balancing synaptic activity. Color code reveals number of 
RBPs binding to depicted transcripts. 
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1.4 Pumilio2 and its role in synaptic balancing 
 
Pum2 belongs to the PUF (Pumilio/FBF) RBP family (109). It binds a short nucleotide sequence 
(UGUANAUA) (110) in the 3’-UTR of its target mRNAs (107). Pum2 regulates different 
aspects in the RNA life cycle including transport (111, 112), stability and translation (109). 
Numerous studies have unraveled the possible mechanisms of how Pum2 regulates mRNA 
expression. By recruiting the main polydeadenylation complex CCR4-NOT (113, 114), Pum2 
can destabilize its target mRNAs (113). Moreover, it is able to bind the 5’-cap of mRNAs in 
Xenopus oocytes. Thereby, it competes with the initiation factor eIF4E for cap recognition, 
which is essential to start translation (115). This finding suggests that Pum2 represses 
translation initiation. An in vitro study, however, showed that (nematode and) mammalian 
Pum2 binds to Ago and the translation elongation factor eEF1A to inhibit ribosome elongation 
(116). Importantly, the diversity of RBPs, their stoichiometry and target mRNAs in different 
model organisms might influence how Pum2 regulates mRNA expression. These limitations 
impeded general conclusions drawn from these studies. Moreover, the impact of Pum2 on 
global protein expression is also unknown, raising the question about the precise cellular 
function of this RBP. This question is of particular interest for neurons. Knock-down of Pum2 
leads to spontaneous epileptic seizures in mice (31, 117), one of the most severe neurologic 
conditions affecting millions of people worldwide (118). This drastic phenotype strongly 
suggests that Pum2 has distinct and numerous functions to regulate neuronal homeostasis. A 
first possible molecular explanation was suggested by the Baines lab. They found that Pum2 
represses translation of the voltage-gated sodium channels Nav1.6 (Scn8a), a known risk gene 
for epilepsy (119, 120). Supportive for this model is the finding that downregulation of Pum2 
increases the sodium current in these neurons (121). Of note, Scn8a is a common mRNA target 
of FMRP (102) and Rbfox1 (28) as well. In addition, Rbfox1 KO mice also exhibit epileptic 
seizures (28), and synaptic hyperexcitability was reported in FMRP KO mice (122). Thus, it is 
tempting to speculate that different RBPs act together to control the expression of particular 
mRNAs that might explain similar phenotypes in KO or KD animal models (see Discussion). 
In addition to its effect on Nav1.6 expression, Pum2 regulates excitatory synapse formation. 
Upon Pum2 knock-down, the number of post- and presynaptic sites increases. In addition, the 
frequency of excitatory currents is significantly elevated (123). Moreover, immunoprecipitation 
experiments using antibodies specific for Pum2 revealed that Scn1a mRNA, encoding Nav1.1 
(another voltage-gated sodium channel), is another target of Pum2 (123). This finding is of 
particular interest as Nav1.1 is highly expressed in parvalbumin positive inhibitory interneurons 
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(45). In addition, 80% of patients suffering from Dravet syndrome, an infantile disorder 
characterized by early-onset seizures beginning around 5 months of age, carry mutations in the 
Scn1a gene (124). At the molecular level, reduced Nav1.1 mediated sodium currents diminish 
the excitation of inhibitory interneurons. This effect, in turn, decreases neuronal inhibition and 
might lead to epilepsy (125). Together, these findings suggest a role of Pum2 in regulating 
neuronal inhibition and excitation, probably acting in different neuronal cell types. 
Additionally, it has been suggested that the interaction of different RBPs crucially controls the 
transcriptome in a cell type and development specific manner (Schieweck et al., Physiol. Rev., 
under revision). Thus, elucidating the interaction network of RBPs is a prerequisite to 
understand the regulatory role of RBPs (see Discussion). The underlying molecular 
mechanisms are, however, basically unknown. 
 
1.5 The RNA transport RBP Staufen2 crucially contributes to synaptic functioning 
 
One of the protein interactors of Pum2 is Stau2 (77). Stau2 is a double-stranded RBP that is 
enriched in nerve cells (126). Importantly, the orthologues of Stau2 and Pum2 were identified 
in a memory screening in Drosophila as crucial factors for learning and memory formation 
(127). Moreover, Stau2 has a key role in regulating cortical neurogenesis in embryos (128, 129) 
and mature neurons (130, 131). It serves as a critical regulator for RNA transport (56, 82). It 
associates with microtubules to enable RNA transport (132, 133). Importantly, a significant 
subset of dendritically localized mRNAs are Stau2 targets (54). In addition, overexpression of 
a mutant version of Stau2 reduces a significant proportion of dendritically localized mRNAs 
(134). Thus, elucidating the role of Stau2 in neurons is key to understand local expression 
control and dynamics as well as synaptic transmission that crucially relies on mRNA supply. 
Pioneer studies aiming at identifying the role of Stau2 in synaptic transmission showed that 
downregulation of this RBP significantly alters – amongst others – the actin cytoskeleton. 
Concomitantly, a reduction in number of mature dendritic spines and in the amplitude of 
excitatory currents was observed (130). Supportive for a role of Stau2 in synaptic transmission 
is the finding that some of its mRNA targets code for proteins involved in the metabotropic 
glutamate receptor (mGluR) pathway (54). In line with this finding is the effect of Stau2 on 
mGluR dependent LTD. Downregulation of Stau2 impairs LTD in cultured hippocampal 
neurons (135). Moreover, Stau2 regulates the dendritic localization of Calm3 (56), one of three 
mRNA isoforms that code for the protein Calmodulin, which is essential for downstream 
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signaling upon synaptic stimulation (56). These findings suggest that Stau2 regulates 
downstream synaptic signaling to control synaptic transmission.  
 
1.6 RBPs and their role in balancing neuronal activity: the aims of my Ph.D. thesis 
 
The ability to regulate neuronal activity through a finely tuned balance between excitation and 
inhibition as well as long-term synaptic strengthening or weakening is a prerequisite for 
synaptic plasticity in the brain. Neurological and neuropsychiatric diseases such as epilepsy, 
ASD or learning and memory deficits have been linked to an impaired synaptic balance (3, 30, 
136). As discussed above, RBPs have the potential to regulate synaptic transmission and 
plasticity through numerous mechanisms and pathways. For only few RBPs their impact on 
balancing neuronal activity has yet been experimentally validated. Due to their prevalence and 
importance for controlling protein expression, RBPs are essential regulators of synaptic 
homeostasis (137). Thus, elucidating the role in neurons is key to understand complex 
neurological and neuropsychiatric diseases. 
In this PhD thesis, I focused on the RBPs Pum2 and Stau2 to unravel their role in synaptic 
balancing. The aims of this PhD thesis are:  
 
(i) to investigate their roles in expression control in the brain and in cultured neurons,  
(ii) to identify and characterize their impact on synaptic transmission and  
(iii) to link their regulatory potential with the behavior of their respective knock-down animals. 
 
Together, these aims allowed me to elucidate the role of Pum2 and Stau2 in balancing synaptic 
activity and plasticity.  
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2. Discussion 
 
2.1 The regulatory potential of RBPs 
 
RBPs regulate essentially all steps in the RNA life cycle (23, 24) including transcription, 
splicing, RNA export/transport, translation and degradation (Fig. 4). Thereby, they are shaping 
the neuronal transcriptome and translatome. In this context, it is important to note that mRNAs 
often contain multiple binding sites for different RBPs suggesting that cooperative and 
antagonistic binding occurs (25). Moreover, RBPs regulate different steps in the RNA life cycle 
by exploiting distinct mechanisms (23). Finally, some steps of the RNA life cycle occur in 
parallel rather than sequentially. This allows antagonistic and synergistic effects to occur at the 
same time, such as transcription and splicing or translation and RNA degradation (Fig. 4). It is 
therefore tempting to speculate that a complex regulatory network for protein expression exists 
at the level of RBPs. 
 
 
Figure 4: The life cycle of RNA molecules. 
The RNA life cycle starts with transcription (138). Upon splicing (139), mRNAs are exported (140) into the 
cytosol, where their RBP composition is remodeled (141). This remodeling is thought to control the RNA fate. 
Transcripts are then transported to their destination (82) where they are translated (142) and/or degraded (143, 
144). Importantly, all these steps do not proceed sequentially but also occur in parallel. This phenomenon allows 
a given RBP to regulate multiple steps in the RNA life cycle. Moreover, each step requires a different duration. 
This fact is particularly important for local expression control, where protein expression also depends on the supply 
of transcripts. Of note, all these steps are interconnected through feedback-loops that are not shown here.  
 
Hence, the RBP regulatory network crucially influences translation and, in turn, protein 
expression. Therefore, for some transcripts translational adaptation occurs, a phenomenon that 
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is called ‘translational buffering’. In brief, to outbalance altered transcript levels, the number of 
translating ribosomes is adjusted to produce similar amounts of protein (145). This means that 
downregulated mRNAs are bound to an increased number of elongating ribosomes while 
upregulated transcripts exhibit a lower number. Translational buffering has been described in 
FMRP KO cells (145). Thus, it is plausible that deletion of a given RBP has a more complex 
impact on protein expression levels. In line with this notion is the observation that RBP deletion 
affects also non-target mRNAs (Schieweck et al., Physiol. Rev., under revision). This effect, in 
turn, might result in compensatory, indirect effects that mask direct effects caused by the 
deletion itself (Fig. 5, Schieweck et al., Physiol. Rev., under revision). Additionally, mRNA 
steady-state levels (RNA-seq) or ribosomal occupancy (Ribo-seq) of transcripts show both only 
weak correlation with the levels of their corresponding encoded proteins (63, 146). Therefore, 
conclusions drawn from RNA-seq or Ribo-seq data are limited and might not fully represent 
the impact of a certain RBP on the resulting proteome. To overcome this limitation, 
investigating primarily the protein levels might be a more reliable strategy to identify the 
pathways regulated by a specific RBP. Therefore, I decided in my PhD thesis to exploit 
quantitative mass spectrometry to address the effect of Pum2 and Stau2 downregulation on 
cultured cortical neurons. 
 
2.1.1 Pum2 and Stau2 selectively shape the neuronal proteome 
 
According to published individual-nucleotide resolution CLIP datasets, Pum2 and Stau2 appear 
to regulate multiple but distinct subsets of mRNAs in neuronal progenitors or nerve cells (56, 
107). Therefore, I anticipate a broad impact of these two RBPs on neuronal protein expression. 
According to my hypothesis, hundreds of proteins were dysregulated in Pum2 and Stau2 
depleted neurons. Importantly, only a minor overlap between both data sets was observed: 16% 
and 5% for Pum2 and Stau2 deficient neurons, respectively. Moreover, depletion of these two 
RBPs seems to impact translation in different directions. While Pum2 depletion results in a 
global downregulation of proteins, Stau2 downregulation selectively enhances levels of a subset 
of proteins (see Fig. 3D-F, in Manuscript 2). In line with this observation are results from 
polysome profiling experiments showing that Pum2 depletion decreases the polysome-to-
monosome ratio, an indication for decreased translational activity (see Fig. 2C-E, in 
Manuscript 2). For Stau2, in contrast, a general increase was observed in both monosome and 
polysome fractions (Schieweck & Kiebler, unpublished). Based on these results, it is tempting 
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to speculate that Pum2 is needed for general translational activation, while Stau2 is 
predominately involved in repression of certain targets. 
 
 
Figure 5: Compensatory effects occur upon depletion of RBPs. 
Neuronal protein expression is regulated through a network of different RBPs that share common mRNA targets 
(RBP-mRNA regulation) and that control each other (RBP-RBP regulation). Together, this network of RBPs 
defines translational activity of the transcriptome. Upon depletion of a particular RBP, direct targets lose their 
regulation conveyed by a particular RBP. Instead, some transcripts are increasingly bound by other RBPs within 
the network. Consequently, they bind less well to their own targets (indirect effects). Alterations in the mRNA-
RBP interactome network crucially influence the translatome. Here, some transcripts can compensate changes at 
mRNA steady-state levels through translational buffering. Together, these effects lead to various indirect effects 
in neurons. These indirect effects are a consequence of a shift in the RBP network interactome and regulatome. 
TL: Translation. 
 
For Pum2, this effect seems to be counterintuitive as this RBP has been shown to repress 
translation both in vitro as well as in different cellular contexts (109). The impact of Pum2, 
however, on global translation in neurons has never been experimentally addressed yet. Thus, 
while Pum2 might repress translation of certain transcripts, its effect on global translation might 
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differ. Supportive for this notion is a recent study addressing the impact of the Pumilio 
interactor FMRP (107) on global translation in Drosophila oocytes. FMRP has been identified 
as a translational repressor (147) that inhibits translation elongation on its target mRNAs 
through direct interaction with the ribosome (102, 148, 149). However, in Drosophila oocytes 
FMRP activates global translation. To address this effect, the authors exploited ribosome 
profiling, a method to determine ribosome positions on mRNAs in a transcriptome-wide 
manner (50). Interestingly, FMRP KO preferentially affects longer CDS meaning that larger 
proteins are translationally activated by FMRP (150). Interestingly, proteins downregulated by 
Pum2 knock-down tend to have a shorter polypeptide chain when compared to upregulated 
proteins. In contrast, proteins downregulated in Stau2 deficient neurons tend to have a longer 
polypeptide chain, similar to FMRP (Schieweck & Kiebler, unpublished). Compared to other 
RBPs such as FUS or TDP-43, Stau2 shows a higher binding to the CDS (56). Thus, Stau2 
might – similar to FMRP – regulate translation of long transcripts through binding to the CDS. 
This length bias might represent another regulatory mechanism as it has been described for the 
RBP PCF11 and its impact on intronic polyadenylation of long genes (151). In summary, the 
loss of Pum2 mediated translational repression might turn into a global shutdown of protein 
synthesis as part of a stress response. This might be the reason, why most of the mRNAs coding 
for dysregulated proteins in Pum2 depleted neurons are not bound by Pum2 (see Fig. 3G, in 
Manuscript 2). Interestingly, Stau2 binds most of the mRNAs encoding dysregulated proteins 
indicating that it conveys a more direct regulation of protein expression (Schieweck & Kiebler, 
unpublished). 
Drosophila Staufen activates the translation of oskar mRNA (152) at the posterior pole. A 
similar effect has been reported for Stau1 in an in vitro translation assay (153). Moreover, 
depletion of Stau2 in cortical neurons leads to an upregulation of chaperons that facilitates 
protein folding and thereby enhances protein stability (154). Thus, the higher number of 
upregulated proteins in Stau2 depleted neurons might, therefore, be due to an indirect effect. In 
addition, Stau2 is needed for the localization of a significant number of mRNAs (134). Thus, 
Stau2 knock-down might cause mRNA accumulation in the soma, where they would be then 
translated. This means that mRNA mislocalization might drive protein upregulation in certain 
cellular compartments as it has been shown for Pum2 (111). Future studies are clearly needed 
to unravel the exact mechanism of how Pum2 and Stau2 regulate translation. 
In summary, Pum2 and Stau2 differently impact neuronal protein expression. These results 
indicate that both RBPs might indeed exploit different mechanisms to regulate the neuronal 
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proteome. Even when we do not (yet) understand the underlying mechanisms in detail, it 
appears that Pum2 enhances, whereas Stau2 rather represses global translation. 
 
2.2 Synaptic protein expression is controlled by Pum2 and Stau2 
 
Pioneer studies have shown that Pum2 and Stau2 selectively regulate synaptic transmission 
(123, 130). In this context, loss of Pum2 increases the frequency, while Stau2 deficiency leads 
to a reduction in the amplitude of excitatory postsynaptic currents (EPSCs) indicating that both 
RBPs are indeed involved in the regulation of distinct synaptic pathways or at least distinct 
steps. Moreover, depletion of Pum2 leads to epileptic seizures in adult mice (29, 31). Epilepsy 
is characterized by neuronal hyperexcitability due to an increase in excitation and/or a decrease 
in inhibition. Stau2 deficiency results in learning and memory deficits in mouse and rat models 
(131, 155). Together, these findings strongly point towards a role of Pum2 and Stau2 in 
regulating synaptic homeostasis.  
Therefore, to get further insight into synaptic pathways that are functionally controlled by these 
RBPs, I took advantage of the list of dysregulated proteins found in Pum2 and Stau2 depleted 
neurons to identify synaptic pathways regulated by these RBPs. 
 
2.2.1 Pum2 activates GABAergic protein expression 
 
To get new insight into the Pum2 regulated proteome, I initially performed bioinformatic 
analysis to cluster functionally related proteins. Gene Ontology (GO) analysis of dysregulated 
proteins revealed a strong cluster enrichment for GABAergic synapses (see Fig. 3C, in 
Manuscript 2). Here, in Pum2 depleted neurons Gephyrin (Gphn), Vesicular inhibitory amino 
acid transporter (Vgat, Slc32a1), Sodium- and chloride-dependent GABA transporter 1 (Gat1, 
Slc6a1), Glutamate decarboxylase 1 (Gad1) and Somatostatin (SST) were all found to be 
downregulated (see Fig. 4A, in Manuscript 2 and Fig. 6). These proteins convey different 
aspects of neuronal inhibition. Gphn is an essential scaffolding protein for the postsynaptic 
GABAA receptor (156). Vgat is presynaptically localized and transports GABA into synaptic 
vesicles (157). Gat1 reuptakes GABA into presynaptic terminals to terminate its action, while 
Gad1 synthesizes GABA in inhibitory interneurons (2). Importantly, proteins localized at 
excitatory postsynaptic sites remained unaffected (see Fig. 4B, in Manuscript 2). Interestingly, 
an in vitro binding assay using recombinantly expressed and purified Pum2 revealed that Gphn, 
Gad1 and Slc6a1 but not Slc32a1 are mRNA targets of Pum2 (Schieweck & Kiebler, 
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unpublished). This finding indicates that not all affected proteins are direct Pum2 targets. In 
addition to the altered Gphn and Gad1 protein levels, also the corresponding transcripts showed 
less expression. Slc32a1, SST and Slc6a1 were unaffected at the mRNA level. Pum2 has the 
potential to destabilize its target mRNAs (113, 114). Neither Gphn nor Gad1, however, showed 
altered transcript stability (Schieweck & Kiebler, unpublished). Together, these results suggest 
that Pum2 might have a direct role in transcriptional regulation as well. In line with this idea is 
a study showing that Pum2 is necessary for maintaining genomic stability (158). Even though 
the Pum2 dependent impact on the genome described in this study is indirect, a proximity-
ligation approach, so-called BioID (159), suggests that Pum2 might regulate transcription of its 
target mRNAs as it interacts with components of polymerases and the mRNA processing 
machinery (Schieweck & Kiebler, unpublished). Notably, the binding motifs of some 
components of the cleavage and polyadenylation complex that is required for 3’-end processing 
of nascent transcripts show a remarkable similarity to the Pum2 recognition site. The cleavage 
stimulating factor 64 (CstF-64) recognizes the polyadenylation signal AAUAAA, while the 
cleavage factor I 68 (CF I 68) rather binds the motif UGUA (160, 161). Interestingly, Pum2 
recognizes an eight nucleotide motif located in the 3’-UTR, UGUANAUA (110). Due to the 
sequence similarity, it is plausible that Pum2 might interfere with the cleavage and 
polyadenylation complex to regulate the 3’-UTR length of its target mRNAs. 
 
 
 
In addition to Gphn, Gad1, Gat1 and Vgat, SST was found to be downregulated as well. SST is 
a neuropeptide that has been linked to numerous processes including motor activity, sleep 
regulation and cognitive processes (162). In addition, it is a marker protein for a certain subclass 
of inhibitory interneurons (163). This finding strongly suggests that Pum2 regulates protein 
expression in inhibitory interneurons. Moreover, my data points toward a dual role of this RBP 
in regulating GABAergic transmission at the post- and the presynaptic site. 
Figure 6: Components of GABAergic transmission regulated by 
Pum2. 
Gphn, Vgat, Gat1 and Gad1 are all found to be downregulated in 
Pum2 deficient neurons. These proteins all convey different aspects 
of neuronal inhibition. Gphn (brown hexagons) is an essential 
scaffold protein for the postsynaptic GABAA receptor (blue cigars). 
Vgat, Gat1 and Gad1 are specifically expressed in inhibitory 
interneurons. Gad1 synthesizes GABA, Vgat imports GABA into 
presynaptic vesicles and Gat1 terminates the action of GABA by 
transporting it from the synaptic cleft into presynaptic terminals. 
Somatostatin, a marker for a subtype of inhibitory interneurons, is not 
shown. 
 
27 
 
Importantly, downregulation of Pum2 led to an increase in the protein expression of sodium 
channel subunit beta-3 (Scn3b) and voltage-gated sodium channel type 2 subunit alpha (Nav1.2, 
Scn2a) in rat cortical neurons in culture. In addition, Nav1.2 is also upregulated in the 
hippocampus of Pum2 depleted mouse brains (29). In conclusion, these findings show that 
Pum2 can regulate key components of both neuronal inhibition and excitation. Another protein 
that regulates both excitation and inhibition is the Slit-Robo Rho GTPase 2 (SRGAP2), also 
known as formin-binding protein 2 (164). Strikingly, SRGAP2 protein interacts with Pum2 in 
cortical neurons according to the BioID results (Schieweck & Kiebler, unpublished). SRGAP2 
regulates the number of Gphn positive inhibitory synapses (164). In addition, Gphn mRNA is 
bound by Pum2 (108). Moreover, Gphn is essential for GABAergic transmission (156). 
Therefore, I focused on Gphn to elucidate the impact of Pum2 on its expression. Interestingly, 
Gphn protein levels were unaffected in the soma of Pum2 depleted neurons, but showed a 
significant decrease in dendrites (see Fig. 4D,E, in Manuscript 2). These findings suggest a 
local expression control of Gphn protein. The assembly of synapses partially depends on the 
self-assembly ability of postsynaptic density proteins (165). However, the number of dendritic 
Gphn clusters remained unaffected (Schieweck & Kiebler, unpublished). This finding indicates 
a selective effect of Pum2 on Gphn expression, but not on the assembly of inhibitory synapses. 
Importantly, Gphn is essential for modifying inhibitory currents (166). Therefore, I asked the 
question whether downregulation of Pum2 impacts GABAergic transmission. 
Electrophysiological recordings revealed that the amplitude, but not the frequency of synaptic 
IPSCs is reduced in Pum2-depleted rat cortical neurons (see Fig. 4G,H, in Manuscript 2). The 
amplitude of inhibitory currents is thought to be regulated from the postsynaptic site while the 
frequency is mainly controlled presynaptically. Thus, Pum2 impacts GABAergic transmission 
preferentially from the postsynaptic side. This notion is in line with the finding that the KO of 
Gphn, the postsynaptic scaffold protein (156), leads to a reduction in the amplitude of GABA 
response (167). Moreover, an increased decay time of the GABA response was observed (see 
Fig. 4I, in Manuscript 2). This finding is mirrored by the downregulation of Gat1. Supportive 
for this notion is the finding that Gat1 KO mice show an increased decay time of the GABA 
response. Importantly, the amplitude is unaffected in these mice suggesting that Gphn and Gat1 
regulate GABA response by two functionally independent pathways (168). Together, my results 
suggest a postsynaptic impact on GABAergic transmission via Gphn expression and/or a 
presynaptic effect via Gat1. It has been shown that Pum2 protein is not really expressed in axons 
(111). Thus, it is tempting to speculate that Pum2 impacts GABAergic transmission 
preferentially at the postsynaptic side, most likely through expression control of Gphn. In turn, 
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decrease in Gat1 expression might be a compensatory effect to counterbalance the drop in IPSC 
amplitude. An alternative explanation might be that Pum2 affects SST positive interneurons. 
The observed decrease in SST expression in Pum2 deficient neuronal cultures suggests that the 
number of this class of inhibitory interneurons is reduced. Following this idea, less SST positive 
interneurons would target less pyramidal cells and, in turn, form less inhibitory synapses on 
dendrites. This model would explain the drop in Vgat, Gat1 and Gad1 expression (Fig. 6). 
Moreover, it would also be a plausible explanation for the downregulation of dendritic Gphn, 
since SST positive interneurons target only dendrites of pyramidal cells (163). Supportive for a 
role of Pum2 in inhibitory interneuron signaling is the finding that Pum2 binds Gad1 mRNA in 
vitro (Schieweck & Kiebler, unpublished). Gad1 is a general inhibitory interneuron marker. A 
Pum2 mediated activation of Gad1 expression in interneurons would be a plausible explanation 
for the reduced inhibition of pyramidal cells observed in the hippocampus of Pum2 KD mice 
(29). Future studies are clearly needed to distinguish between these two interesting scenarios. 
Important to note is that these two possibilities are not mutually exclusive, as Pum2 is expressed 
in both pyramidal cells and inhibitory interneurons (45). Hence, Pum2 might play a post- and 
presynaptic role in controlling circuit excitability. 
As discussed above, Gphn is crucial for GABAA receptor clustering (156). To investigate the 
effect of Pum2 depletion on the GABAA receptor, I tested all subunits for their mRNA 
expression in Pum2 depleted brains. Strikingly, the α2 subunit of the GABAA receptor 
(Gabra2) was the only one significantly upregulated at the mRNA level in Pum2 depleted 
brains (see Fig. 1B, in Manuscript 1). Moreover, Gabra2 protein levels were starkly upregulated 
(see Fig. 1D, in Manuscript 1), while the α1 subunit (Gabra1) remained unaffected (Schieweck 
& Kiebler, unpublished). Complementary, cultured cortical Pum2 depleted neurons 
recapitulated these effects (see Fig. 2C,D in Manuscript 1). Furthermore, Gabra2 mRNA was 
found to be enriched in Pum2 granules (see Fig. 1E,F, in Manuscript 1). Supportive for these 
observations is the finding that there are two computationally predicted Pum2 binding sites 
present in the Gabra2 3’-UTR. Gabra2 is known to interact with numerous proteins in brain. 
One of its protein interactors is Ephexin1 (Ngef) (169), a guanine nucleotide exchange factor 
which modulates growth cone collapse in neurons (170, 171). Based on these interesting and 
promising findings, I speculate that Gabra2 might serve as a binding platform for Ephexin1 to 
modulate dendrite outgrowth. In brief, downregulation of Pum2 leads to translationally 
upregulation of Gabra2. Gabra2 protein is subsequently incorporated into the assembled 
GABAA receptor. Through protein-protein interaction, Gabra2 recruits Ephexin-1 that, in turn, 
reduces the number of dendritic growth cones and inhibits dendritic branching of mature 
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neurons. Supportive for this idea is the genetic interaction of Gabra2 and Ngef. Downregulation 
of Gabra2 leads to a drop in Ngef expression (Schieweck & Kiebler, unpublished). In line with 
this idea, double knock-down of Pum2 and Gabra2 rescued the deficits in dendritic complexity 
observed in Pum2 depleted neurons (see Fig. 3A-C, in Manuscript 1). Importantly, dendrites 
receive excitatory or inhibitory inputs from presynaptic neurons (172). Thus, it is tempting to 
speculate that reduced dendritic complexity in Pum2 depleted neurons diminishes synaptic 
input that, in turn, will decrease the frequency of excitatory action potentials. Strikingly and in 
line with my working hypothesis, Pum2 and Gabra2 double knock-down led to a strong increase 
in the number of c-Fos positive neurons, a marker for neuronal activation in epilepsy models 
(28) (see Fig. 4A,B, in Manuscript 1). Together, these results suggest that upregulation of 
Gabra2 serves as a rescue mechanism to balance increased excitability of Pum2 depleted 
neurons. Therefore, I would like to propose the following working model: Pum2 is essential for 
efficient GABAergic transmission as well as for reduction in sodium channel mediated action 
potentials. This regulation is important for neuronal excitability regulation (173). In addition to 
this regulatory hub, a second pathway would have been established during evolution: Gabra2 
mediated reduction in synaptic input that is controlled by Pum2. Hence, loss of Pum2 leads to 
a reduction in GABAergic transmission with a concomitant upregulation of Gabra2 
accompanied by a reduction in synaptic input (see Fig. 4C, in Manuscript 1). In this model, 
Pum2 balances neuronal excitation and inhibition. In addition, it also regulates synaptic input 
and output through Gabra2. Together, these findings suggest that Pum2 balances two important 
determinants of neuronal excitability: excitation through sodium channels and inhibition 
through the GABAergic signaling cascade as well as the ratio between synaptic input and output 
through the complexity of the dendritic tree. In sum, my data provide first molecular and 
mechanistic insight into posttranscriptional regulation of key components of inhibitory 
synapses through a RBP. Moreover, my results show the complex impact of RBPs in balancing 
neuronal activity. 
 
2.2.1.1 Pum2 and the maturation of the GABAergic system 
 
Pum2 has an important role during neuronal development. It has been shown that Pumilio 
proteins are necessary for the survival of neuronal stem cells and that, in particular, Pum2 is 
needed for neuronal specification (107, 108). These findings are of utmost importance to 
understand neurological diseases that require a certain developmental window to manifest 
pathological alterations in synaptic transmission. For epilepsy, this process is called 
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epileptogenesis (174). As discussed above, GABAergic inhibition crucially relies on the 
balanced expression of KCC2 and NKCC1 during development (see also 1.1 Synaptic 
transmission and plasticity). Thus, an imbalance in the KCC2-to-NKCC1 ratio has been 
discussed to be causal for epileptic seizures in adults (175). Supportive for this notion are 
pioneer studies showing that altered expression of KCC2 and NKCC1 is linked with epilepsy 
and Schizophrenia (10, 176). Interestingly, downregulation of Pum2 in developing cortical 
neurons leads to an increased KCC2-to-NKCC1 ratio indicating an accelerated maturation of 
the GABAergic system (Schieweck & Kiebler, unpublished). Importantly, knock-down of 
FMRP leads to a delayed maturation of the GABAergic system (41) indicating that the effect 
of Pum2 on the KCC2-NKCC1 ratio is not a general effect of RBPs. This maturation involves 
the switch from a depolarizing to a hyperpolarizing action of GABA (so-called GABA switch, 
see also 1.1 Synaptic transmission and plasticity). An increased KCC2 expression in newly 
fertilized zebrafish embryos, when endogenous KCC2 is not expressed, perturbs neuronal 
development (177). This effect might also explain the reduction in axon outgrowth in 
developing Pum2 depleted neurons (111). Moreover, a single seizure period in neonatal mice 
induces a higher surface expression of KCC2 (178). This, in turn, leads to a higher Cl- ion 
extrusion, which might compensate the higher neuronal excitability (175). In addition, Pum2 
knock-down in developing neurons also reduces Gphn expression indicating impaired 
GABAergic signaling (Schieweck & Kiebler, unpublished). Based on these findings, it is 
plausible that the increase in KCC2 expression in developing Pum2 deficient neurons represents 
an indirect effect to compensate for deficits in the GABAergic system. Together, it is tempting 
to speculate that the impact of Pum2 on the maturation of GABAergic signaling critically 
contributes to epileptogenesis that would cause seizures in the adult animals. Moreover, this 
effect might also explain deficits observed in Pum2 depleted animals during development (107, 
108). 
 
2.2.1.2 GABA regulates Pum2 expression 
 
Neurotransmitters have the potential to directly regulate gene expression as it has been shown 
for serotonin (11). In this context, RBPs might also be regulated by neurotransmitters to directly 
couple posttranscriptional gene regulation with synaptic activity. For Pum2, it was shown that 
its expression levels are adjusted according to neuronal activity (121). Here, enhanced activity 
increases Pum2 expression, while decreased neuronal activity reduces its protein level (121). 
The exact mechanism of this process, however, is unclear. Since Pum2 is involved in the 
31 
 
regulation of GABAergic signaling, it is tempting to speculate that GABA has the potential to 
control Pum2 expression. Indeed, treatment of cultured cortical neurons with GABA for one 
hour significantly reduced Pum2 expression levels. Interestingly, this effect was not observed 
upon thirty minutes or two hours of treatment suggesting a narrow time window for the 
regulation. In addition, Pum2 mRNA levels were unaffected (Schieweck & Kiebler, 
unpublished). A possible explanation for this drop in protein expression might be that Pum2 is 
cleaved by Calpain proteases. Calpains belong to the family of cytosolic calcium-dependent 
proteases (179). Interestingly, Calpain-1 cleaves Gphn upon calcium influx indicating the 
importance of Calpain proteases for inhibitory synapses (180). Supportive for this model is the 
finding that Calpain-2 was identified as a Pum2 protein interactor in a BioID screening 
(Schieweck & Kiebler, unpublished). Due to the ability of the GABAA receptor to induce 
depolarization in dendrites (4), it is plausible that GABA treatment of cortical neurons would 
lead to depolarization in dendrites. This, in turn, might activate voltage-gated calcium channels 
and lead to calcium influx. Consequently, Calpain-2 would be activated, yielding to Pum2 
cleavage. Even though this model is purely hypothetical, it would provide an elegant feedback 
mechanism to restrict the expression of key components of GABAergic synapses to terminate 
the action of GABA. Supportive for this idea is the finding that the Pum2 target Gad1 exhibits 
reduced mRNA expression upon one hour of GABA treatment, but not upon thirty minutes or 
two hours of incubation, concomitant with the decrease in Pum2 protein expression (Schieweck 
& Kiebler, unpublished). Together, these results indicate that Pum2 is regulated by GABA and 
that this regulation might be a regulatory feedback loop to restrict GABA availability. 
 
2.2.2 Stau2 functionally regulates synaptic organization 
 
Research in the Kiebler lab has shown that Stau2 binds and regulates mRNA coding for proteins 
involved in the mGluR pathway (54). Moreover and particularly important in this context are 
two key signaling pathways involving either serotonin or dopamine receptors, both have been 
previously linked with learning and memory (181, 182). 
GO term analysis of downregulated proteins in Stau2 depleted neurons revealed an enrichment 
for ‘neurotransmitter secretion’ and ‘action potential’ (Schieweck & Kiebler, unpublished). 
One of the proteins essential for neurotransmitter secretion and significantly downregulated in 
Stau2 depleted neurons is Complexin1 (Cplx1). Cplx1 mRNA is bound and regulated by Stau2 
(54). Importantly, Cplx1 is located at presynaptic terminals and regulates neurotransmitter 
release (183), while Stau2 is preferentially postsynaptic (133). These apparently contradictory 
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results suggest that Stau2 might regulate Cplx1 expression in the cell body or control Cplx1 
mRNA localization through retaining the transcript in the soma as shown for Pum2 targets 
(111). However, a recent study has suggested that a fraction of Cplx1 is also located at the 
postsynaptic side, where it might regulate AMPA receptor exocytosis during LTP (184). 
Consequently, this fraction might be under the control of postsynaptic Stau2. 
Moreover, components of the actin cytoskeleton were also significantly downregulated in Stau2 
depleted neurons. This observation is in line with the finding that the actin cytoskeleton network 
is found to be fundamentally reorganized, when Stau2 is depleted in primary hippocampal 
neurons (130). The actin cytoskeleton is a key remodeler of synaptic organization and important 
for synaptic transmission as well as long-term plasticity (185). 
Additionally, a reduction in the AMPA1 receptor (Gria1) was observed. Gria1 is bound by 
Stau2 (56). Importantly, KO of Gria1 in mice leads to alterations in hippocampal space coding 
and synaptic plasticity (186–188). Complementary to these findings, Stau2 depletion caused a 
reduction in the density of excitatory synapses (130). The impact of Stau2 on Cplx1, the actin 
cytoskeleton and Gria1 expression strongly suggests that Stau2 regulates synaptic transmission. 
The reduction of presynaptic vesicle release proteins such as Cplx1 and postsynaptic receptors 
such as Gria1 in Stau2 knock-down neurons suggests an impact on synaptic scaling (137). Here, 
a drop in postsynaptic protein expression would simultaneously downregulate presynaptic 
components as part of a homeostatic feedback loop. Thus, it is plausible that the downscaling 
of synaptic proteins represents a feedback mechanism causing a lower threshold to induce long-
term synaptic changes. Strikingly, such a lower threshold for LTP induction has been observed 
in a Stau2 depleted rat model (131). Importantly, both LTP and LTD are not two isolated 
mechanistic phenomena, but rather two sides of the same coin, which has been taken into 
consideration in the BCM theory (189). Consequently, loss of Stau2 shifts the LTP-to-LTD 
ratio favoring LTP over LTD. This finding suggests that Stau2 controls the balance between 
synaptic strengthening and weakening and promotes synaptic strengthening (131). 
To further elucidate the role of Stau2 in synaptic transmission, I exploited a Stau2 knock-down 
mouse model (155). To test for transcripts that are dysregulated upon learning, Stau2 KD mice 
– as their corresponding control mice –underwent a battery of behavior assays (see also 2.3.2 
Stau2 is necessary for motor learning and novelty response) (155). Transcriptome-wide 
analysis of naïve and trained animals revealed a significant upregulation of the mRNAs coding 
for cerebellin1 (Cbln1) and glutamate receptor ionotropic delta subunit 2 (GluD2 or Grid2) 
upon training (190) (see Fig. 1B-D and Fig. 4, in Publication III). Interestingly, Cbln1 and 
GluD2 are both core components of cerebellar synapses. Thereby, Cbln1 appears to be the 
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bridging molecule that binds postsynaptic GluD2 in Purkinje cells and connects it with 
presynaptic neurexin in granule cells (191). To serve as a bridging molecule, Cbln1 is secreted 
by granule cells (191, 192). This synaptic connection mediated by the interaction between 
GluD2, Cbln1 and neurexin is essential for motor learning and coordination (192). Grid2 is 
bound and regulated by Stau2 (56, 190). Moreover, Stau2 is strongly expressed in Purkinje cells 
(see Fig. 2A, in Publication III) indicating that the primary effect on cerebellar synapse 
organization is mediated via postsynaptic GluD2 rather than presynaptically secreted Cbln1 
(190). Therefore, it is tempting to speculate that Stau2 regulates synaptic transmission from 
granule cells towards Purkinje cells in the cerebellum. 
Together, these results suggest that Stau2 balances both synaptic potentiation (LTP) and 
depression (LTD). These two types of synaptic plasticity are not only essential for learning and 
memory formation in the hippocampus (193), but also in the cerebellum (194). Thus, it is 
tempting to speculate that Stau2 critically contributes to distinct aspects of learning such as 
spatial and motor learning in the mouse brain, again highlighting its importance for memory 
formation in vivo. 
 
2.3 Pum2 and Stau2 are needed for circuit homeostasis and plasticity 
 
The presented proteomics and transcriptomics data together with the electrophysiology 
experiments presented in this PhD thesis strongly argue that Pum2 and Stau2 are needed for 
homeostatic excitability and synaptic plasticity. To test this novel and exciting hypothesis and 
to understand their physiological role in vivo, Pum2 and Stau2 KD mouse lines as well as a 
Stau2-depleted rat line were investigated. 
 
2.3.1 Knock-down of Pum2 causes epileptic seizures 
 
My work has established Pum2 as an essential regulator for GABAergic transmission. In 
addition, it has been shown that it also regulates sodium channel mediated action potentials 
(121). Thus, the impact of Pum2 on neuronal excitation ex vivo might reflect the effect on circuit 
excitability in the brain. Indeed, adult Pum2 knock-down mice exhibit epileptic seizures starting 
between three and five months of age (29, 31). Interestingly, electrophysiological recordings 
reveal that general excitation appears not to be affected in these mice. Pum2 deficient mice, 
however, show reduced paired-pulse inhibition suggestive for impaired GABAergic inhibition 
(see Fig. 3A-I , in Publication I) (29), which is in line with the in vitro results discussed above. 
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Importantly, the effect of Pum2 on neuronal excitability seems to be evolutionary conserved as 
seizures can be prevented through increased Pumilio expression in Drosophila (195). Together, 
these findings clearly state an essential role of Pum2 in seizure control in different experimental 
models. Moreover, a recent study has found that Pum2 is downregulated in patients suffering 
from temporal lobe epilepsy (196). This finding clearly indicates that understanding Pum2 
controlled expression is key for the development of future medical applications towards seizure 
treatment. Of note, epilepsy shows a high comorbidity with autism spectrum disorders (ASD) 
(197). Interestingly, Pum2 targets such as Scn1a, Scn2a, Scn8a and Gphn are known genes 
mutated and/or dysregulated in patients suffering from ASD (SFARI database, 
https://gene.sfari.org). Together, these results suggest that Pum2 has a role in the pathology of 
ASD as well. Of note, other RBPs that are involved in the ASD pathology either interact with 
Pum2, e.g. FMRP (107), or regulate the same target mRNAs, e.g. Rbfox1 (28). Hence, Pum2 
might be an important hub within a common RBP regulatory network (Fig. 5) that crucially 
controls ASD relevant mRNAs. Further studies, however, are clearly needed to unravel the 
precise role of Pum2 in ASD. 
 
2.3.2 Stau2 is necessary for motor learning and novelty response 
 
Recent studies have established that Stau2 is necessary for synapse formation and organization 
(126). Thus, it is tempting to speculate that Stau2 crucially contributes to memory formation. 
Indeed, knock-down of Stau2 in mice leads to impaired spatial detection in a spatial memory 
assay, the so-called Barnes maze (see Fig. 4A-F, in Publication II) (155). A possible molecular 
explanation for this behavior might be the drop in Gria1 expression observed in Stau2 depleted 
neurons. Gria1 is known to be necessary for proper spatial detection (187). Similarly, Stau2 KD 
rats show altered response to spatial memory (131). Moreover, Stau2 knock-down mice show 
impaired novelty response in novel object recognition (NOR) assays (see Fig. 3B,C, in 
Publication II) (155). NOR requires the hippocampus as well as additional brain regions such 
as the cerebral cortex (198, 199). Impaired novelty response indicates altered synaptic 
transmission between different hippocampal areas (155). Indeed, Stau2 KD rats exhibit an 
imbalance between LTP and LTD, thereby favoring LTP. Therefore, it is tempting to speculate 
that increased synaptic potentiation might interfere with novelty recognition and memory 
formation. 
In addition to hippocampus-dependent learning, motor learning depends on coordinated 
synaptic transmission and plasticity. Here, synapses formed between parallel fibers originated 
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from granule cells and Purkinje cells are crucial for motor learning and motor coordination 
(194). Interestingly, Stau2 KD mice show impaired motor coordination when tested on a rotarod 
(see Fig. 3C,D, in Publication III) (190), a motor learning assay (200). Strikingly, Stau2 KD 
mice display a significant improvement in their rotarod performance when compared to WT 
controls upon training (see Fig. 3C,D, in Publication III). This suggests an increase in synaptic 
transmission efficiency. In line with this finding is the observed upregulation of the known 
synaptic organizers GluD2 and Cbln1 (190). Together, these results clearly establish Stau2 as 
critical for synaptic plasticity and a prerequisite for proper memory acquisition. 
 
2.4 The RBP network as key to understand neuropsychiatric and neurological diseases? An 
outlook 
 
Immense effort has been made to identify and characterize key RBPs during the last 20-30 
years. Thanks to these studies, it becomes more and more clear that RBPs act through a complex 
interplay between different RBPs and between RBPs and their target mRNAs: the RBP 
network. In this last section, I focus on this network idea and discuss obvious gaps in the RBP 
field. A special focus will be on the role of RBPs to explain neurological and neuropsychiatric 
diseases. 
 
2.4.1 The RBP network to regulate synaptic homeostasis: what we know and where we go 
 
The findings discussed in this PhD thesis clearly show the potential of RBPs to regulate synaptic 
transmission as well as synaptic plasticity. Future studies are therefore necessary to unravel the 
precise mechanisms how Pum2 and Stau2 control synaptic homeostasis. Special emphasis 
should be put on the interaction between different RBPs such as Rbfox1, FMRP, Stau2 and 
Pum2. RBPs form RNA granules that are distinct in both their contained mRNAs and protein 
interactors (77), indicating a differential impact on mRNA target expression depending on the 
RNA granule identity. For instance, Stau2 and Pum2 bind both to FMRP as well as to each 
other (77, 107). Moreover, RBPs share a significant set of common mRNAs (32) (Schieweck 
et al., Physiol. Rev., under revision, Fig. 3). Based on these results, it is plausible that they can 
partially compensate for each other. Thus, elucidating the underlying RBP regulatory network 
is key for understanding complex regulations of cellular pathways (Figs. 5,7). Therefore, future 
studies should focus on the dynamic interaction between RBPs and their respective target 
mRNAs. To address these important questions, proximity ligation assays (PLA) using biotin 
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ligases to biotinylate both protein and RNA interactors appear as ideal approaches (159, 201–
203). Pilot experiments in this direction yielded a list of high-confidence Pum2 protein 
interactors in cortical neurons (Schieweck & Kiebler, unpublished). Moreover, by exploiting 
the MS2 system to tag specific mRNAs in cells (82) combined with PLA allowed to identify 
the interactome of a single mRNA (25). These assays will clearly give novel insight into the 
dynamics of RBP network regulation. As a complementary approach, genetic studies using 
double or triple knock-down mouse lines will provide valuable information on the RBP 
regulatome. In particular, their ability to compensate each other can be investigated using these 
models. 
 
 
 
Figure 7: RBPs and their potential to balance neuronal excitability. 
The neuronal transcriptome is critically regulated by a network of different RBPs that bind either antagonistically 
or synergistically to their target mRNAs. Under normal conditions, this leads to translational homeostasis, which 
means a balanced supply with newly synthesized proteins according to the physiological demands. By disruption 
of RBP binding and/or regulatory functions, this network will be rearranged. Consequently, expression of a wide 
range of transcripts will be altered. This, in turn, would lead to general translation dysregulation and, in some 
cases, to an imbalance in neuronal activity. 
 
In summary, research during the last twenty years has shown that RBPs have an immense 
regulatory potential. In neurons, they shape the transcriptome and crucially regulate the 
translatome to eventually establish translational homeostasis in the cell. Consequently, they are 
needed for numerous key neuronal pathways such as synaptic transmission and plasticity. 
Importantly, recent findings strongly suggest that it is not a single RBP conveying co- and 
posttranscriptional regulation but the collectivity of RBPs, the “RBPome”, that controls these 
cellular pathways. Therefore, it is of utmost importance to understand the underlying dynamic 
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interactions and how they change during development, in health and disease, as well as upon 
aging (Fig. 7). 
 
2.4.2 RBPs and their therapeutic potential 
 
As discussed above, RBPs are promising targets for the development of new therapeutic 
approaches to treat patients suffering from epilepsy or ASD. Different RBPs such as FMRP, 
Rbfox1, Pum2 and CPEB4 have been linked to neurological and neuropsychiatric diseases (29, 
31, 99, 102, 106, 147). Arguably, one of the best therapeutic strategies to treat multigenic 
diseases is gene therapy. Here, the WT locus of a particular RBP is delivered through a viral 
vector. A prominent example for gene therapy based restoring of RBP expression is 
ZOLGENSMA®, a FDA approved drug (204) to treat spinal muscle atrophy (SMA). SMA is 
caused by mutation in the survival motor neuron 1 (SMN1) gene. SMN1 is a RBP and acts 
preferentially as a chaperone for RNP assembly (205–207). The exact pathomechanism of how 
loss of SMN1 induces neuronal death is still unknown. However, a pioneer study suggested that 
translational misregulation might contribute to the phenotype in presymptomatic mice (208). 
Even though gene therapy for SMA seems to be promising, there are several limitations and 
gaps that need to be addressed for other RBPs in the future. First, RBPs show a certain degree 
of cell type specificity. Although RBPs such as FMRP, Pum2, Stau2 and Rbfox1 are 
ubiquitously expressed in different neuronal cell types (45), their target mRNA expression 
profile is distinct between different neuronal cell types. Moreover, a significant fraction of 
RBPs control translation of their targets. A pioneer study has shown that translational activity 
exhibit a certain degree of cell type specificity meaning that reduction in protein synthesis rate 
affects one cell type over others (209). Thus, expression of an RBP in different cell types might 
differently impact the cellular translatome. Second, except for some splicing factors, it is 
essentially unknown how RBPs are regulated. However, this information is crucial for future 
therapeutic approaches, since RBPs also affect the expression of other RBPs (Fig. 5). To 
overcome this problem, their regulatory pathways need to be identified. Third and in line with 
the aforementioned regulation of RBPs, adjusting the expression levels of these proteins is 
essential for their regulation. Many RBPs tend to aggregate (210). Overexpression might 
promote this effect leading to nonfunctional and toxic protein assemblies. 
In conclusion, these obstacles currently limit the usage of RBPs for gene therapy available to 
date. Future studies are clearly needed to provide sufficient information for the development of 
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new strategies to treat patients. Nevertheless, targeting RBPs seem to be an elegant and effective 
approach to treat multigenic and complex neurological and neuropsychiatric diseases.
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ABSTRACT
Epilepsy is a neurological disease that is caused by abnormal
hypersynchronous activities of neuronal ensembles leading to
recurrent and spontaneous seizures in human patients. Enhanced
neuronal excitability and a high level of synchrony between
neurons seem to trigger these spontaneous seizures. The
molecular mechanisms, however, regarding the development of
neuronal hyperexcitability andmaintenance of epilepsy are still poorly
understood. Here, we show that pumilio RNA-binding family member
2 (Pumilio2; Pum2) plays a role in the regulation of excitability in
hippocampal neurons of weaned and 5-month-old male mice. Almost
complete deficiency of Pum2 in adult Pum2 gene-trap mice (Pum2
GT) causes misregulation of genes involved in neuronal excitability
control. Interestingly, this finding is accompanied by the development
of spontaneous epileptic seizures in Pum2GTmice. Furthermore, we
detect an age-dependent increase in Scn1a (Nav1.1) and Scn8a
(Nav1.6) mRNA levels together with a decrease in Scn2a (Nav1.2)
transcript levels in weaned Pum2 GT that is absent in older mice.
Moreover, field recordings of CA1 pyramidal neurons show a
tendency towards a reduced paired-pulse inhibition after stimulation
of the Schaffer-collateral-commissural pathway in Pum2 GT mice,
indicating a predisposition to the development of spontaneous
seizures at later stages. With the onset of spontaneous seizures at
the age of 5 months, we detect increased protein levels of Nav1.1 and
Nav1.2 as well as decreased protein levels of Nav1.6 in those mice. In
addition, GABA receptor subunit alpha-2 (Gabra2) mRNA levels are
increased in weaned and adult mice. Furthermore, we observe an
enhanced GABRA2 protein level in the dendritic field of the CA1
subregion in the Pum2 GT hippocampus. We conclude that altered
expression levels of known epileptic risk factors such as Nav1.1,
Nav1.2, Nav1.6 and GABRA2 result in enhanced seizure
susceptibility and manifestation of epilepsy in the hippocampus.
Thus, our results argue for a role of Pum2 in epileptogenesis and the
maintenance of epilepsy.
KEY WORDS: RNA-binding protein, Pumilio2, PUM2, Epilepsy,
Epileptogenesis, Risk factor
INTRODUCTION
Epilepsy is one of the most common neurological diseases in
humans. It is characterized by the occurrence of spontaneous
seizures (Pernice et al., 2016). These seizures can be caused by
hyperexcitability of neurons as well as hypersynchronous network
activity. Great effort has been made to identify possible risk factors
responsible for epileptogenesis (Bertram, 2003). Among others,
voltage-gated sodium and potassium channels as well as the
γ-aminobutyric acid receptor A (GABAA)-receptor family have
particularly been linked to epilepsy in animal models and human
patients (Staley, 2015). It remains elusive, however, how those
proteins act together during development and maintenance of
epilepsy in adulthood.
Research in the last decades unraveled that RNA-binding proteins
(RBPs) control the expression of their target RNAs (Jung et al.,
2014). Thereby, they provide another regulation level to guide
remote protein expression. One of the best characterized RBPs is the
fragile-X mental retardation protein (FMRP). Loss of FMRP causes
fragile-X syndrome (Pieretti et al., 1991), a disease that is
hallmarked by mental retardation and the occurrence of seizures
(Darnell and Klann, 2013). Therefore, it has been suggested that
RBPs play an important role in the development and maintenance of
healthy homeostasis in the brain. The RBP pumilio RNA-binding
family member 2 (Pumilio2; Pum2) is a posttranscriptional
regulator whose function is conserved from yeast to human
(Quenault et al., 2011). Pum2 binds an eight-nucleotide
consensus sequence in the 3′-untranslated region (3′-UTR) of its
target mRNAs (White et al., 2001). Thereby, it regulates the
expression of the encoded protein. In addition, Pum2 controls
the expression of the voltage-gated sodium channel (Nav) Nav1.6
and dendrite morphogenesis of dissociated hippocampal neurons
(Driscoll et al., 2013; Vessey et al., 2010), indicating a role in the
regulation of neuronal excitability. Furthermore, Pum2 was reported
to be downregulated in two epilepsy models in Drosophila (Lin
et al., 2017). Moreover, knockdown of Pum2 in mice has been
shown to cause spontaneous epileptic seizures (Siemen et al., 2011).
In the study presented here, we investigated the molecular
mechanisms of Pum2-loss-induced spontaneous epileptic seizures
and present the first evidence of how Pum2 deficiency might cause
late-onset epilepsy in Pum2 gene-trap (Pum2 GT) mice.
Here, we took advantage of a previously published Pum2 GT
mouse model that shows Pum2 deficiency (Siemen et al., 2011).
Male mice that are largely deficient of Pum2 develop spontaneous
epileptic seizures in adulthood, mainly at the age of 5 months. In
order to investigate the underlying mechanism of the development
of spontaneous seizures, we analyzed mRNA levels of ion channels,Received 23 February 2017; Accepted 6 September 2017
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ion transporters and receptors that guide neuronal excitability, and
found these to be dysregulated in the absence of Pum2. In detail, we
observed age-dependent alterations of mRNA and protein levels for
Scn1a (Nav1.1) and Scn8a (Nav1.6) in the brain of weaned and 5-
month-old mice. Strikingly, we detected a twofold upregulation of
γ-aminobutyric acid receptor A (GABA) subunit α2 (Gabra2)
mRNA for both ages tested. Strikingly, electrophysiological
recordings of the Schaffer-collateral-commissural (SCC) pathway
revealed reduced paired-pulse inhibition. Furthermore, we observed
enhanced dendritic localization of the GABRA2 subunit in
hippocampal CA1 neurons. Together, these findings suggest a
role of Pum2 in the development and maintenance of epilepsy in
adulthood that is, inter alia, mediated by altered neuronal inhibition.
RESULTS
Brain-widePum2knockdown leadstomisregulationof genes
associated with epilepsy
To investigate the effect of Pum2 knockdown on epilepsy risk-factor
expression, we took advantage of an existing Pum2 GT mouse
exhibiting reduced Pum2 expression levels (Siemen et al., 2011; Xu
et al., 2007). Quantitative reverse-transcription PCR (qRT-PCR) of
total RNA from brains revealed an 80% reduction of Pum2 mRNA
(Fig. 1A, left) and more than 90% for the corresponding protein
(Fig. 1A, middle, quantification right). Similar results were obtained
for Pum2 protein levels in the hippocampus (Fig. 1B, quantification
right). Immunohistochemistry of coronal hippocampal sections
showed a prominent Pum2 signal in the pyramidal cell layers
(CA3-CA1) and less intense in the granular cell layer [dentate gyrus
(DG)] that was absent in the hippocampus of Pum2 GT mice
(Fig. 1C).
In previous studies, it has been shown that Pum2 mRNA targets
Scn1a and Scn8a mRNAs (Driscoll et al., 2013; Vessey et al.,
2010). In addition, bioinformatic analysis of known epileptic risk
factors revealed a possible Pum2-binding site in the 3′-UTR of
Scn1a and Scn8a mRNAs. These results suggest that Pum2 is
involved in the regulation of voltage-gated sodium-channel
expression and thereby might control neuronal excitability in
mice. To get further insight into the expression levels of target
mRNAs in the absence of Pum2, we performed a transcriptome-
wide microarray analysis in Pum2 GT and wild-type (WT) brains at
the age of 5 months, the time of onset of spontaneous epileptic
seizures in Pum2 GTmice. Strikingly, we found mRNAs coding for
proteins involved in cell communication and synaptic transmission
to be upregulated (Fig. 2A). Among others, our microarray analysis
revealed an altered expression level of transporters for sodium,
potassium and calcium ions (Table S1). Interestingly, we also
observed the translational repressors Nanos2 and Nanos3 to
be upregulated and mRNAs encoding for components of the
eukaryotic initiation factor 3 complex (eIF3) to be downregulated
(Table S1). Strikingly,Gabra2, which has been linked to epilepsy in
Fig. 1. Gene-trap (GT) vector insertion reduces Pum2
expression level in the hippocampus. (A) qRT-PCRof
Pum2 mRNA levels (left) and western blot analysis of
Pum2 protein levels (middle: representativewestern blot;
right: quantification) of WT and Pum2 GT mouse brain
lysates. β-actin (ACTB) was used as loading control (n=3
animals/group). Significance was determined using
unpaired t-test. *P<0.05. (B) Representative western blot
and quantification of Pum2 protein levels in
homogenates obtained from WT and Pum2 GT
hippocampi. β-actin (ACTB) was used as loading control
(n=3 animals/group). Significancewas determined using
unpaired t-test. *P<0.05. (C) Immunohistological
stainings of WT and Pum2 GT hippocampus (coronal
sections). Scale bars: 200 µm. StO, stratum oriens; StP,
stratum pyramidale; StR, stratum radiatum; StLM,
stratum lacunosum-moleculare; DG, dentate gyrus.
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humans (Loddenkemper et al., 2014), was upregulated twofold. For
known Pum2 targets such as Scn1a and Scn8a, we did not detect
changes at the mRNA level in 5-month-old brains. The
transcriptome data described above served as a starting point to
further test expression levels of these well-known epilepsy genes.
Therefore, we performed qRT-PCR for Scn1a and Scn8a, coding
for the voltage-gated sodium channels Nav1.1 and 1.6, as well as for
the epilepsy gene Scn2a, coding for Nav1.2, in brain lysates from
Fig. 2. Epileptogenic factors are misregulated in Pum2 GT mice. (A) Gene ontology (GO) classification of mRNAs identified by microarray analysis that are
upregulated (top) and downregulated (bottom) in Pum2 GT compared to WT mice (n=3 animals/group). FDR, false discovery rate. (B-D) qRT-PCR mRNA
expression analysis for Scn1a (B), Scn2a (C) and Scn8a (D) coding for Nav1.1, Nav1.2 and Nav1.6, respectively, in total brain lysates obtained from weaned
(3-week-old) and 5-month-old Pum2 GT and WT mice (n=6 animals for all groups). Significance was determined using unpaired t-test. *P<0.05, **P<0.01,
***P<0.001.
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weaned and 5-month-old mice. Pum2 GT mice show spontaneous
epileptic seizures at the age of 5 months (Siemen et al., 2011). We
chose this age for mRNA quantification to investigate the onset of
epileptic seizures. In addition, we analyzed mRNA levels of the
above-mentioned targets in weaned animals [postnatal day 21
(P21)] in order to address the effect of Pum2 deficiency on the
development and establishment of neuronal activity during late
brain development (Fig. 2B-D). Interestingly, mRNAs coding for
Nav1.1 and Nav1.6 showed a strong upregulation in weaned Pum2
GT mice compared to WT. We did not observe this effect in
5-month-old animals (Fig. 2B,D). In addition, Scn2a (Nav1.2)
mRNA levels were reduced in weaned Pum2 GT animals and
returned to control values at the age of 5 months (Fig. 2C). Thus, our
results suggest that Scn1a, Scn2a and Scn8a expression is
dynamically regulated during postnatal development in response
to Pum2 knockdown.
Increased paired-pulse ratios in CA1 pyramidal cells of Pum2
GT mice after SCC pathway stimulation
In order to get further insight into the development of spontaneous
seizures in adult (P70-P84; no spontaneous epileptic seizures were
yet observed at this age) Pum2 GT mice, we performed field
recordings in acute hippocampal slices. Evoked population spikes
in CA1 pyramidal neurons were recorded after SCC pathway
stimulation. After correct positioning of the stimulation and
recording electrode (Fig. 3A), we performed an input-output
analysis and analyzed the normalized amplitudes of the
presynaptic fiber volley (FV) as well as of the population spike
(PS) as a function of the stimulation intensity (Fig. 3B,C). The
stimulus-response relation of PS amplitudes in control and Pum2GT
mice were similar, indicating no alterations in the overall network
excitability. This finding was further supported by the fact that we
failed to detect significant differences in the magnitude of the FV or
PS responses (Fig. 3D,E). However, in three out of five slices from
Pum2 GT mice, we did detect a higher probability for multiple
population spikes in response to afferent stimulation. Moreover,
excitability was analyzed by plotting the PS amplitude as a function
of the FV amplitude, and we detected no differences in WT and
Pum2 GT mice (Fig. 3F). Next, in order to measure the ability of
hippocampal interneurons to inhibit subsequent population
responses, we performed paired-pulse stimulations at different
interpulse intervals (IPIs), ranging from 750 ms to 20 ms IPI, at a
stimulation intensity of around 60% (Fig. 3G,H). Paired-pulse ratios
(PPRs) were plotted as a function of the IPI and we found a higher
tendency in Pum2 GT mice for decreased paired-pulse inhibition
compared to control mice, suggestive of reduced network inhibition
(Fig. 3I). We conclude that this reduced network inhibition might be
a cause for the development of spontaneous epileptic seizures.
Altered expression of sodium channels with the onset of
spontaneous seizures
Pum2 is highly expressed in the hippocampus (Allen Brain Atlas:
www.brain-map.org/). The occurrence of epileptic seizures and,
eventually, epilepsy is caused by disturbed excitability mediated,
inter alia, by voltage-gated sodium channels. Within those, Nav1.1,
Nav1.2 and Nav1.6 have been linked to epilepsy in human patients
(Oliva et al., 2012). To test for protein expression levels of Nav1.1,
Nav1.2 and Nav1.6, we performed immunohistochemistry on
coronal brain slices of the dorsal hippocampus (Fig. 4). All Nav
channels tested showed a staining pattern that followed the in situ
hybridization results of the Allen Brain Atlas. In addition, we
observed a clear dendritic localization for Nav1.6 in the CA1
subregion in the WT hippocampus that is reduced in Pum2 GTmice
(Fig. S2A). Strikingly, fluorescent signal quantifications showed
significantly altered protein expressions of Nav channels in the
hippocampus of 5-month-old Pum2 GT mice. Whereas protein
levels of Nav1.1 and Nav1.2 were increased, Nav1.6 protein showed
a reduced staining intensity. However, we did not detect statistically
significant differences in staining intensity for Nav1.1, Nav1.2 and
Nav1.6 in the hippocampus of weaned mice (WT versus Pum2 GT)
(Fig. S1).
Loss of Pum2 impacts GABRA2 expression levels and
localization in CA1 pyramidal neurons
GABAA receptors are chloride ion channels activated by the
neurotransmitter GABA that have been linked to epilepsy
(Loddenkemper et al., 2014). Our transcriptome analysis revealed a
twofold upregulation of Gabra2 levels in adult Pum2 GT mice that
we confirmed by qRT-PCR in weaned and 5-month-old mice
(Fig. 5A). This effect is specific forGabra2 and not a general effect of
GABA receptor expression because γ-aminobutyric acid receptor B
subunit 2 (Gabbr2), a member of the GABAB-receptor family,
remained unaffected (Fig. S2E). To test for alterations in protein
levels, we performed immunohistochemistry on coronal slices of the
dorsal hippocampus with antibodies specific for GABRA2 (Quadrato
et al., 2014). Interestingly, we detected a significantly higher staining
intensity in the dendritic field [stratum radiatum (StR)] of CA1
neurons compared to the pyramidal cell layer [stratum pyramidale
(StP)] in 5-month-old Pum2 GT mice (Fig. 5B; Fig. S2B,C).
Importantly, the expression levels of GABRA2 in pyramidal cells of
the CA3-CA1 subregions and in granule cells in the DG as well as in
the corresponding dendritic fields remained unaffected.
In summary, our expression analysis show that knockdown of
Pum2 affects the expression of Gabra2 age-independently, in
contrast to the tested Nav channels. Furthermore, Pum2 GT mice
show reduced network inhibition. Thus, our results suggest that
neuronal inhibition is mostly affected in Pum2 GT mice.
DISCUSSION
In this study, we investigated the age-dependent expression of
known epileptogenic genes in Pum2-deficient mouse brains. In
order to investigate the effect of Pum2 knockdown on mRNA
levels, we performed a transcriptome-wide microarray analysis.
Strikingly, gene ontology (GO) analysis revealed significantly
enriched categories for genes involved in cell communication and
synaptic transmission – two processes known to be affected in
epilepsy models (Staley, 2015). Furthermore, Pum2 deficiency
resulted in altered expression levels for a subset of genes coding for
proteins involved in neuronal excitability. Among those genes,
using microarray and qRT-PCR experiments, Gabra2 levels were
shown to be upregulated by 100% in weaned and adult Pum2 GT
brains. Interestingly, we also detected altered Scn1a, Scn2a and
Scn8a expression levels in weaned but not in 5-month-old Pum2GT
mice. According to binding-site screening in the 3′-UTR, all four
candidate genes have a Pum2 consensus sequence in their 3′-UTR.
It has been shown that Pum2 recruits the deadenylase complex
CCR4-NOT (Van Etten et al., 2012), which has been linked to RNA
decay (Collart, 2016). Therefore, it is tempting to speculate that the
upregulation in expression levels for Scn1a, Scn8a and Gabra2
might be caused by increased mRNA stability in the absence of
Pum2.
Additionally, it has been shown that Pum2 regulates the
translation of Nav1.6 in dissociated hippocampal neurons
(Driscoll et al., 2013). Therefore, we tested protein expression
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Fig. 3. Field recordingsofacutehippocampal slicesafterSchaffer-collateral-commissural (SCC)pathwaystimulationshow reducedpaired-pulse inhibition
inPum2GTmice. (A) Representative bright-field image of the recording setup: amonopolar or bipolar stimulation electrodewas placed onto theSCCpathwayand the
corresponding population spike was recorded from the pyramidal layer of the CA1 region of the hippocampus. Scale bar: 500 µm. (B) Input-output analysis of evoked
fiber volley (FV) responses in WT (white circles) and Pum2 GT (black circles) mice (n=5 animals/group), represented as the normalized FV amplitude (given as
percentageof themaximal amplitude)asa functionof the relativestimulation intensity (aspercentageof themaximal current intensity).Dataaremeans±s.e.m. (C) Input-
output analysisof evokedpopulation spike (PS) responses inWT (white circles) andPum2GT(black circles)mice. ThenormalizedPSamplitude isplottedasa function
of the relative current intensity (n=5animals/group). (D)Representative singlePS tracesafter stimulationwith the following relative current intensities: 0.3 (light gray), 0.6
(mediumgray),0.8 (darkgray) and1.0 (black) units.Whitecircle:WTmouse;blackcircle:Pum2GTmouse.Arrows indicate thestimulationonset; thestimulationartefact
was removed from the single traces. (E) Overall FV (top) or PS (bottom) amplitudes in WT and Pum2 GT slides (n=5 animals/group). Data are means±s.e.m.
(F)NormalizedPSamplitude isplotted asa functionof thenormalizedpresynapticFVamplitude (n=5animals/group).Dataaremeans±s.e.m. (G,H)Single tracesof PS
in WT mice (G) and Pum2 GT mice (H) after paired-pulse stimulations with different interpulse intervals (IPIs) are overlaid. Black trace: IPI 100 ms; dark gray trace:
IPI 75 ms; medium gray trace: IPI 20 ms; light gray trace: IPI 10 ms. Arrows indicate the onset of stimulation; the stimulation artefact was truncated. (I) Ratio of the
amplitudeof the secondPS (PS2) compared to the first one (PS1) asa functionof the IPI.Theblack solid line indicates thecoefficient of variance (CV) of recordings from
WT mice; the dashed line indicates the CV of PS2:PS1 ratios in Pum2 GT mice. WT, white circles; Pum2 GT, black circles.
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levels for Nav1.1, Nav1.2 and Nav1.6 in the hippocampus.
Interestingly, we observed higher Nav1.1 and Nav1.2 levels in
both the DG and pyramidal cell layer, respectively, but reduced
Nav1.6 levels in the pyramidal cell layer in 5-month-old Pum2 GT
brains. In weaned mice, protein levels are not significantly altered.
We suggest that there are at least two possible explanations for the
differences in mRNA and protein levels for Scn1a, Scn2a and
Scn8a: (i) protein levels for the sodium channels are significantly
changed in weaned mice in extrahippocampal regions such as
forebrain or (ii) other translation repressors, such as Nanos, inhibit
the translation of these sodium channels as a compensatory effect.
For 5-month-old Pum2 GT mice, unaffected RNA levels but altered
protein levels argue for translational regulation.
Next, in order to test for a functional impact of Pum2 knockdown
on neuronal activity, we recorded evoked population spikes in CA1
pyramidal neurons after SCC pathway stimulation. Importantly, a
previous study has shown that Pum2 GT animals show abnormal
discharging in EEG recordings (Siemen et al., 2011). Our results
Fig. 4. Pum2 knockdown affects expression of
Nav channels in different hippocampal areas.
Immunohistological stainings for Nav1.1, Nav1.2 and
Nav1.6 of the hippocampus of 5-month-old WT and
Pum2 GT mice. Boxed areas indicate the magnified
field that is shown. Quantification is shown for dentate
gyrus (DG; Nav1.1) and pyramidal cell layer (Nav1.2,
Nav1.6) (n=3 animals for all groups). Scale bars:
200 µm; insets: 20 µm. Significance was determined
using unpaired t-test. *P<0.05.
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suggest that Pum2 has no impact on overall neuronal activity. CA1
pyramidal neurons do not seem to exhibit a higher excitability level
in Pum2 GT mice compared with WT. This is in line with our
observation that weaned mice show no differences in the protein
expression of Nav1.1, Nav1.2 and Nav1.6. We found that Pum2
knockdown resulted in increased Nav1.1 and Nav1.2 levels in 5-
month-old mice, a finding that could possibly be accompanied by a
higher excitability of principal cells after afferent stimulation. A
likely explanation(s) for the fact that we did not observe increased
excitability in Pum2 GT mice might be that: (i) principal cells as
well as interneurons show a similar increase in Nav protein levels,
therefore maintaining the overall excitation to inhibition ratio;
(ii) Nav protein levels of β-subunits that regulate the gating behavior
of their associated α-subunits are reduced/dysfunctional; or (iii) the
analyzed young adult mice had not yet developed spontaneous
seizures and, therefore, a clear phenotype is not yet detectable. We
suggest that the generation of spontaneous seizures in 5-month-old
Pum2 GT mice is likely due to reduced network inhibition and less
likely due to increased neuronal excitability. This hypothesis is
further supported by the finding that we detected a tendency towards
reduced inhibition after paired-pulse stimulation in Pum2 GT mice
compared to controls. In agreement with this interpretation, it is
known that dysfunctional or loss of GABAergic inhibition can
cause paroxysmal activity and a loss of paired-pulse inhibition
(Kapur et al., 1989a,b; Sloviter and Brisman, 1995).
Loss of paired-pulse inhibition, indicative of reduced GABAergic
inhibition, points towards a reduction of GABRA2 levels. However,
we detected an upregulation of Gabra2 levels in Pum2 GT brains. It
remains to be investigated whether these increased GABRA2 levels
are accompanied by increased expression of functional synaptic
GABAA receptors or whether this effect is specific for certain brain
regions. Moreover, we detected an enhanced dendritic localization
of GABRA2 in CA1 pyramidal neurons of Pum2 GTmice, possibly
due to potentially higher neuronal input from CA3 neurons and/or
the entorhinal cortex (Pettit and Augustine, 2009). Moreover, given
the small volume of the dendritic compartment and thus a higher
probability of a shift of its chloride equilibrium potential towards
more positive values, increased dendritic localization of GABAA
receptors is able to actively contribute to action-potential induction
in CA1 neurons of Pum2 GT mice (Jedlicka et al., 2011; Staley and
Proctor, 1999). Moreover, depolarizing actions of GABA have been
reported in neocortical pyramidal cells of adult mice (Gulledge and
Stuart, 2003). Interestingly, a transition from dominant phasic
GABAergic inhibition to dominant phasic GABAergic excitation
has also been shown in a mouse model of epilepsy (Derchansky
et al., 2008). Another possible explanation for reduced paired-pulse
inhibition despite higher levels of dendritic GABAA receptor
expression could stem from findings showing that the function of
chloride transporters that actively extrude chloride out of the cell can
be impaired in epilepsy (Buchin et al., 2016; Conti et al., 2011;
Doyon et al., 2016). It remains to be investigated whether chloride
transporters, especially the K-Cl cotransporter KCC2, are affected
by Pum2 knockdown.
It is generally believed that voltage-gated sodium channels and
GABAA receptors crucially contribute to the development and
manifestation of epilepsy in human patients and animal models
(Staley, 2015). In our study, we observed altered mRNA levels of
Scn1a, Scn2a and Scn8a in weaned but not in adult mice. Based on
our results, we conclude that brain-wide knockdown of Pum2
causes a predisposition in developing animals to develop epileptic
seizures that might be mediated by altered mRNA levels of known
epileptogenic factors. At this age, we did not observe differences on
the corresponding protein level in the hippocampus. We speculate
that this effect is, preferentially, due to increased translational
repression. During epileptogenesis, mRNAs are released from
repression, which then affects the protein levels in the hippocampus
of adult, 5-month-old animals and leads to manifestation of
spontaneous epileptic seizures (Siemen et al., 2011). In summary,
the aim of the study presented here was to identify, in mice,
epileptogenic risk factors during the development and maintenance
Fig. 5. GABRA2 shows increased mRNA levels and enhanced dendritic
protein localization in the hippocampus of adult Pum2 GT mice.
(A) Gabra2mRNA levels are quantified by qRT-PCR in 3-month-old (weaned)
and 5-month-old WT and Pum2 GT brains (n≥3 animals/group).
(B) Representative staining of GABRA2 in the hippocampus of 5-month-old
WT and Pum2 GT animals, and quantification of GABRA2 protein expression
in the stratum radiatum (StR) compared to stratum pyramidale (StP) in the CA1
area of WT and Pum2 GT mice. Scale bars: 200 µm; insets: 20 µm.
Significance was determined using unpaired t-test. *P<0.05.
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of epilepsy that are known to increase the risk for epilepsy when
misregulated. Together with the fact that Pum2 is downregulated in
postmortem brains of patients who suffered from epileptic seizures
(Wu et al., 2015), we conclude that Pum2 is a key regulator of
epileptogenic risk factors.
MATERIALS AND METHODS
Mice
For all experiments, male mice homozygous for GT-vector insertion
[B6.129P2-Pum2GT(XE772)Byg] in the Pum2 locus (Pum2 GT) and WT
control animals (genetic background forWT and Pum2GTmice: C57Bl6/J)
at the age of P21 (weaned) or 5 months (adult) were investigated. Pum2 GT
mice were a gift from Dr Eugene Xu (Northwestern University, IL, USA).
Mice were kept under specified pathogen-free conditions and housed in
groups of two to five animals in individually ventilated cages and a 12 h/
12 h light/dark cycle. Mice had free access to water and standard rodent
chow. All experiments were approved by the authors’ institutional
committee on animal care and were performed according to the German
Animal Protection Law, conforming to international guidelines on the
ethical use of animals.
Microarray analysis
RNA was isolated as described in qRT-PCR. Samples were processed
according to the manufacturer’s instructions (Affymetrix) and hybridized on
a Mouse Gene 2.0 ST Array. Signal intensities were extracted and
normalized using RMA (R/bioconductor package ‘oligo’). Probesets with
log2-expression levels of >5 in at least three samples were subjected to
differential expression analysis using limma and multiple-testing correction
according to Benjamini and Hochberg (Benjamini and Hochberg, 1995) (R/
bioconductor package ‘limma’). GO analysis was performed using the
STRING database (version 10.0; http://string-db.org). False discovery rate
(FDR) was calculated according to the method of Benjamini and Hochberg
(Benjamini and Hochberg, 1995; Franceschini et al., 2013).
Tissue preparation for fluorescent immunochemistry
For immunohistochemistry, mice were deeply anaesthetized with CO2 and
immediately prepared for tissue preservation. Mice were transcardially
perfused with 1% PBS (pH 7.4) followed by 4% PFA (pH 7; Roti®-
Histofix, Germany) for 12 min (Gage et al., 2012; Kohler et al., 1999).
Brains were carefully removed and post-fixed in 4% PFA (pH 7; Roti®-
Histofix) for 12-72 h at 4°C, then dehydrated in 30% sucrose in ddH2O at
4°C for 24-48 h. Brains were cut into 30-µm coronal sections using a
cryotome. Free-floating coronal brain sections werewashed 3×10 min in 1%
PBS (pH 7.4), blocked in blocking solution [1% (w/v) BSA, 0.5% (v/v)
Triton X-100 in PBS] for 45 min at room temperature (RT; approx. 22°C)
and incubated with primary antibody overnight at 4°C. Antibodies were
diluted separately in blocking solution [polyclonal rabbit anti-Nav1.1, 1:200;
rabbit anti-Nav1.2, 1:200; rabbit anti-Nav1.6, 1:200; rabbit anti-GABRA2,
1:500 (all Alomone Labs, Israel)] and co-stained with chicken anti-NeuN
(1:500; Millipore, Germany) or mouse anti-MAP2 (1:1000; Sigma-Aldrich,
Germany). After overnight incubation, sections were washed 3×10 min in
1% PBS (pH 7.4) and incubated with secondary antibodies in blocking
solution for 2 h at RT. Sections were incubated with donkey anti-rabbit IgG
Alexa Fluor 488 (1:500) and goat anti-chicken IgY Alexa Fluor 647 (1:500)
or donkey anti-mouse IgG Alexa Fluor 647 (1:500; all Life Technologies,
Germany). To counterstain nuclei, sections were incubated with DAPI
(2 µg/ml; Thermo Fisher, Germany) for 5 min at RT andwashed 3×10 min in
1% PBS (pH 7.4). After washing, the sections were mounted with
Fluomount (Sigma-Aldrich). Confocal microscopy was performed with an
inverted Leica SP8 microscope equipped with lasers for 405, 488, 552 and
638 nm excitation. Images were acquired with a 40×1.3 oil objective; image
pixel size was 80 nm. The following fluorescence settings were used for
detection: DAPI: 430-470 nm; AF488: 500-550; AF555: 560-600; AF647:
650-700. Images were scanned in a sequential fashion to avoid bleed-
through. AF488, AF555 and AF647 were recorded with hybrid photo
detectors (HyDs), and DAPI with a conventional photomultiplier tube.
Overview images with high resolution were obtained by stitching.
Acute slice preparation
Mice were deeply anaesthetized with CO2 before decapitation. Brains were
quickly removed and submerged in ice-cold cutting solution consisting of
(in mM) 135 N-methyl-D-glucamine, 1.5 KCl, 1.5 KH2PO4, 23 NaHCO3,
0.5 CaCl2, 3.5 MgCl2, 0.4 ascorbic acid and 25 D-glucose (pH at 28°C: 7.4;
osmolarity: 310-330 mOsm) for 60 s. Coronal slices (slice thickness:
300 µm) were cut on a vibrating microtome (HM 650 V, Thermo Scientific
Microm, Walldorf, Germany). Slices were collected and submerged in
artificial cerebrospinal fluid (ASCF) containing (in mM): NaCl (125), KCl
(3), NaH2PO4 (1.25), NaHCO3 (25), CaCl2 (2), MgCl2 (2) and D-glucose
(25), and left to recover for 1 h at 28°C and for another 1 h at RT. Both
solutions were continuously perfused with 95% O2/5% CO2 to maintain a
pH of 7.4. For electrophysiological analysis, slices were transferred to a
recording chamber mounted on the stage of a microscope (Zeiss Axioskop
FS with a 40×, 0.75 NA objective). The recording chamber was
continuously perfused with artificial cerebrospinal fluid (ACSF). The
recording temperaturewas maintained at 30°Cwith the help of a temperature
controller (Automatic Temperature Controller TC-324B, Warner Instrument
Corp., CT, USA).
Electrophysiological field recordings
The CA1 pyramidal cell layer was visualized and identified by means of an
upright microscope equipped with differential interference contrast (DIC)-
infrared optics. Infrared images were acquired with the help of a CCD
camera and controller (Orca-ER, Hamamatsu, Shizouka, Japan). The
electrodes for field recordings were fabricated from borosilicate glass
capillaries (OD: 1.5 mm, ID: 0.86 mm; Hugo Sachs Elektronik-Harvard
Apparatus, March-Hugstetten, Germany) and were filled with 1 mM NaCl
solution. The electrodes were connected to the headstage of the amplifier
(ELC; npi electronic, Tamm, Germany) via a chlorided silver wire. A silver/
silver chloride pellet immersed into the recording solution served as
reference electrode.
Electrode capacitance and resistance were compensated and bias and
offset current were zeroed before the start of recordings. Evoked population
spikes were recorded from CA1 pyramidal neurons after placing a
monopolar or bipolar stimulation electrode in the SCC pathway. The
stimulation intensity was increased in a stepwise fashion to obtain the
optimal stimulation intensity (∼60% of the maximal response).
Data acquisition and analysis
Recorded voltage signals were amplified (×20), filtered at 10 kHz and
digitized at a sampling rate of 5 kHz. Data acquisition and generation of
command pulses was accomplished by means of an analog-digital converter
(CED Power1401; Cambridge Electronic Design, Cambridge, UK) in
conjunction with the Signal data-acquisition software (version 6; Cambridge
Electronic Design). Data analysis was performed using IGOR Pro 6
(WaveMetrics, Lake Oswego, OR, USA) together with the NeuroMatic
IGOR plugin (www.neuromatic.thinkrandom.com).
Image analysis
Images of coronal hippocampal slices were analyzed with Fiji 1.50 g
(Schindelin et al., 2015). Regions of interest were selected and quantified
as mean pixel intensity. To identify the StP (CA1-CA3), NeuN images
were thresholded using the mean gray value autothreshold after
median filtering of the image (radius 15). For DG, mean pixel intensity of
cell bodies in the stratum granulare (StG) were measured. For GABRA2,
signal was measured in CA1 (StP) for cell bodies and in StR CA1 for the
dendritic field. The inverse mask of the pyramidal cell layer was used to
quantify signal intensity in the dendritic compartment. All values were
normalized to WT. Intensities were measured on the original, non-filtered
images.
qRT-PCR
Total mRNA was obtained from brain samples using TRIzol (Ambion)
according to the manufacturer’s protocol. DNA was depleted using the
Mini RNeasy kit (Qiagen, Germany). cDNA was synthesized from
purified mRNA by reverse transcription using Superscript III reverse
transcriptase (Invitrogen) and random primers according to the
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manufacturer’s manual. For qPCR cDNA amplification, Hot Start Taq
(New England Biolabs, MA, USA) was used with SYBR Green for
amplicon detection. All primers were used with an optimal efficiency rate of
2.0±0.5. Target gene signal was normalized to Ppia as reference gene using
the comparative ΔΔCT method (Schmittgen and Livak, 2008).
Normalization to 18S gave similar results. Runs were performed on a
Lightcycler 96 (Roche Bioanalytics, Germany). Primers used in this
study were (5′ to 3′): Scn1a, GAATCCCAAGCCAGACAAA and
ACCATCTCTGGAGGAATGT; Scn2a, ACAGGAATTTATACTTTTGA-
ATCA and AGTATCATGACGTCAGACAG; Scn8a, CTTCAGTGTCAT-
CATGATGG and GCCCACGATTGTCTTCA; Gabra2, GAAAGGCTC-
CGTCATGATAC and GCTTGTTCTCTGGCTTCTT; Gabbr2, CTACG-
ACGGTCTTACTCTCA and GGCCTCTCTCCTTTGTCTA; Pum2, AG-
CAACCAAGCACTAACC and CCAGGTCCATGAGAGAATAAAG;
Ppia, GTCAACCCCACCGTGTTCTT and CTGCTGTCTTTGGAACTT-
TG; and 18S, GAAACTGCGAATGGCTCATTAAA and CCACAGTT-
ATCCAAGTAGGAGAGGA.
Western blot
To analyze protein expression in Pum2 GT mice, brains were homogenized
in RIPA buffer [150 mM NaCl, 1.0 vol% NP-40, 0.5% (w/v) sodium
deoxycholate, 0.1% (w/v) SDS, 50 mMTris-HCl pH 8.0, complete protease
inhibitor (Roche)]. Proteins were transferred to a nitrocellulose membrane
(pore size 0.2 µm). Membrane was blocked in blocking buffer [2% (w/v)
BSA, 0.1% (v/v) Tween 20, 0.1% (w/v) sodium azide in 1× TBS pH 7.5] for
1 h. Pum2 was detected by incubation with polyclonal rabbit anti-Pum2
antibody (1:10,000; Abcam, Cambridge, UK) in blocking buffer. Protein
bands for β-actin served as loading control and were detected with mouse
anti-β-actin (anti-ACTB) antibody (1:2000; Sigma Aldrich). Proteins were
visualized by incubation of the nitrocellulose membranes with secondary
anti-rabbit antibody (1:10,000; Li-Cor, Germany) in blocking buffer. For
quantification, the Pum2 signal was normalized to the loading control.
Quantification of optical density (OD) was performed using Image Studio
Lite Software (Li-Cor).
Statistics
Data are presented as means±s.e.m. Statistics were calculated using the
software GraphPad Prism (version 5; GraphPad, San Diego, CA, USA).
Unpaired two-tailed Student’s t-test was used to determine P-values. P<0.05
was considered statistically significant if not stated otherwise.
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A B S T R A C T
Staufen2 (Stau2) is a double-stranded RNA-binding protein (RBP) involved in posttranscriptional gene expres-
sion control in neurons. In flies, staufen contributes to learning and long-term memory formation. To study the
impact of mammalian Stau2 on behavior, we generated a novel gene-trap mouse model that yields significant
constitutive downregulation of Stau2 (Stau2GT). In order to investigate the effect of Stau2 downregulation on
hippocampus-dependent behavior, we performed a battery of behavioral assays, i.e. open field, novel object
recognition/location (NOR/L) and Barnes maze. Stau2GT mice displayed reduced locomotor activity in the open
field and altered novelty preference in the NOR and NOL paradigms. Adult Stau2GT male mice failed to dis-
criminate between familiar and newly introduced objects but showed enhanced spatial novelty detection.
Additionally, we observed deficits in discriminating different spatial contexts in a Barnes maze assay. Together,
our data suggest that Stau2 contributes to novelty preference and explorative behavior that is a driver for proper
spatial learning in mice.
1. Introduction
Plasticity of neuronal circuits is the key for learning and memory
formation and its maintenance (Kandel, Dudai, & Mayford, 2014).
Consequently, any dysfunction in these networks may cause neurolo-
gical disorders (Paoletti, Bellone, & Zhou, 2013). Two distinct me-
chanisms critically enable neurons to alter the long-term efficacy of
individual synapses within neural networks: the activation of gene
transcription in the nucleus and the experience dependent synthesis of
key proteins at selected synapses (Doyle & Kiebler, 2011; Govindarajan,
Kelleher, & Tonegawa, 2006). To allow for the latter in the postsynaptic
compartment, selected mRNAs become localized into dendrites, near
synapses (Holt & Bullock, 2009). This is achieved by a set of RNA-
binding proteins (RBPs) that recognize and bind to cis-elements pre-
ferentially within the 3′-untranslated region (3′-UTR) of target mRNAs
(Nakielny, Fischer, Michael, & Dreyfuss, 1997) allowing the assembly of
ribonucleoprotein particles (RNPs). With the help of molecular motor
proteins, these RNPs are then transported along the neuronal cytoske-
leton towards synapses. Upon synaptic activation RBPs then critically
contribute to regulate local translation of localized mRNAs (Jung,
Gkogkas, Sonenberg, & Holt, 2014; Kiebler & Bassell, 2006). Im-
portantly, RBPs also contribute to posttranscriptional control of protein
expression in the cell body (Hutten, Sharangdhar, & Kiebler, 2014; Jung
et al., 2014). One of the best studied examples of RBPs which mediate
the posttranscriptional expression control is the fragile X mental re-
tardation protein (FMRP). Its loss-of-function or knock-out are asso-
ciated with increased metabotropic glutamate receptor signaling, which
has been hypothesized to contribute to the intellectual disability and
mental illness associated with its mutation in human patients (Antar,
Afroz, Dictenberg, Carroll, & Bassell, 2004; Bear, Huber, & Warren,
2004; Darnell & Klann, 2013), highlighting the importance of RBPs for
memory formation and maintenance.
Staufen2 (Stau2) is a known multifunctional RBP involved in var-
ious aspects of posttranscriptional control of protein expression in dif-
ferent neuronal cell types (Heraud-Farlow & Kiebler, 2014). In neuronal
progenitor cells, Stau2 is important for cortical neurogenesis through
the asymmetric segregation of its target mRNAs during neurogenic
progenitor cell divisions (Kusek et al., 2012; Vessey et al., 2012). In
mature neurons, it contributes to dendritic mRNA localization depen-
dent on synaptic signaling (Sharangdhar et al., 2017). Isolation of
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Stau2-containing RNA granules from rat brain revealed an enrichment
of transcripts that are involved in synaptic transmission and function
(Heraud-Farlow et al., 2013). Furthermore, the presence of a series of
translational regulators in these granules suggested that transported
transcripts are translationally repressed in these neuronal RNPs
(Fritzsche et al., 2013). In line with these findings, Stau2 is required for
dendritic spine morphogenesis (Goetze et al., 2006; Berger et al., 2017)
and the establishment of miniature excitatory postsynaptic currents in
cultured hippocampal neurons (Goetze et al., 2006). In addition,
weakening of synaptic connections, a process called long-term depres-
sion (LTD), has been indicated to be regulated by Stau2 in organotypic
slices in vitro (Lebeau et al., 2011). Moreover, LTD is impaired and long-
term potentiation (LTP) is enhanced in Stau2 deficient rats (Berger
et al., 2017). Together, these studies strongly suggest that Stau2 criti-
cally contributes to synaptic morphogenesis and function. However, the
impact of Stau2 on hippocampus dependent learning and memory
formation on the organismic level is not well understood.
Here, we have generated a novel gene-trap mouse model showing a
Stau2 deficiency of approx. 40% and investigated hippocampus-de-
pendent behavior such as novelty response and spatial learning in these
mice. A battery of different behavioral tests such as open field, novel
object recognition/location and the Barnes maze assay revealed that
Stau2 deficiency significantly impacted novelty preference and reduced
performance in a spatial learning assay.
2. Materials and Methods
2.1. Generation and housing of Stau2GT mice
All experiments were approved by the authors' institutional com-
mittees on animal care and were performed according to the American
and German Animal Protection Laws, conforming to international
guidelines on the ethical use of animals. Stau2GT mice (B6.129P2-
Stau2GT(RRG396)Byg) were generated from a gene-trap cell line purchased
from the gene-trapping resource BayGenomics (Stryke et al., 2003). The
gene-trap cassette inserted in Stau2, intron 7 of transcript EN-
SMUST00000027052.12 predicted to result in a C-terminally truncated
Stau2 protein. ES cells were injected into blastocysts and transferred
into pseudo-pregnant recipients to generate chimeric male mice.
Germline transmission was assessed by breeding chimeric male mice
with wildtype (WT) females. Animals were mated with C57BL/6NTac
mice (Taconic Biosciences) before initiating a backcross to C57BL/6J
(The Jackson Laboratory) for at least 5 generations. Genetic back-
ground characterization of Stau2GT mice using a panel of 1450 single
nucleotide polymorphisms (SNPs) across inbred strains (Taconic Bios-
ciences) revealed animals to be congenic ranging from 99.2% to 99.5%
of the C57BL/6J genome. Mixed and non-C57BL/6 genomes remain
only on chromosome 1, near the Stau2 locus, and on SNPs known to
differentiate between C57BL/6N and C57BL/6J. To differentiate
homozygous vs heterozygous animals, Stau2GT mice were genotyped
via two separate PCR reactions using primers that span from the in-
tronic DNA into the integrated gene-trap sequence as follows: WT allele
Stau2-F: 5′-ACAGTGTCCACTGAAAGCTGGT-3′ and Stau2-R 5′-TGGGT
CCGCTGTTCCCAGTTATTT-3′(400 bp product); Gene-trap allele Stau2-
F (as above) and Stau2GTVect-R: 5′-TCCAACCTCCGCAAACTCCTAT-3′
(210 bp product).
2.2. Behavioral analysis
For behavioral tests, we used mature adult males (4 months old).
For behavioral tests of younger mice carried out in Albany, please refer
to Supplementary Material. Stau2GT mice were tested for homozygous
gene-trap vector insertion in Stau2 loci before doing behavioral tests.
Mice were housed under specific pathogen free conditions in groups of
2–5 animals of the same sex, if not stated otherwise, with a 12-hour
light, 12-hour dark light cycle and they had free access to water and
Fig. 1. Gene-trap vector insertion reduces Stau2 expression level in mouse brains. (A)
Scheme of the WT Stau2 and the resulting Stau2-β-galactosidase fusion protein upon
gene-trap vector insertion in the Stau2 gene locus. (B) Stau2 mRNA levels in WT and
Stau2GT mouse brains (n= 6 animals/group). Significance was determined using the
Mann-Whitney U-Test. Mean+SEM. ***p < 0.001. (C) Representative Western blot of
Stau2 protein in adult WT and Stau2GT brain lysates. Vinculin was used as loading control
(n= 3 animals/group). (D) Detection of the β-galactosidase activity encoded by the LacZ
gene of the gene-trap vector (left). HE staining of Stau2GT hippocampus (right). Sub:
subiculum, DG: dentate gyrus. Scale bar: 200 µm. (E) Immunohistochemistry of Stau2
protein in the hippocampus of WT (left) and Stau2GT (right) brains. Scale bar: 200 µm. (F)
Magnification of β-galactosidase activity (left) and HE (right) stained slices of the CA1
region. Scale bar: 50 µm.
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food.
Between individual testing phases (see time line in Fig. 2A, 3A and
4A), animals were kept in their familiar housing cages. All mice un-
derwent a standardized four-weeks behavior training starting at the age
of 16 weeks. AnyMaze Software (Stoelting Co., USA) and automated
activity monitors were used to track the locomotor activity of mice and
to analyze the data, if not stated otherwise.
Open field (OF): The first week of behavioral testing of 4-month
Stau2GT mice started with the OF. For habituation, mice were placed in
the center of the 80 x 40 cm OF box and were allowed to freely in-
vestigate the testing environment for 4min. With a 24-hour delay
(second day), mice were re-tested in the OF for 4min. Locomotor ac-
tivity was investigated using AnyMaze Software (Stoelting Co., USA).
Novel object recognition/location assays (NOR/NOL): In the second
week of testing, adult Stau2GT mice, NOR/NOL tests were performed in
the already familiar open field environment (Leger et al., 2013). Testing
Fig. 2. Adult Stau2GT mice are less active in the open field test. (A) Time line for open field tests of adult mice (left) and representative track blots for WT and Stau2GT animals during
habituation and test phases (right). (B and C) Quantification of total distance traveled (B, left), mean speed (B, right), time mobile (C, left) and number of mobile episodes defined as
number of transitions from immobile to mobile (C, right) between the two test groups during the habituation and test phase. N numbers are depicted. Significance for all tests was
determined using the Wilcoxon rank test for repeated measures or the Mann-Whitney U-Test. Mean+ SEM. *p < 0.05, ***p < 0.001, ns= not significant.
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consisted of habituation and familiarization trials on the first two
consecutive days with a 24 h delay, a NOL assay on day three and NOR
assay on day four (Vogel-Ciernia & Wood, 2014). As described pre-
viously, mice were placed in the center of the OF box and were allowed
to investigate the objects for 4min for each trial. During habituation/
familiarization trials, two identical objects (identical in size, shape and
color) were placed in the same location of the OF box (Fig. 3A, right
panel). For NOR, one of the objects was replaced by a novel one dif-
fering in size, shape and color in the same location. NOL was performed
on day four with one novel object and one familiar object in the op-
posite corner of the OF box (Fig. 3A, right panel). Based on the total
time spent with the familiar and novel object, the discrimination index
(DI) was calculated (Antunes & Biala, 2012). For habituation/famil-
iarization, a discrimination index was calculated comparing the left to
the right object, respectively.
Barnes maze: Behavioral experiments were performed as previously
described (Barnes, 1979) using the Barnes maze platform adapted to
mice. Stau2GT mice were placed in the center of the platform (starting
point) for a total test duration of 4min. The Barnes maze platform
(Stoelting Europe, Ireland) consists of a circular surface (diameter
91 cm) with 20 circular holes (diameter 5 cm) around its circumference.
The table surface is brightly lit by overhead lightning (900 lx), under
one hole is a “flight box” (diameter 5 cm, depth 6 cm, length of the
flight box: 15 cm). For each trial, mice had 240 s to find the target zone
and hide in the flight box (Fig. 4B). Recording was stopped either when
the mouse entered the flight box or automatically after 240 s. One week
before testing, mice were trained in 2 trials per day on 4 consecutive
days. The test set up was not changed along the training and test phase.
No extra maze cues were used, and all surfaces were carefully cleaned
with water after each individual.
2.3. Histology
Whole animal perfusion fixation was performed as described pre-
viously (Calzolari et al., 2015). In brief, mice were deeply anaesthetized
with CO2 and intracardially perfused with PBS followed by 4% PFA (pH
7, Roti®-Histofix, Carl Roth, Germany) in PBS (Gage, Kipke, & Shain,
2012; Kohler, Meier, Busato, Neiger-Aeschbacher, & Schatzmann,
1999). Dissected brains were dehydrated in increasing ethanol gradient
(50–100% steps) and embedded in paraffin. Sections (approx. 5 µm
thickness) were cut on a Reichert Jung Microtome (Leica, Germany).
Subsequently, sections were mounted on glass slides (Wenzel,
Fig. 3. Downregulation of Stau2 impairs novelty detection in adult male mice. (A) Time line for novel object recognition and location (NOR/L) (left). Scheme for NOR/L test setup with a
24 h delay between individual test phases (right). (B and C) The discrimination indexes for NOR (left) and NOL (right) were calculated with the indicted formula for the first 30 s for each
test condition (B) as well as for the entire test phase of 4min (C) as depicted. N numbers are depicted. Significance was determined using the Mann-Whitney U-Test. Mean+SEM.
*p < 0.05, **p < 0.01, ns= not significant.
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Germany), deparaffinized in decreasing ethanol gradient (100–50%
steps) and rehydrated, stained with hematoxylin, eosin (Sigma-Aldrich,
Germany) and mounted with Histomount (Roth, Germany). Pictures
were taken with a Leica DM2500 microscope equipped with a
DMC2900 CMOS camera (Leica, Germany). Images were processed as
previously described (Follwaczny et al., 2017).
Immunohistochemistry: After FA perfusion, dissected brains were
post-fixed in 4% PFA in PBS for 12–72 h at 4 °C, then cryoprotected in
30% sucrose in ddH2O for at least 48–72 h at 4 °C and then embedded in
Tissue Tek OCT (Sakura/ Science Services). Brains were cut in 30 µm
coronal sections on a Leica cryotome and immunostained as described
previously (Calzolari et al., 2015). In brief, slices were washed three
times in PBS, blocked in blocking solution (1% (w/v) BSA, 0.5% (v/v)
Triton X-100 in PBS) for 45min at room temperature (RT) and in-
cubated with primary antibody in blocking solution overnight at 4 °C.
Selfmade polyclonal rabbit anti-Stau2 antibody (Heraud-Farlow et al.,
2013) was diluted 1:200. Sections were washed three times in PBS and
incubated for 2 h at RT with secondary donkey anti-rabbit IgG antibody
conjugated with Alexa Fluor 488 (Life Technologies, Germany) diluted
1:500 in blocking solution. Nuclei were counterstained by 5min in-
cubation in 4′,6-diamidino-2-phenylindole (DAPI, Carl Roth, Germany)
solution. Slices were washed 3 times in PBS and mounted in Fluomount
(Sigma-Aldrich). Confocal microscopy was performed with an inverted
Leica SP8 microscope (Leica).
LacZ-staining: To monitor gene-trap cassette insertion, we detected
LacZ expression by determining the encoded β-galactosidase activity in
slices of Stau2GT mouse brains according to the manufacturers’ manual
(LacZ tissue staining kit from Invivogen, Germany). In brief, brains of
PBS perfused animals were carefully removed and stored in cold PBS
(4–5 h). Brains were cut with a cryotome in 30 µm sagittal sections and
fixed in 2% glutaraldehyde (Sigma-Aldrich). Samples were washed in
PBS and stained with staining solution at 37 °C followed by rinsing in
PBS. Pictures were taken with a Leica DM2500 microscope equipped
with a DMC2900 CMOS camera (Leica).
2.4. Expression analysis
qRT-PCR: RNA was isolated from whole brain samples according to
the manufacturers manual using TRIzol (Ambion, Germany). DNA was
depleted with the Mini RNeasy kit (Qiagen). For cDNA synthesis from
1 µg RNA Superscript III reverse transcriptase (Invitrogen) was used.
For qPCR, HotStart polymerase (New England Biolabs, MA, USA) for
cDNA amplification and SYBR-green for detection were used. Target
gene signal was normalized to PPIA or 18S, respectively, as reference
Fig. 4. Stau2 downregulation impacts long-term memory. (A) For long-term memory formation, adult WT and Stau2GT mice were tested for 4 consecutive days with a 24 h delay. (B)
Scheme for Barnes maze behavior testing. Mice were located in the “start” arena and had to find a target zone and enter a flight box located below one of the 20 holes. (C) Occupancy blots
of WT and Stau2GT mice (all individual blots merged) represented as heat maps. (D) Kaplan-Meier curves for WT and Stau2GT mice for successful entry in the target zone (left) and
subsequently in the flight box (right) are depicted. P-values were calculated using log-rank test. (E and F) Mean speed (E) and time in target zone (F) for WT and Stau2GT mice. N numbers
are depicted. P-values for repeated observations on day 1 to 4 (WT vs. Stau2GT) were calculated using Friedman‘s test followed by Dunn‘s multiple comparison. Mean+SEM. ns=not
significant.
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genes. Sets of primers used for qRT-PCR: Stau2 F: 5′-AGTTGCGACTG
GAACAGGAC-3′ R: 5′-TGGACCACTCCATCCTTTGT-3′; PPIA F: 5′-GTC
AACCCCACCGTGTTCTT-3′ R: 5′-CTGCTGTCTTTGGAACTTTG-3′; 18S
F: 5′-GAAACTGCGAATGGCTCATTAAA-3′ R: 5′-CCACAGTTATCCAAGT
AGGAGAGGA-3′
Western blot: To analyze expression levels of Stau2, brains were
homogenized in RIPA buffer (150mM NaCl, 1.0 vol% NP-40, 0.5% (w/
v) sodium deoxycholate, 0.1% (w/v) SDS, 50mM Tris-HCl pH 8.0,
complete protease inhibitor from Roche, Germany). Samples were
electrophoresed using 10% SDS-PAGE. For blotting, nitrocellulose (pore
size 0.2 µm) membrane was used. Polyclonal rabbit anti-Stau2
(Fritzsche et al., 2013; Heraud-Farlow et al., 2013) and polyclonal anti-
Vinculin antibody (Santa Cruz, USA). Secondary anti-rabbit antibodies
(IRDye CW 800, LICOR, Germany) were used accordingly. Vinculin
served as loading control.
2.5. Statistics
All data were first tested for Gaussian distribution. Normally dis-
tributed data were either analyzed by Student’s t-test while data not
showing a Gaussian distribution were analyzed by Mann-Whitney U
Test or Wilcoxon rank test for repeated measures. For multiple com-
parisons of paired observations, Friedman’s test followed by Dunn’s
multiple comparison was applied. Grubbs’ test (GraphPad, San Diego,
CA, USA) was used to determine outliers.
Significant differences between WT and Stau2GT mice in Kaplan-
Meier curves were calculated by using log-rank test. Data are presented
as means + or± SEM. Statistics were calculated using the software
GraphPad Prism (Version 5, GraphPad, San Diego, CA, USA) or
Statview 5.0 (SAS Institute Inc., Cary, NC). p < 0.05 was considered
statistically significant.
3. Results
3.1. Stau2 protein expression is reduced in the hippocampus of Stau2GT
mice
To reduce normal Stau2 protein expression levels in an unbiased
manner, we exploited the gene-trap vector technology (Gossler, Joyner,
Rossant, & Skarnes, 1989). The murine Staufen2 gene was disrupted by
inserting a gene-trap construct into the intronic region 7 yielding a C-
terminally truncated Stau2 protein that lacks the RNA-binding domains
4 and 5 as well as the tubulin-binding domain (see Materials and
Methods and Fig. 1A). Examining whole brains of adult Stau2GT mice
(homozygous for the GT insertion), full-length Stau2 mRNA levels were
reduced by 50% (Fig. 1B). The corresponding protein level of all iso-
forms showed a reduction by 40% compared to WT animals (Fig. 1C).
Importantly, we did not detect the Stau2-βGal fusion protein on Wes-
tern Blots from brain lysates of Stau2GT mice (Fig. S1A) suggesting that
the resulting fusion protein was not accumulated in the brains. How-
ever, we were able to detect β-galactosidase activity in Stau2GT brain
slices (Fig. 1D, left panel).
The reduced immunoreactivity of Stau2 in the hippocampus of
Stau2GT mice (Fig. 1E) paralleled the staining pattern of β-galactosidase
encoded by the gene-trap cassette in the pyramidal (CA3-CA1) and
granular (DG) cell layers of the hippocampus (Fig. 1D, left). The gene-
trap vector was also expressed in thalamic and cortical brain regions
(Fig. S1B and C). Thus, the homozygous insertion of the gene-trap
cassette into the endogenous Stau2 locus significantly reduced Stau2
expression level in the brain. Importantly, reduction of Stau2 expres-
sion did not yield any obvious morphological abnormalities in the adult
Stau2GT hippocampus (Fig. 1D,F), thalamus or cortex (Fig. S1B and C).
In addition, we failed to detect differences in expression of the gluta-
mate receptor 1 (GluR1) and neuronal nitric oxide synthase (nNOS) in
the amygdala of Stau2GT brains which are misregulated in animals
suffering from neurodevelopmental disorders (Fig. S1D and E).
3.2. Adult Stau2GT males display reduced activity in the open field
Next, we performed the OF tests with 4-month-old WT and Stau2GT
mice (Fig. 2A, left panel). Although they did not show a difference in
distance traveled during the test phase (Fig. 2A, right panel, B left
panel), Stau2 males showed a reduction in distance traveled during the
habituation phase (Fig. 2B left panel). In contrast, younger Stau2 males
showed increased locomotor activity in the open field relative to WT
mice (Fig. S2A), while their anxiety-like behavior in the elevated zero
maze and social behavior in the three-chamber social preference test
were unaffected (Fig. S2B and C). Interestingly, mature adult Stau2GT
males displayed a significant reduction in mean speed in comparison to
WT mice during the test phase (Fig. 2B, right panel) while time mobile
was unaffected (Fig. 2C, left panel). Furthermore, a significant increase
in the number of mobile episodes was observed indicating that vigi-
lance was not affected (Fig. 2C, right panel). In addition, we detected
enhanced nesting skills of mature adult Stau2GT males ruling out pos-
sible deficits in motor activity (Fig. S3A and B). Finally, we did not
detect differences in body weight at either age ruling out the possibility
that changes in body weight might affect locomotor activity (Fig. S3C).
Together, the open field assays displayed reduced levels of locomotor
and explorative activity in adult Stau2GT mice.
3.3. Mature adult Stau2 mice showed impaired novelty detection
Response to novelty and learning are two behavioral parameters
that are known to depend on the hippocampus (Kandel et al., 2014; Van
Kesteren, Ruiter, Fernández, & Henson, 2012). To address novelty
preference in mature adult mice, we performed the novel object loca-
tion (NOL) assay that requires predominantly hippocampal circuits and
the novel object recognition (NOR) assay that relies not only on the
hippocampus but also additional brain regions such as the cerebral
cortex (Broadbent, Gaskin, Squire, & Clark, 2010; Cohen & Stackman,
2015) (Fig. 3A). Based on the ability of either Stau2GT or WT mice to
recognize novel objects or novel localization of familiar objects, we
calculated their respective discrimination indices (Antunes & Biala,
2012). In the NOR test, the animal is assessed on its ability to recognize
a novel object. During the first 30 s of testing, WT mice showed - as
expected - an increased ability to discriminate a novel from a familiar
object between familiarization and testing phases. In contrast, mature
adult male Stau2GT animals revealed no changes in the NOR dis-
crimination index when comparing the familiarization and testing
phases (Fig. 3B, left panel). After 4min, Stau2GT mice showed com-
parable attention to the newly introduced object (Fig. 3C, left panel).
In the NOL assay, a familiar object is changed in its position. NOL
thereby addresses hippocampus-dependent spatial learning and
memory. At the 30 s time point, Stau2GT mice showed a stark increase
in attention for the relocated familiar object compared to WT mice
(Fig. 3B, right panel). Upon 4min of recording, WT and Stau2GT mice
showed nearly the same degree of attention for the relocated object
(Fig. 3C, right panel). Based on these behavioral experiments, we hy-
pothesize that Stau2 downregulation leads to an altered response to
novelty in mature adult mice.
3.4. Stau2 deficiency affects long-term memory formation
Based on our results from the NOR/L assays with mature adult an-
imals, it is tempting to speculate that altered novelty preference might
affect learning and memory formation. To test whether Stau2GT animals
had affected memory formation, we performed Barnes maze experi-
ments with mature adult mice (Fig. 4A). This test does not use a strong
aversive stimulus or food deprivation that might influence the animal’s
behavior (Barnes, 1979) and addresses hippocampus-dependent spatial
learning. In the Barnes maze, rodents have to find a hidden escape box
localized below one out of 20 holes in a circular platform. To quantify
mouse activity during the test, we measured total test duration and
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distance traveled. Therefore, we defined three general areas on the test
platform (1: start zone, 2: target zone and 3: flight box; as depicted in
Fig. 4B).
To investigate long-term memory formation, mice were tested once
per day (24 h intertrial interval) on four consecutive days (Fig. 4A).
Mice were tracked to measure total time and traveled distance. Both
mature adult Stau2GT and WT mice exploited a similar search strategy,
which seemed to be directed towards the flight box with episodes of
trial and error (Fig. 4C) and showed no difference in entering the target
zone that surrounded the flight box (Fig. 4D, left panel). Furthermore,
we did not observe any statistically significant differences between WT
and Stau2GT animals in either mean speed, time in the target zone
(Fig. 4E and F) or total test duration and total distance traveled (Fig.
S4A and B). Stau2GT mice, however, showed a significantly higher
failure to enter the escape hole than WT mice (Fig. 4D, right panel).
In summary, Stau2GT mice showed a range of behavioral differences
compared to WT mice. Adult Stau2GT males displayed reduced loco-
motor activity and impaired recognition of newly introduced objects
but enhanced interest to relocated objects. In addition, we found this
impaired novelty detection to lead to higher incidence of Stau2GT ani-
mals failing to complete the Barnes maze task. This, in turn, suggests
that downregulation of Stau2 impairs selective learning abilities.
4. Discussion
In the last few decades, detailed analysis on various RBPs have re-
vealed their importance for neuronal functions. However, the impact of
RBP dysfunction(s) on complex behaviors is sparse and has only been
investigated for few RBPs (Bakker et al., 1994; Berger-Sweeney, 2006;
Park et al., 2017). In this study, we have generated a novel constitutive
Stau2GT mouse model that shows a 40% reduction in Stau2 protein
levels, that allowed us to investigate the role of Stau2 on hippocampus
dependent behavior such as spatial learning and novelty response. Our
behavior assays demonstrate that Stau2 deficiency impacts explorative
activity, novelty preference and spatial learning.
4.1. Stau2 knock-down affects explorative activity
It has been shown that Stau2 is necessary for dendritic spine for-
mation in hippocampal neurons (Goetze et al., 2006; Berger et al.,
2017). Furthermore, in Drosophila staufen has been linked to long-term
memory (Dubnau, Chiang, & Grady, 2003). Thus, it is tempting to
speculate that Stau2 also guides neuronal circuit formation in mice.
Explorative activity and social behavior rely on specific subregions of
the limbic system such as the hippocampus (Inoue et al., 1996; Van
Kesteren et al., 2012). Our results indicate that Stau2 depletion may
affect locomotor activity in mice. We hypothesize that the age-depen-
dent effect on explorative activity is mainly driven by changes in neu-
ronal circuit formation within the limbic system during aging. Clearly,
these age-dependent effects need to be investigated in further detail
before any significant conclusions can be drawn.
4.2. Altered novelty response in adult Stau2GT males
To unravel the physiological role of Stau2 in mice, we performed a
series of behavioral assays to address spatial memory and novelty
preference. Mice have a natural drive for novelty, so in the NOR test,
WT mice spend more time with a newly introduced object compared to
a familiar object. Thus, deficits in novelty detection would change this
behavior towards an equal interest for both objects. In particular, the
early phase of NOR is thought to be dependent on extra-hippocampal
regions such as the perirhinal cortex (Antunes & Biala, 2012; Vogel-
Ciernia & Wood, 2014), although with increasing sampling time
memory is further strengthened by the involvement of the hippo-
campus. Our results revealed that Stau2GT males showed no preference
for the newly introduced object in contrast to WT animals. Surprisingly,
in the NOL assay we observed an increased preference for the relocated
object. Importantly, according to hippocampus lesion experiments in
rats NOR depends primarily on the hippocampus, but requires other
brain regions such as the cerebral cortex in addition to hippocampus,
while NOL depends primarily on the hippocampus (Broadbent, Squire,
& Clark, 2004). It is generally believed that for object recognition, the
hippocampus, the perirhinal and medial prefrontal cortex are essential
brain structures (Warburton & Brown, 2015). In this context, the CA1
region receives inputs from the perirhinal cortex and the CA3 region
and projects to the entorhinal cortex. Importantly, mice depleted of
NMDA receptor subunit 1 in CA1 neurons show impaired NOR
(Rampon et al., 2000). In this context, it is worth mentioning that two
known physiological mRNA targets of Stau2, Rgs2 and Rgs4 (Heraud-
Farlow et al., 2013) act in the adrenergic receptor pathway to modulate
NMDA receptor function (Liu et al., 2006).
According to our immunohistochemistry results, the Stau2GT CA1,
CA3 and dentate gyrus (DG) regions show a prominent downregulation
of Stau2 expression. In our NOR assays, Stau2GT mice revealed no
preference between familiar or novel objects, indicating that adult
Stau2GT males failed to discriminate between them. We therefore hy-
pothesize that altered synaptic transmission in CA1 neurons is re-
sponsible for the impaired NOR, possibly influenced by Rgs4. For NOL
test paradigms, neurotoxic lesion experiments have shown that the DG-
CA3 connection is essential for spatial novelty detection while CA1
lesioned mice showed only mild impairment of novelty detection (Lee,
Hunsaker, & Kesner, 2005). Interestingly, adult Stau2GT mice revealed
enhanced preference for the relocated familiar object compared to
control animals. We hypothesize that altered synaptic transmission
between subregions responsible for spatial navigation and novelty de-
tection, such as the DG-CA3 axis, results in enhanced spatial novelty
detection in Stau2GT mice.
4.3. Adult Stau2GT males reveal impaired spatial learning
To investigate the effect of Stau2 downregulation on hippocampus-
dependent spatial learning, we performed Barnes maze tests. Our data
suggests that adult Stau2GT males were as efficient in finding the target
area as WT controls. This is in line with the NOL results where mutant
males revealed enhanced spatial novelty detection. However, we ob-
served that a significant higher number of Stau2GT animals fail to enter
the flight box. Together with the NOR results we therefore speculate
that Stau2 downregulation leads to defects in discrimination in the
open area of the Barnes maze platform and the flight box as novel
spatial object. This, in turn, would cause a higher incidence of mutant
male mice to fail.
In summary, our results demonstrate that Stau2 might have (at
least) two distinct roles for novelty detection addressing different hip-
pocampal and extrahippocampal brain regions. Novel object recogni-
tion was impaired in male mice while they showed enhanced dis-
crimination in relocation tasks. This, in turn, affected spatial learning
and deficits in discriminating different spatial contexts in Barnes maze
tests. We speculate that altered synaptic transmission in the hippo-
campal trisynaptic circuitry is responsible for the observed phenotype
in Stau2GT mice. In the course of this study, a conditional Stau2 knock-
down rat model in pyramidal neurons primarily displayed deficits in
spatial learning (Berger et al., 2017). Our Stau2GT mice displaying
constitutive Stau2 depletion enabled us to unravel another important
behavioral deficits, namely altered novelty preference. We therefore
speculate that Stau2 may play a role in novelty detection. Future in-
vestigations are clearly necessary to unravel the molecular role of Stau2
in synaptic transmission between different hippocampal subregions and
connecting cortical areas.
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Abstract: Staufen2 (Stau2) is an RNA-binding protein that is involved in dendritic spine morphogenesis
and function. Several studies have recently investigated the role of Stau2 in the regulation of its
neuronal target mRNAs, with particular focus on the hippocampus. Here, we provide evidence for Stau2
expression and function in cerebellar Purkinje cells. We show that Stau2 downregulation (Stau2GT) led
to an increase of glutamate receptor ionotropic delta subunit 2 (GluD2) in Purkinje cells when animals
performed physical activity by voluntary wheel running compared with the age-matched wildtype (WT)
mice (C57Bl/6J). Furthermore, Stau2GT mice showed lower performance in motor coordination assays
but enhanced motor learning abilities than did WT mice, concomitantly with an increase in dendritic
GluD2 expression. Together, our results suggest the novel role of Stau2 in Purkinje cell synaptogenesis in
the mouse cerebellum.
Keywords: staufen2; synaptogenesis; cerebellum; purkinje cells; GluD2
1. Introduction
Research over the last few decades has shown the importance of posttranscriptional regulation
mechanisms in neuronal function, particularly for synaptogenesis [1]. Key players for these processes
are RNA-binding proteins (RBPs) [2,3]. By binding to their target mRNAs, RBPs control different
steps of the RNA life cycle, such as splicing, RNA export and localization, translation control and
degradation [1] underlining their importance for neuronal functioning. Depletion of RBPs can cause
severe neuropathologies, such as mental retardation or epilepsy, as well as motor defect disorders,
such as amyotrophic lateral sclerosis (ALS) [4–7]. Staufen2 (Stau2) is an RBP involved in different
regulatory networks ranging from embryonic neurogenesis to synaptic transmission and morphogenesis
in mature hippocampal neurons [8]. Recent studies of Stau2-deficient mice and rats have shown that
Stau2 is important for learning and memory formation [9,10]. In this study, we took advantage of
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the previously reported Stau2 gene trap mouse model (Stau2GT), which shows a brain-wide Stau2
downregulation of about 40% [9]. Transcriptome-wide analysis of differentially expressed RNA
in the Stau2GT mouse brain revealed an upregulation of glutamate receptor ionotropic delta subunit 2
(Grid2) and cerebellin1 (Cbln1) mRNAs when compared with wildtype (WT) mice during extensive
learning and motor activity. These mRNAs code for glutamate receptor ionotropic delta subunit
2 (GluD2) and Cbln1, two components of the cerebellar synaptic apparatus [11,12]. GluD2 and
Cbln1 are believed to connect the synapses of granule cell parallel fibers and Purkinje cell dendrites.
While GluD2 is expressed in the postsynaptic membrane of Purkinje cells, Cbln1 is secreted from
the presynaptic compartment, binds to presynaptic neurexins and postsynaptic GluD2, and therefore
connects pre-synapses deriving from parallel fibers of granule cells with post-synapses of Purkinje
cells [13,14]. The consolidation of synapses through the interaction of these molecules has been shown
to be the basis of synaptic transmission in Purkinje cells. Furthermore, Cbln1 and GluD2 play relevant
roles in motor coordination and learning, while deficits lead to motor impairment, such as ataxia in
mouse models [15–17]. Interestingly, naive Stau2GT showed reduced motor coordination in a rotor
rod assay compared with age-matched WT animals. Strikingly, mutant animals displayed enhanced
motor learning skills during repeated training. These effects were concomitant with an increased
GluD2 expression, suggesting improved synaptic transmission in the cerebellum. Together, our results
suggest that Stau2 plays a role in motor activity-induced synaptogenesis in the mouse cerebellum.
2. Results
2.1. Adult Stau2GT Mice Show an Upregulation of Cbln1 and GluD2 mRNA during Behavior Testing
To identify genes that are Stau2-dependently affected during training, 4-month-old Stau2GT mice
and age-matched WT controls were exposed to a battery of behavioral tests for 4 consecutive weeks,
as previously described [8] (Figure 1A). Subsequently, the mouse brains were dissected, and microarray
analysis was performed. Interestingly, compared with the WT mice, we detected a significant 15%
increase in the Stau2GT mice for Cbln1 and Grid2 mRNA expression in brain lysates, which code for
cerebellar proteins involved in synaptogenesis [12,18]. In naive mice, in contrast, there was no apparent
changes in the expression of these mRNAs detectable (Figure 1B). To validate the upregulation of Cbln1
and Grid2 mRNAs, qRT-PCR was performed on Stau2GT and control brain lysates. Here, mRNA levels
of Cbln1 and Grid2 showed a significant increase in the adult Stau2GT mice that underwent behavioral
experimentation (Figure 1C,D).
2.2. Reduced Stau2 Expression in Cerebellar Purkinje Cells of Adult Stau2GT Mice
The increase in expression of the cerebellar genes Cbln1 and Grid2 prompted us to examine Stau2
expression in the mouse cerebellum. First, we performed immunostainings against Stau2 in frontal
cerebellar sections in adult WT mice. Co-staining for calbindin was used to clearly distinguish Purkinje
cells from NeuN-expressing cells. Stau2 staining was prominent in the somatic area of the Purkinje
cell layer (StP) and the stratum moleculare (StM) (Figure 2A). To evaluate Stau2 downregulation
in the cerebellum of transgenic mice, we performed immunostainings against Stau2 in cerebellar
sections of Stau2GT mice. Quantification of Stau2 protein intensity in Purkinje cells showed a 50%
reduction in adult Stau2GT animals compared with the controls (Figure 2B). Furthermore, staining
for the β-galactosidase activity encoded by the gene trap construct in Stau2GT mice [9] revealed a
strong expression in Purkinje cells, indicating a knockdown preferentially in the stratum purkinjense
(Figure 2C) underlining our previous results (Figure 2B).
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Figure 1. Adult Staufen2 knock-down (Stau2GT) mice show an upregulation of cerebellin1 (Cbln1)
and glutamate receptor ionotropic delta subunit 2 (Grid2) mRNA during behavioral tests. (A) Schematic
representation of the experimental approach followed by the behavioral tests. Here, 4-month-old
Stau2GT and wildtype (WT) mice were exposed to a battery of behavioral tests (OF = open field test,
NOR/NOL = novel object recognition/location test, and BM = Barnes maze), enabling physical trainings
(= trained). Subsequently, the mouse brains were dissected, and microarray analysis was performed.
(B) Microarray analysis of brain lysates of 5-month-old Stau2GT and WT mice before and after training
conditions. (C,D) Quantification of Cbln1 (C) and Grid2 (D) mRNA levels before (naive) and after
behavioral tests (= trained) measured by qRT-PCR. N = 3 animals (B–D). Statistics: Students t-test.
Mean + SEM, * p < 0.05, *** p < 0.001; ns = not significant (B–D).
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Figure 2. Stau2 expression in cerebellar Purkinje cells is reduced in adult Stau2GT mice. (A) Representative
confocal images of immunohistofluorescence staining for Stau2 (neuronal markers: NeuN and calbindin;
nuclearmarker: 4′,6-diamidino-2-phenylindole (DAPI))onfrontal sectionsofcerebelli takenfrom5-month-old
WT mice. Scale bars = 200 µm (left), 50 µm (middle, right). (B) Representative confocal images of
immunohistofluorescence staining against Stau2 on frontal sections of the cerebellum of 5-month-old Stau2GT
and WT mice (left) and relative Stau2 intensity (right). Scale bar = 20 µm. (C) Light microscopic image of
LacZ staining in a representative frontal section of Stau2GT mouse cerebellum. Scale bar = 200 µm. N = 3 (B).
Statistics: Students t-test. Mean + SEM, * p < 0.05. StG, stratum granulare; StP, stratum pyramidale; and StM,
stratum moleculare. Arrows point to Purkinje cell bodies (B).
2.3. Decreased Motor Coordination Abilities but Increased Motor Learning Capacity in Adult Male
Stau2GT Mice
The fact that Stau2 was found to be expressed in Purkinje cells and that its downregulation affected
the gene expression of cerebellar proteins during behavior testing prompted us to investigate the impact of
Stau2 depletion on motor activity and coordination. First, we measured the overall motor activity of adult
Stau2GT and WT mice exposed to a low-profile running wheel [19] during a three-week period (Figure 3A).
Interestingly, the Stau2GT mice showed a significantly higher tendency to use the running wheel at night
(6 p.m.–6:00 a.m.) when compared with the tendency observed in the WT mice (Figure 3B), indicating
that Stau2 does not affect general motor activity. To investigate the effect of Stau2 downregulation on
motor coordination, we used the rotarod performance test [20] (Figure 3C). Then, 10-week-old Stau2GT
and WT mice were exposed to the rotarod running wheel. The duration of running until the animals
fell from the wheel was measured in tests performed over two consecutive days. We observed that both
Stau2GT males and females showed a lower latency to fall than the age- and sex-matched controls on day
1 (Figure 3C,D). On day 2, male Stau2GT mice improved significantly their test performance compared
with the age-matched WT males (compare day 1 and day 2 for the Stau2GT and WT animals), although
the general performance was still lower in the StauGT mice (Figure 3C). Interestingly, for StauGT females,
we did not observe a performance improvement during training (Figure 3D). Our expression analysis using
mutant and WT brains from males (Figure 1) mirrored the effect that we observed in rotarod experiments.
We therefore continued with male mice.
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Figure 3. Adult male Stau2GT mice show decreased motor coordination abilities but increased motor
learning capacity. (A) Setup for voluntary wheel running experiments. Low-profile running wheels as
depicted were placed into the home cages of 10-week-old Stau2GT mice and age-matched WT controls
for 3 weeks (w.). (B) Graph depicting the number of total rotations per week at night and day used by
either the WT or Stau2GT mice. (C) Quantification of rotarod running wheel testing. Here, 10-week-old
male (left) or female (right) Stau2GT mice, as well as age- and gender-matched controls, were set on the
rotarod three times per day on two consecutive days and time until fall off was measured (the mean
value per day was calculated). Mean latency to fall (in seconds) for either the WT or Stau2GT male or
female mice is plotted as boxplots. Individual data points represent different trials for single animals
per day. N = 5 animals/group. Statistics: mean + SEM (B) or mean + min/max (C/D), one-way ANOVA
and Bonferroni’s multiple comparison test. * p < 0.05, ** p < 0.01, *** p < 0.001, ns. = not significant.
2.4. Increased Dendritic GluD2 Protein Expression in Adult Stau2GT Mice after Motor Activity.
Based on our microarray and rotarod test results and because enhanced motor activity induces
synaptogenesis in the cerebellum [21], we speculated that Stau2 might play a role in this process.
Therefore, we analyzed histological sections of the cerebellar cortex. We stained against GluD2 protein
and vesicular glutamate transporter 1 (vGLUT1), a protein located at the presynaptic side of synapses
between parallel fibers and Purkinje cells [22] (Figure 4A). Naive Stau2GT mice (10 weeks old) showed
weak expression of GluD2 in the StM and cell bodies of Purkinje cells. In contrast, motor activity
by voluntary wheel running (3 weeks) increased GluD2 expression in the Stau2GT mice by 50%,
whereas no difference in GluD2 was observed in the WT animals. Furthermore, we detected elevated
GluD2/vGLUT1 colocalization in the StM, suggesting an increase in the number of functional synapses
in Stau2GT mice after motor activity (Figure 4B,C). We next analyzed the GluD2 intensity in Purkinje
cell dendrites of naive mice, as well as mice exposed to running wheels. Here, we detected higher levels
of dendritically localized GluD2 protein in cerebellar Purkinje cells (Figure 4D). Naive 10-week-old WT
and Stau2GT mice, in contrast, showed no difference in GluD2 protein expression. Confirming previous
experiments, the effect was much stronger in the Stau2GT mice after motor activity than in the WT mice
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(Figure 4D). In summary, the Stau2GT mice showed higher voluntary motor activity, a steeper motor
learning curve, and a more prominent increase of dendritic GluD2 expression after motor activity.
Figure 4. Dendritic GluD2 protein expression increases in adult Stau2GT mice after motor activity.
(A) Representative confocal images of immunofluorescent staining against GluD2, (vesicular glutamate
transporter 1) vGLUT1, and calbindin (negative conversion for Purkinje cell morphology) on frontal
sections of the cerebellum taken from 5-month-old WT mice. Scale bar = 200 µm (left), 100 µm (middle,
right); arrow points to Purkinje cell bodies. (B) Representative confocal images of immunofluorescent
staining against GluD2 and vGLUT1 in the Stau2GT and WT mice before and after exposure to the
running wheel (setup Figure 3). Scale bar = 40 µm. (C) Quantification of the mean staining intensity
of GluD2 normalized to the mean staining intensity of vGLUT1 before (10 w. = mice at the age of
10 weeks) and after (13 w. = mice at the age of 13 weeks) 3 weeks of voluntary wheel running. N = 3.
Statistics: Student’s t-test. Mean + SEM. (D) Histogram showing the average intensity of the GluD2
signal in calbindin-positive cerebellar Purkinje cell dendrites before (10 w.) and after (13 w.) running
wheel exposure. The WT (filled grey circles) and Stau2GT mice (empty black circles). N = 20 dendritic
stretches in each group, from three different animals. Statistics: One-way ANOVA and Bonferroni’s
multiple comparison. Mean +SEM, * p < 0.05, ** p < 0.01, *** p < 0.001; ns. = not significant. StM,
stratum moleculare; StP, stratum pyramidale; and StG, stratum granulare.
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3. Discussion
Stau2 is an essential RNA-binding protein involved in posttranscriptional gene regulation in
the brain [8,23,24]. Its role in hippocampus-dependent learning and memory formation has been
studied in Stau2-deficient rat and mouse animal models [9,10]. However, little is known about its
function in other brain regions. Here, we report a potential impact of Stau2 on synaptogenesis in the
mouse cerebellum. Increased physical activity during behavior testing induced increased expression of
Grid2, Cbln1, and Cbln3 mRNA in adult Stau2GT mice, which act together in the formation of parallel
fiber-Purkinje cell synapses [11]. Interestingly, Grid2 was detected in an iCLIP Stau2 study suggesting
that it is a target of Stau2 [24]. Furthermore, the Stau2GT mice showed lower motor coordination
abilities but increased motor learning capacity in the rotarod test. Of note, we did not observe a
similar effect in female Stau2GT mice. Because we aimed at reducing the animal number used in
our experiments, leading to a number of five mice per group, a larger cohort of females might be
needed to observe enhanced motor learning skills. Similar to exposure to voluntary physical exercise
experiments, these repeated rotarod trainings correlated to increased GluD2 protein expression in
parallel fiber dendrites of cerebellar Purkinje cells.
The importance of GluD2 as a key component of the Purkinje cell post-synapse, thereby inducing
synapse formation by interacting with presynaptic neurexins through secreted Cbln1, has been
reported by several groups in the last few years [11–14,25]. GluD2 knockout (KO) mouse models
have demonstrated a prominent motor dyscoordination and cerebellar ataxia [16,26,27]. Rotarod
tests performed by GluD2 KO mice have resulted in a lower latency to fall [27], identifying GluD2
as an essential regulator of cerebellar synaptic transmission and, eventually, of motor coordination.
Consequently, it is tempting to speculate that higher expression of GluD2 in Stau2GT males during
training contributes to the enhanced learning of motoric skills in these mice.
A possible basis of reduced motor coordination and motor learning in GluD2 KO mice is reduced
long-term depression (LTD) in the cerebellum [28–30]. Interestingly, reduced Stau2 expression also
leads to the disruption of LTD in the hippocampus [10,31]. Reduced LTD in the cerebellum caused by
Stau2 deficiency might explain the generally weaker performance of adult Stau2GT mice in rotarod
tests compared with WT mice. Another possible reason for the lower test performance of Stau2GT
mice could be their generally reduced locomotor activity in a new environment, as has recently been
reported [9].
Besides GluD2, we observed increases in Cbln1 mRNA after stimulation of motor activity through
behavioral tests in Stau2GT mice when compared with WT mice. We interpret this result as a
feedback response to enhanced synaptogenesis in adult Stau2GT mice compared with WT animals
after stimulation of motor activity. Cbln proteins are secreted by cerebellar granule cells and are
predominantly expressed in the cerebellum, although involvement in other brain areas, such as
the frontal brain have been reported [32–34]. Cbln1-null mice exhibit a cellular and physiological
phenotype mimicking that of the GluD2 KO, underlining the tight functional interplay between these
two proteins [32]. In another study, cerebellar ataxic gait in Cbln1-null mice was found to be clinically
improved through Cbln1 injections into the cerebellum [35].
In summary, our results suggest that Stau2 is involved in Purkinje cell synaptogenesis in the
adult mouse cerebellum and might contribute to the regulation of motor coordination and learning.
These findings therefore hold consequences for new clinical approaches. For example, GluD2 mutations
have been shown in cases of congenital cerebellar ataxia in patients [17]. A better understanding
of the involvement of Stau2 in GluD2-dependent synapse formation could therefore provide new
therapeutic options for cerebellar ataxia and similar disorders. It will be interesting to investigate
further gender-specific differences in Stau2 function. Future studies are needed to unravel the impact
of Stau2 in cerebellar synaptogenesis at the molecular level and its relevance for motor coordination
and activity defects in humans.
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4. Materials and Methods
4.1. Generation and Housing of Stau2 Gene Trap Mice
All experiments were performed according to local animal protection laws and were approved
by the district government of upper bavaria (55.2-1-54-2532-167-2013, 23 May 2014) Adult
B6.129P2-Stau2Gt(RRG396)Byg mice [9] and WT C57Bl/6J mice (aged 10–13 weeks and 16–20 weeks) were
housed in groups of 2–5 animals with a 12-h light/12-h dark light cycle in individually ventilated cages.
The mice had free excess to autoclaved water and food.
4.2. Behavioral Analysis
All behavioral tests were performed under identical environmental conditions. Between individual
testing phases, the animals were kept in their housing cages. First, 4-month-old male Stau2GT and
WT mice were exposed to a stimulation of exploratory and motor behavior for 4 consecutive weeks
via different behavioral tests (open field, novel object recognition/location, Barnes maze) as described
previously [9].
Running wheel: Low-profile running wheels (Med associates Inc, Fairfax, VT, USA) were placed in
home cages of age- and gender-matched Stau2GT and WT mice for a time period of 3 weeks. Motor
activity was tracked by measuring total rotations of the running wheel per day.
Rotarod test: The rotarod test was performed as previously described [36]. Age- and
gender-matched Stau2GT and WT mice were set on a rotating rod (accelerating rotations during
5-min test duration), and the latency until fall from the rod was measured in seconds. The test was
performed for two consecutive days. WT male and Stau2GT males, as well as WT female and Stau2GT
female mice, were investigated.
4.3. Histology
Whole animal perfusion fixation was performed as previously described [37]. Cerebellar tissue
was prepared as previously described [38].
Immunohistochemistry: Brains of perfusion fixed mice were postfixed, cryoprotected, cut in
30-µm frontal sections, and immunostained as described previously [38]. Self-made rabbit polyclonal
anti-Stau2 antibody [39] was diluted 1:200, additionally anti-GluRD2 (rabbit polyclonal, Alomone, 1:200),
anti-vGLUT1 (guinea pig polyclonal, Synaptic Systems, 1:500, Göttingen, Germany), calbindin (mouse
monoclonal, Abcam, 1:500), and anti-NeuN (chicken polyclonal, Millipore, 1:500, Darmstadt, Germany)
were used. To detect the primary antibody, sections were washed three times in PBS and incubated
with secondary antibodies (goat anti-rabbit IgG Alexa Flour 488 labeled (Jackson Immunoresearch,
Cambridgeshire, UK), goat anti-guinea pig IgG Cy3 labeled (Jackson Immunoresearch), goat
anti-chicken IgY Alexa Flour 647 labeled (Life Technologies, Carlsbad, CA, USA), and donkey
anti-mouse IgG Alexa Flour 555 labeled (Life Technologies) diluted 1:500 in blocking solution for 2 h at
room temperature. Nuclei were stained by 5-min incubation in 4′,6-diamidino-2-phenylindole (DAPI)
solution. Slices were washed three times in PBS and mounted in Fluomount (Sigma-Aldrich, Munich,
Germany). Pictures were taken by a confocal SP8 microscope (Leica, Wetzlar, Germany).
Imaging: Dendritic stretches of cerebellar Purkinje cells were identified using calbindin staining
and the Imaris software package (Bitplane, South Windsor, CT, USA). Fiji 1.50g (PMID 26153368)
software was used to outline 20 randomly chosen dendritic stretches per group in the WT and Stau2GT
mice at 10 or 13 weeks, respectively. Immunofluorescence intensity of GluD2 was measured in images
taken at the same gain level by a confocal microscope (Leica, Germany).
LacZ-staining: To monitor gene trap vector insertion in murine brains, we detected LacZ expression
by determining the encoded β-galactosidase activity in slices of Stau2GT mouse brains according to
the manufacturer’s instructions (InvivoGen, San Diego, CA, USA). The procedure was performed as
described previously [9].
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4.4. RT-qPCR
Total mRNA was obtained from brain samples using TRIzol (Ambion, Carlsbad, CA, USA)
according to the manufacturer´s protocol. Genomic DNA was depleted using the Mini RNeasy kit
(Qiagen). cDNA was synthesized from purified mRNA by reverse transcription using Superscript III
reverse transcriptase (Invitrogen, Carlsbad, CA, USA) according to the manufacturer´s instructions.
For qPCR cDNA amplification, Hot Start Taq (New England Biolabs, Ipswich, MA, USA) was used with
SYBR Green for amplicon detection. All primers were used with an optimal efficiency rate of 2.0 ± 0.05.
Runs were performed on a Lightcycler 96 (Roche Bioanalytics, Basel, Switzerland). Primers used in
this study were (5′ to 3′): Cbln1: GCTTTCTCTGCCATCAGG and TCTGAGTCAAAGTTGTTCCC,
Grid2: TGACACCATGAGGATAGAGG and ACCTCACTTATGAAGGATTTGG, 18S:
GAAACTGCGAATGGCTCATTAAA and CCACAGTTATCCAAGTAGGAGAGGA.
4.5. Expression Analysis
Microarray analysis: RNA was isolated as described above. The samples were processed according
to the manufacturer’s instructions (Affymetrix, Santa Clara, CA, USA) and hybridized on a Mouse
Gene 2.0 ST Array. Signal intensities were extracted and normalized using RMA (R/bioconductor
package ‘oligo’). Samples with log2-expression levels of >5 in at least 3 samples were subjected to
differential expression analysis using limma and multiple testing correction according to Benjamini and
Hochberg (R/bioconductor package ‘limma’). Data were deposited in the Gene Expression Omnibus
(GEO) database (accession no. GSE126996).
4.6. Statistics
Data were first tested for Gaussian distribution using the KS-test. Normally distributed data were
analyzed by Student’s t-test or one-way ANOVA followed by Bonferroni’s post-hoc test for multiple
comparison. Data are presented as mean + SEM. Statistical analysis was performed using the software
GraphPad Prism (Version 5, GraphPad, San Diego, CA, USA). p < 0.05 (*) was considered statistically
significant if not stated otherwise.
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of the GABA Receptor to Control
Neuronal Inhibition
Rico Schieweck* and Michael A. Kiebler*
Department of Cell Biology and Anatomy, Medical Faculty, Biomedical Center (BMC), Ludwig-Maximilians-University
of Munich, Munich, Germany
Behavior and higher cognition rely on the transfer of information between neurons
through specialized contact sites termed synapses. Plasticity of neuronal circuits, a
prerequisite to respond to environmental changes, is intrinsically coupled with the
nerve cell’s ability to form, structurally modulate or remove synapses. Consequently,
the synaptic proteome undergoes dynamic alteration on demand in a spatiotemporally
restricted manner. Therefore, proper protein localization at synapses is essential for
synaptic function. This process is regulated by: (i) protein transport and recruitment; (ii)
local protein synthesis; and (iii) synaptic protein degradation. These processes shape
the transmission efficiency of excitatory synapses. Whether and how these processes
influence synaptic inhibition is, however, widely unknown. Here, we summarize findings
on fundamental regulatory processes that can be extrapolated to inhibitory synapses.
In particular, we focus on known aspects of posttranscriptional regulation and protein
dynamics of the GABA receptor (GABAR). Finally, we propose that local (co)-translational
control mechanism might control transmission of inhibitory synapses.
Keywords: posttranscriptional gene regulation, GABA receptors, inhibitory synapse, co-translational
folding/assembly, RNA binding, RNA transport, local translation, RNA-binding proteins
INTRODUCTION
The enormous capacity of the brain to store information and respond to different environmental
conditions and challenges crucially rely on underlying mechanisms like synaptic plasticity. This
depends on the ability to modulate the strength of transmission between two nerve cells as well
as the growth and removal of synapses. Synapses consist of (at least) hundreds of proteins that
need to be organized and correctly assembled to ensure proper synaptic function. Changes in
synaptic transmission and structure are accompanied and conveyed by local alterations in protein
levels. Understanding the regulation of synaptic protein composition is, therefore, crucial to gain
insight into complex neurological processes such as learning and memory and, eventually, into
neuropsychiatric diseases such as autism spectrum disorders, schizophrenia and bipolar disorders.
In order to remodel the synaptic proteome, neurons exploit different mechanisms that allow
spatial and temporal control of protein levels. Protein synthesis was one of the first molecular
mechanisms that were discovered to be indispensable for memory formation (Hershkowitz
et al., 1975; Shashoua, 1976). Pioneer experiments showed that inhibiting translation blocked
the ability of an animal to remember after training (Flexner et al., 1963). In line with this
observation, several experiments have shown that strengthening and weakening of synaptic
transmission, so called long-term potentiation (LTP) and depression (LTD), respectively,
need active translation in a time-dependent manner (Krug et al., 1984; Linden, 1996).
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The spatial selectivity of synapses to undergo changes upon
stimulation raised the question of how a cell knows, which
synapse is destined for functional and structural remodeling.
This inspired Frey and Morris (1997) to the idea of ‘‘synaptic
tagging.’’ Repetitive activation of synapses, therefore, equips such
a synapse with a labile molecular ‘‘tag.’’ Eventually, the synaptic
tag allows the synapse to recruit newly synthesized proteins. The
concept of ‘‘synaptic tagging’’ is a very elegant model to explain
processes such as LTP and LTD at excitatory synapses (Frey and
Morris, 1997). The precise identity of the tag(s) is still lacking.
Furthermore, synaptic plasticity depends on additional processes
such as mRNA localization, which is mainly independent of
translation activity (Steward et al., 1998). mRNA transport and
localization are important determinants of synaptic function
(Jung et al., 2014). To date, it is generally believed that mRNAs
are assembled into ribonucleoprotein particles (RNPs) consisting
of mRNAs and RNA-binding proteins (RBPs). The protein
and mRNA composition of these particles differ substantially
(Kanai et al., 2004; Fritzsche et al., 2013) giving raise to the
idea that different subtypes of particles or granules co-exist
in a nerve cell. The function of these RNA granules is: (i) to
transport mRNA—in a translationally dormant stage—along
cytoskeletal elements such as microtubules to their destination
at the synapse; and (ii) to regulate the translation of their
target mRNAs. Activity-dependent disassembly of these RNA
granules then allows the release of mRNAs and subsequent
induction of translation. How neuronal stimulation, recruitment
of mRNAs and unpacking of RNPs are synchronized is largely
unknown. A pioneer study identified the kinase mechanistic
target of rapamycin (mTOR) as a central hub to recruit RNAs.
The authors suggest that mTOR might be the tag that controls
mRNA recruitment at the synapse (Sosanya et al., 2015).
mTOR is essential for proper neuronal function (Costa-Mattioli
and Monteggia, 2013; Pernice et al., 2016). It needs to be
experimentally verified though whether it might represent an
universal synaptic tag or whether it might be specific for a subset
of mRNAs.
Local protein expression control comprising mRNA
transport, local protein synthesis and recruitment of
newly synthesized protein remodel the synaptic proteome.
Consequently, protein degradation is compulsive to complete
synaptic remodeling. Synaptic protein degradation is induced
in an activity-dependent manner (Bingol and Schuman, 2006).
Moreover, it is tightly linked to translation to balance the
protein need (Klein et al., 2015). In line with this finding,
the translation repressor poly(A)-binding protein interacting
protein 2A (PAIP2A) is degraded by calpain in neurons upon
stimulation (Khoutorsky et al., 2013). Interestingly, calpain also
degrades gephyrin (Gphn), a major scaffold protein at inhibitory
synapses (Tyagarajan and Fritschy, 2014). This finding indicates
that translational activation at excitatory synapses may modulate
inhibitory synapses to alter transmission.
In this review article, we provide insight into
posttranscriptional regulatory mechanisms that control synaptic
protein expression. Since most of these studies investigated
these processes at excitatory synapses, we aim to expand these
fundamental aspects to inhibitory synapses. We speculate that
local expression control also regulates inhibitory transmission to
balance neuronal excitation.
TO LOCALIZE OR NOT TO
LOCALIZE—IT’S A MATTER OF RBP
BINDING TO THE 3′-UTR
With the emergence of the individual-nucleotide resolution
UV crosslinking and immunoprecipitation (iCLIP) technology
(Huppertz et al., 2014), transcriptome-wide identification of
RBP mRNA targets and binding site became experimentally
addressable. iCLIP has now been performed for a series of
RBPs (Tables 1, 2). Interestingly, most of the RBP binding
occurs within the 3′-untranslated region (3′-UTR) of transcripts
(Andreassi and Riccio, 2009). In addition, it was shown that
the median of the 3′-UTR length of mRNAs bound to the
RBP Staufen2 that is necessary for RNA transport (Heraud-
Farlow and Kiebler, 2014) is longer than the median of
the transcriptome (Heraud-Farlow et al., 2013). This finding
indicates that a certain 3′-UTR length is needed to allow
association with RBPs and, consequently, mRNA transport
and/or expression control (Heraud-Farlow and Kiebler, 2014).
To test whether mouse GABA receptor (GABAR) subunits
show a similar tendency towards longer 3′-UTR length, we
analyzed the nucleotide length of their 3′-ends of all GABAA
and GABAB receptor subunit isoforms (see ‘‘Methods’’ section).
Strikingly, GABAR subunits reveal a significant increase in their
3′-UTR compared to the total mouse 3′-UTRome (Figure 1A).
Moreover, the 3′-UTR length was significantly extended when
comparing the GABAR subunits with the 3′-UTRome of the
somatic and neuropil layer of the hippocampal CA1 region
(Cajigas et al., 2012; Figure 1A). An increase in 3′-UTR
length is linked with decreased translational activity in HEK
cells and human neurons (Floor and Doudna, 2016; Blair
et al., 2017) probably due to a higher number of miRNA
and RBP binding sites. In addition, 3′-UTR length is extended
during neuronal development indicating increased translation
regulation in mature neurons compared to developing nerve
cells (Blair et al., 2017). Of note, GABAR subunits exhibited a
trend towards longer 3′-ends when compared with ionotropic
glutamate receptor subunits (Figure 1B). Together, these results
suggest that GABAR subunit 3′-UTRs have a high(er) potential
to be bound by RBPs. Supportive for this hypothesis is the
fact that GABAR subunit mRNAs are enriched in the dendrite
containing neuropil layer of CA1 neurons in the hippocampus
(Cajigas et al., 2012) suggesting that these mRNAs are localized
there. The recognition of mRNA targets by RBPs relies on
binding sites within their 3′-UTRs and that each mRNA might
have its own specific RNA signature. In detail, these binding
sequences consist of both sequence and structural elements
(Kiebler and Bassell, 2006; Doyle and Kiebler, 2011; Jung et al.,
2014; Sugimoto et al., 2015). Interestingly, GABAR subunits
exhibited a lower GC content compared to the total, somatic
CA1 and neuropil 3′-UTRome (Figure 1C). Concomitantly, we
observed a higher AT content (Figure 1C). Moreover, the same
statistically significant effects were detected when comparing
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TABLE 1 | Hand-selected list of RBPs with RNAs related to GABAR as targets.
Rbp Method Tissue RNA targets related to GABAR Reference
Nova iCLIP Brain Gabbr2, Gabrg2 Ule et al. (2003)
FMRP iCLIP Brain Gabbr1, Gabbr2 Darnell et al. (2011)
Staufen1 iCLIP Brain Gabbr2 Sugimoto et al. (2015)
Staufen2 RIP, iCLIP Embryonic brain Gabra2, Gabra3, Gabbr1, Gabbr2, Gabrb1,
Gabrb2, Gabrb3, Gabrg3
Heraud-Farlow et al. (2013)
and Sharangdhar et al. (2017)
Unkempt iCLIP Embryonic brain Gabra3, Gabrb2 Murn et al. (2015)
Celf4 iCLIP Brain Gabra1, Gabra2, Gabra3, Gabra4, Gabra5,
Gabrb1, Gabrb2, Gabrb3, Gabbr1, Gabbr2,
Gabrg1, Gabrg2, Gabrg3, Gabrd
Wagnon et al. (2012)
Rbfox1, 2, 3 iCLIP Brain Gabra1, Gabra3, Gabra6, Gabbr1, Gabrb2,
Gabrb3, Gabrg1, Gabrg2
Lee et al. (2016)
Pumilio1 iCLIP Brain Gabra1, Gabra5, Gabbr1, Gabrb2, Gabrg2 Zhang et al. (2017)
Pumilio2 iCLIP Brain Gabra4, Gabrb2, Gabrg2, Gabrq Zhang et al. (2017) and
Zahr et al. (2018)
4E-T RIP Embryonic brain Gabrg2 Yang et al. (2014)
hnRNP R iCLIP Embryonic primary
mouse motorneurons
Gabra4, Gabbr1, Gabrb1, Gabrb3, Gabrg2,
Gabrg3
Briese et al. (2018)
CPEB1 RIP Striatum Gabrb1, Gabrb2 Parras et al. (2018)
CPEB4 RIP Striatum Gabra1, Gabra2, Gabra4, Gabrb1, Gabrb2,
Gabrb3, Gabrg3
Parras et al. (2018)
nELAV iCLIP Human dorsolateral
prefrontal cortex
Gabra4, Gabrb2, Gabrb3, Gabrg1, Gabrg3 Scheckel et al. (2016)
TABLE 2 | Hand-selected list of RBPs with RNAs related to scaffold protein, GABAR auxiliary and transport proteins as targets.
Rbp Method Tissue RNA targets related to GABAR Reference
Nova iCLIP Brain Gphn Ule et al. (2003)
FMRP iCLIP Brain NSF, Trak2, Ubqln1 Darnell et al. (2011)
Staufen1 iCLIP Brain KCTD12, GABARAPL3, NSF, Arfgef2,
Ubqln1
Sugimoto et al. (2015)
Staufen2 RIP, iCLIP Embryonic brain Gphn, Arhgef9, KCTD16, NSF, Arfgef2,
GABARAPL1, Zdhhc3, Plcl1, Ubqln1
Heraud-Farlow et al. (2013) and
Sharangdhar et al. (2017)
Rbfox1, 2, 3 iCLIP Brain Gphn, NSF, Arfgef2, Ubqln1 Lee et al. (2016)
Pumilio1 iCLIP Brain KCTD12, Trak2 Zhang et al. (2017)
Pumilio2 iCLIP Brain Gphn, KCTD12, Arfgef2, Trak2, Plcl1 Zhang et al. (2017) and
Zahr et al. (2018)
4E-T RIP Embryonic brain Gphn, Trak2 Yang et al. (2014)
hnRNP R iCLIP Embryonic primary
mouse motorneurons
Gphn, Arhgef9, KCTD16, NSF, Arfgef2,
Zdhhc3, Trak2, Plcl1
Briese et al. (2018)
CPEB1 RIP Striatum Arfgef2, Zdhhc3 Parras et al. (2018)
CPEB4 RIP Striatum Gphn, Arfgef2, Zdhhc3, Trak2, Ubqln1 Parras et al. (2018)
nELAV iCLIP Human dorsolateral
prefrontal cortex
KCTD16, Plcl1 Scheckel et al. (2016)
ionotropic GluR and GABAR subunit mRNAs (Figure 1D).
A lower GC content accounts for less stable secondary structures
in the 3′-UTRs of GABAR compared to the total, somatic
CA1 and neuropil 3′-UTRome as well as to GluR 3′-ends.
Interestingly, the cytoplasmic polyadenylation binding element
binding protein (CPEB) binds a short, AT-rich sequence within
the 3′-UTR of target mRNAs to control translation and to
induce the elongation of polyA tails (Mendez and Richter,
2001). By using RNA immunoprecipitation (RIP), it was shown
that CPEB1 and 4 bind different GABAR subunits as well as
mRNAs coding for scaffold protein such as Gphn (Parras et al.,
2018; see also Tables 1, 2). Moreover, ELAV proteins, among
others, bind so-called AU-rich elements (ARE) to stabilize
its target mRNAs (Fan and Steitz, 1998; Peng et al., 1998).
Therefore, it is tempting to speculate that ELAV proteins
also bind mRNAs coding for GABAR subunits to regulate
their abundance. Supportive for this idea is an iCLIP-based
ELAV target screen from human brain, which detected selective
mRNAs encoding GABAR subunits, GABAB receptor auxiliary
proteins and GABAR transport proteins (Scheckel et al., 2016;
see also Tables 1, 2).
To date, several GABAR subunits, scaffold, auxiliary and
GABAR transport proteins have been detected as targets for RBPs
by iCLIP or RIP (Tables 1, 2). Among those, known translation
regulators such as fragile X mental retardation protein (FMRP),
Pumilio1, 2, 4E-T as well as CPEB1 and 4 all bind GABAR
subunit mRNAs. However, how these RBPs act together to locally
control the expression of GABAR subunits in dendrites is still
unknown. Future studies are clearly needed to unravel the role of
RBP mediated protein expression control.
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FIGURE 1 | GABA receptor (GABAR) subunits exhibit extended 3′-untranslated region (3′-UTR) length. 3′-UTR lengths of GABAR (GABAA and GABAB receptor)
subunits compared to the global mouse, hippocampal CA1, neuropil 3′-UTRome (A) and the 3′-UTR lengths of ionotropic GluR subunits (B). GC and AT content of
GABAR subunits 3′-UTRs compared to the global mouse, hippocampal CA1 and neuropil 3′-UTRome (C) as well as ionotropic GluR subunits (D). Abbreviation:
+represents the mean. P-values were calculated using the Mann-Whitney U-test, ∗∗p < 0.01, ∗∗∗∗p < 0.0001.
TRANSLATION CONTROL: A POSSIBLE
REGULATION OF GABA RECEPTOR
PROTEIN ABUNDANCE AND COMPLEX
ASSEMBLY
Translation is a multistep process that is regulated by versatile
proteins (Jackson et al., 2010). Different sequence features of the
mRNA that influence translation activity and association with
ribosomal polysomes have been characterized in human cell lines
(Floor and Doudna, 2016). In detail, the length and structural
stability of the 3′-UTR, the number of miRNA binding sites as
well as AU elements in the 3′-UTR aremain drivers of translation
activity located at the 3′-end of the untranslated region. An
increase in these features is associated with decreased translation
activity in non-neuronal cells (Floor and Doudna, 2016) as well
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as nerve cells (Blair et al., 2017). For GABAR subunit 3′-UTRs,
we observed an increase in 3′-UTR length and AT content
(Figures 1A,C,D). These results suggest that translation of
these subunits is strongly regulated. Supportive for this idea is
the finding that GABAR subunit mRNAs are recognized and
subsequently bound by different RBPs (Table 1). In the last
decade, several studies revealed that RBPs control translation
of their target mRNAs (Hentze et al., 2018). One extensively
studied example is the FMRP. FMRP mediated translational
control is crucial for neuronal homeostasis and function since
loss-of-function leads to severe neurological impairments in
synaptic plasticity which cause intellectual disability and social
deficits hallmarked for autism spectrum disorders (Bassell and
Warren, 2008; Darnell and Klann, 2013). Furthermore, recent
studies showed that FMRP is needed for proper differentiation
of neuronal stem cells (Castrén et al., 2005; Gao et al., 2018).
FMRP has been shown to co-migrate with translationally
active ribosomal polysomes (Stefani et al., 2004). However,
this finding was challenged by the same study showing that
polysomal co-migration is detergent sensitive (Stefani et al.,
2004). A mechanistic study combining in vitro assays and
cryoelectronmicroscopy reported that FMRP inhibits translation
through binding to the ribosomal intersubunit space thereby
precluding binding of tRNAs and translation elongation factors
(Chen et al., 2014). A transcriptome-wide screen for FMRP
targets associated with polysomes identified mRNAs coding
for subunits of the GABAB receptor complex (Darnell et al.,
2011; see Table 1). Moreover, a recent study showed that the
GABAA receptor subunit δ was downregulated in an FMRP
knock-out mouse model (Gantois et al., 2006). These findings
suggest that FMRP may regulate selected subunits of the GABAB
and/or GABAA receptor, most likely at the translational level.
Another known translation regulator is Pumilio2 (Pum2). For
Pum2, it was shown that it represses translation by competing
with the eukaryotic initiation factor (eIF4E) for mRNA 5′-cap
binding (Cao et al., 2010), an essential step to start translation
initiation (Jackson et al., 2010). Moreover, Pum2 is able to form
a complex with the miRNA binding protein Argonaute (Ago)
and the eukaryotic translation elongation factor 1A to repress
translation elongation (Friend et al., 2014). Next to its role as
translation regulator, Pum2 regulates transcript stability through
recruitment of the polyA deadenylase complex CCR4-NOT (Van
Etten et al., 2012), which is the major protein complex to induce
RNA degradation (Collart, 2016). Based on a published iCLIP
dataset, Pum2 is able to bind subunits of the GABAA and
GABAB receptor (Table 1). Interestingly, double knockdown of
Pumilio1 and 2 lead to a decrease in the mRNA levels of certain
GABAR subunits (Zhang et al., 2017) indicating that they may
be regulated posttranscriptionally by Pumilio proteins. Another
RBP that impacts the expression of GABAA receptor subunits, is
the non-octamer, POU-domain DNA-binding protein (NONO,
also known as p54NRB). NONO belongs to the family of
polypyrimidine tract-binding protein-associated splicing factors
that are known to regulate various aspects of the RNA lifecycle
including transcription regulation, splicing, RNA processing and
RNA transport (Yarosh et al., 2015). Interestingly, mutations
in the NONO locus causes intellectual disability in humans
(Mircsof et al., 2015). Moreover, the authors found that the
GABAA receptor-mediated inhibition is mainly affected when
NONO is depleted (Mircsof et al., 2015) suggesting that this
RBP regulates directly or indirectly the expression of the GABAA
receptor. Nonetheless, it is widely unknown which GABAR
subunits are translationally regulated. However, the binding
of RBPs that are known to control RNA metabolism and
translation, clearly suggests the existence of posttranscriptional
gene regulation mechanisms for GABARs.
It is commonly accepted that the 3′-UTR allows for
translational regulation of mRNAs. Research in the last
years, however, has shown that the coding sequence (CDS)
can also regulate protein synthesis rate, protein folding
and protein complex assembly (Hanson and Coller, 2018).
Dynamic translation regulation mediated by the CDS became
experimentally accessible with the emergence of deep sequencing
technologies and ribosome profiling protocols (Ingolia et al.,
2009). Studies in cell lines and cultured neurons revealed
that longer CDS are associated with translationally active
‘‘heavy’’ polyribosomes; most likely because a longer CDS can
accumulate more ribosomes (Floor and Doudna, 2016; Blair
et al., 2017). Interestingly, subunits of the GABAAR receptor
complex display a shorter CDS compared to ionotropic GluR
subunits (Figure 2A) suggestive for differences in translation
activity. Another exciting possibility to regulate protein synthesis
rate and output is the usage of synonymous codons. Twenty-one
amino acids are encoded by 64 codons including three stop
codons in the eukaryotic genome (Alberts et al., 2014). This
degeneration of the genetic code leads to a codon bias, the
preferred usage of certain codons over others to encode the
same amino acid. Research in the last decades has shown that
the usage bias is not random, but in contrast is driven and
influenced by certain features such as translation activity, mRNA
stability, protein folding, protein assembly and transcription
factor binding (Grantham et al., 1980; Stergachis et al., 2013;
Hanson and Coller, 2018). Codons can influence translation
speed (Sørensen and Pedersen, 1991) most likely through the
levels of cognate and near-cognate tRNAs (Anderson, 1969;
Zhang and Ignatova, 2011; Fedyunin et al., 2012; Yu et al.,
2015; Hanson and Coller, 2018). Since the nascent chain initiates
folding already in the ribosomal exit tunnel (Lu and Deutsch,
2005), the elongation rate can also influence protein folding
and, thereby, the protein conformation as it has been shown
for the Cystic Fibrosis Transmembrane Regulator (CFTR) in
mammalian cells (Kirchner et al., 2017). In line with this
finding, Yu et al. (2015) showed using an in vitro translation
system that codon usage determines co-translational folding
through variation in the elongation rate. In particular for
a multi-domain protein, it has been suggested that cluster
of rare codons flank the parts of the mRNA that code for
protein domains. Thus, ribosomes attenuate at these sites
allowing the nascent domains to fold first to prevent misfolding
(Schieweck et al., 2016; Hanson and Coller, 2018). Protein
domains, that are encoded by the downstream mRNA, can
then interact with already folded protein substructures to
form a functional complex. Moreover, codon usage dependent
protein folding can also influence protein specificity, which
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was reported for the Multi-Drug Resistance 1 protein (MDR1).
A silent mutation in a rare codon changes the specificity of
MDR1 (Kimchi-sarfaty et al., 2007). Together, these results
strongly indicate that dynamics in the translation elongation
rate determine trajectories of (co-)translational folding. Based
on these results, an intriguing question raises: can codon
usage influence protein folding of transmembrane proteins such
as subunits of the GABAA receptor? Interestingly, GABAAR
subunits contain more transmembrane helices compared to
ionotropic GluR subunits (Figure 2B). This suggests that
GABAAR subunits may need more variation in translation
speed to allow co-translational folding than ionotropic GluR
subunits. Furthermore, GABAAR subunits differ in their codon
usage compared to GluR subunits (Figure 2C). Overall, the
codon usage profiles between the two receptor groups are
similar. For some codons, however, we detected significant
differences in their frequency (Figures 2D,E). Interestingly,
impaired translation of AGA codons leads to neurodegeneration
in a mouse model (Ishimura et al., 2014). Moreover, GABAAR
andGluR subunits exploit different stop codons.While GABAAR
subunit mRNAs display an almost 1:1:1 ratio, GluR subunits
prefer the TGA stop codon that yields the highest readthrough
potential in mammalian cell lines (Howard et al., 2000; Bidou
et al., 2004; Loughran et al., 2014; Manuvakhova et al., 2014). In
addition to co-translational folding, the assembly of large protein
complexes can also occur co-translationally (Balchin et al., 2016).
It has been shown that this process is crucial for the complex
formation in eukaryotic cells (Shiber et al., 2018). It is tempting
to speculate that for large neuronal protein complexes such as
GABAA receptors, a similar mechanism exists to ensure proper
protein-protein interaction. Of note, codon usage and optimality
differ dramatically in their impact on RNA stability comparing
neurons and non-neuronal cells (Burow et al., 2018). Therefore,
a thorough analysis of the neuronal translatome and tRNAome
is needed to understand the impact of codon usage on GABAA
receptor functioning.
To sum up, findings from different model organisms and
cells demonstrate that translation is a highly dynamic process
necessary for many aspects of the protein life cycle. For GABAA
receptors, it is widely unknown: (i) whether and how they
are translationally regulated; and (ii) whether co-translational
folding/assembly is necessary for proper GABAR function.
However, our bioinformatic predictions suggest that for some
aspects, GABAR are prone to be subject to posttranscriptional
regulation. Future studies will be clearly needed to unravel the
dynamics and regulatory factors of their translation.
FIGURE 2 | GABAA receptor codon usage differ from ionotropic glutamate receptors. CDS length (A) and the number of transmembrane (TM) helices (B) in
GABAAR and ionotropic GluR subunits. (C) Codon usage frequency of GABAAR and GluR for 20 amino acids and stop codons. Dots represent synonymous
codons. (D) Codon frequency for CAG (Q) and AGA (R). (E) Relative fraction of stop codon usage between GABAAR and GluR subunits. Abbreviations: CDS, coding
sequence; aa, amino acid. P-values were calculated using the Mann-Whitney U-test, ∗∗∗∗p < 0.0001.
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FIGURE 3 | Possible posttranscriptional regulation mechanisms for GABAA receptors. Different posttranscriptional regulatory mechanisms exist. RNA transport,
translational control and (co-translational) protein folding and assembly control local protein expression. We propose that GABARs might be regulated at inhibitory
synapses in a similar manner. Abbreviation: Gphn, Gephyrin.
IS LOCAL PROTEIN SYNTHESIS A
PREREQUSITE FOR PLASTICITY OF
INHIBITORY SYNAPSES: A PERSPECTIVE
Since the discovery of LTP by Bliss and Lomo (1973), numerous
studies have unraveled the plasticity of excitatory synapses
in the brain aiming to explain the mechanism of learning
and memory formation (Kandel et al., 2014). However, how
inhibitory synapses undergo structural and molecular plasticity
has been widely overlooked for some time (Gaiarsa and Ben-
Ari, 2006). One of the first examples that inhibitory synapses
show long-term plasticity was a study on Purkinje cells in
the cerebellum published in 1998 (Aizenman et al., 1998).
Since that time, various studies have addressed the mechanisms
of how inhibitory LTP is conveyed (Castillo et al., 2011).
Interestingly, in some aspects, inhibitory and excitatory LTP
share similar mechanisms including the exchange of synaptic
receptors (de Luca et al., 2017) as well as the importance
of scaffold proteins for LTP (Petrini et al., 2014). In this
context, it was shown that clustering of Gephyrin (Gphn),
the major scaffold protein for inhibitory synapses (Tyagarajan
and Fritschy, 2014), is essential for GABAA receptor surface
dynamics and iLTP (Petrini et al., 2014). In line with its
importance for iLTP, Gphn is posttranslationally modified in
response to neuronal activity (Flores et al., 2015; Ghosh et al.,
2016), whichmay represent amolecular hub to control inhibitory
transmission. Arguably, one of the most impressive examples
showing the dynamics of inhibitory synapse formation is the
study by Oh et al. (2016). Upon GABA stimulation, newly
formed Gphn cluster appear that are the structural basis for
inhibitory synapse formation (Tyagarajan and Fritschy, 2014).
Based on our bioinformatic predictions (Figures 1, 2) and
RBP target screens (Tables 1, 2), it is tempting to speculate
that the appearance of Gphn clusters upon GABA stimulation
requires mRNA transport and, subsequently, translation. We
propose that these mechanisms are necessary for inhibitory
synapse formation (Figure 3). In general, future studies are
clearly necessary to address the importance of posttranscriptional
gene regulation for GABAergic synaptic transmission. Therefore,
it needs to be investigated: (i) which GABAR component is
regulated by RBPs; (ii) whether their expression is regulated
at the translation, splicing and/or stability level; and (iii)
whether their posttranscriptional regulation occurs locally
at the synapse. Unraveling the role of RBPs in neuronal
inhibition will clearly improve our understanding how neuronal
networks are coordinated to find the balance between excitation
and inhibition.
METHODS
For analysis, 3′-UTR sequences and length of transmembrane
domains were extracted from the EMSEMBL database
(genome assembly GRCm38.p6) using the Gene Ontology
ID ‘‘GO:0016917’’ for GABARs, ‘‘GO:0008066’’ for glutamate
receptors and ‘‘GO:0004970’’ for ionotropic glutamate receptors.
Only annotated mRNA isoforms were analyzed. Statistics were
calculated using GraphPad Prism (version 5; GraphPad, San
Diego, CA, USA).
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Abstract 
The RNA-binding protein (RBP) Pumilio2 (Pum2) is known to regulate neuronal 
excitability through translational repression of voltage-gated sodium channels. Pum2 
deficiency in linked to epilepsy, a neurological disease characterized by neuronal 
hyperexcitability, in mice and humans. The underlying mechanisms of this process are, 
however, widely unknown. Here, we identified the α2 subunit of the GABAA receptor 
(Gabra2) as mRNA target of the Pum2. Pum2 represses expression of Gabra2 both in 
the brain and in cortical neurons. Interestingly, upregulation of Gabra2 is responsible 
for dendritic branching deficits in Pum2 depleted neurons. Accordingly, enhanced 
Gabra2 expression represses activity of presynaptic neurons. Together, our data 
strongly suggest that the Pum2 mediated repression of Gabra2 expression represents 
a compensatory mechanism to counterbalance enhanced activity observed in Pum2 
deficient neurons. Our study provides new insight into the regulatory network of RBPs 
and how they balance neuronal excitability. 
Introduction 
Neuronal inhibition is mediated by GABAergic interneurons that release γ-
aminobutyric acid (GABA) from their presynaptic terminals to inhibit neuronal activity 
of their target cells, e.g. pyramidal cells. Therefore, GABA binding to the GABAA 
receptor (GABAAR) leads to chloride ion influx and hyperpolarization1. This process is 
essential for balancing neuronal activity in the brain2. Dysregulation of this delicate 
equilibrium is linked to neurological and neuropsychiatric diseases such as epilepsy 
and autism spectrum disorders (ASD)3,4. Thus, identifying physiologically relevant 
upstream regulators of GABAergic transmission is key to understand these diseases 
on a molecular level. 
RNA-binding proteins (RBPs) bind numerous target mRNAs in the cell5,6. Thereby, 
they regulate versatile processes in the RNA life cycle such as splicing, transport, 
stability and translation6. The RBP Pumilio2 (Pum2) is a known translation regulator7. 
It controls translation through distinct mechanisms8–12. Pum2 represses excitatory 
synapse formation in cultured hippocampal neurons. Moreover, it inhibits the 
translation of voltage-gated sodium channels such as Nav1.6 (Scn8a)13. These results 
suggest a role of Pum2 in regulating neuronal excitability. Supportive for this notion is 
the finding that knock-down (KD) of Pum2 in mice causes epileptic seizures14,15. Even 
though dysregulation of voltage-gated sodium (Nav) channels is a plausible 
explanation for epileptic seizures, electrophysiological recordings in Pum2 KD brains 
have shown that general excitability, which is mediated by Nav channels, is 
unaffected14. Instead, these recordings suggested impaired neuronal inhibition as 
possible cause for epilepsy in Pum2 KD mice. This is in line with recent findings 
showing that Pum2 is necessary for GABAergic transmission (Schieweck & Kiebler, 
unpublished). Thus, it is tempting to speculate that loss of Pum2 impacts GABAergic 
inhibition in vivo.  
Here, we found that Pum2 binds and regulates the α2 subunit of the GABAAR 
(Gabra2) in both mouse brain and in cultured cortical neurons. Interestingly, Gabra2 
was upregulated in Pum2 depleted neurons. Knock-down of Gabra2 rescued dendritic 
branching deficits observed in Pum2 KD neurons. In line with this finding is the 
observation that double knock-down of Pum2 and Gabra2 enhanced neuronal activity. 
Together, these results suggest that upregulation of Gabra2 counteracts the increased 
excitability observed in Pum2 KD neurons. We propose that this pathway represents a 
rescue mechanism to balance neuronal activity through decreased dendritic branching. 
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Materials and Methods 
 
Animals 
Pum2 gene trap (Pum2GT) and WT mice (background: C57Bl6/J and C57Bl6/JRccHsd) 
were used throughout. All experiments were approved by the authors’ institutional 
committee on animal care and performed according to German welfare legislation. 
 
Polysome Profiling 
One P21 mouse brain hemisphere was homogenized in polysome buffer (150 mM 
NaCl, 5 mM MgCl2, 10 mM Tris-HCl pH 7.4, 1vol% NP-40, 1% (w/v) sodium 
deoxycholate supplemented with 100 µg/mL cycloheximide, CHX, and 2 mM 
dithiothreitol, DTT) on ice. Cultured cortical neurons (5 million cells per condition) were 
transduced with either shControl or shPum2 lentivirus after 10 days in vitro (DIV10) as 
described16. Medium was changed the day after and one day prior to lysis. Upon four 
days of shPum2 expression, cells were incubated with 100 µg/mL CHX for 10 min, 
washed 3 times with prewarmed Hank’s Balances Salt Solution (HBSS) supplemented 
with 100 µg/mL CHX and then lysed in polysome buffer. Lysates were spun at 13,000 
x g for 5 min at 4°C. Supernatant was layered onto a sucrose gradient (18% to 50% 
(w/v) sucrose in 100 mM KCl, 5 mM MgCl2, 20 mM Hepes pH 7.4). Gradients were 
centrifuged at 35,000 rpm (SW55Ti, Beckman) for 1.5 h at 4°C and then fractionated 
using an automated fractionator (Piston Fractionator, Biocomp) with RNA detection at 
254 nm. RNA was extracted using acidic phenol-chloroform17. 
 
Western Blotting and Antibodies 
Lysates were separated by SDS-PAGE, proteins were then transferred to 
nitrocellulose (pore size 0.2 µm). Membranes were blocked in blocking solution (2% 
(w/v) BSA, 0.1 vol% Tween 20, 0.1% (w/v) sodium azide in 1xTBS pH 7.5) for at least 
1 h. Primary antibodies were diluted in blocking buffer and incubated overnight at 4°C. 
Membranes were washed in PBS supplemented with 0.2vol% Tween 20. Primary 
antibodies were detected using infrared dye labeled secondary anti-rabbit, anti-goat or 
anti-mouse antibodies (all 1:10,000, Li-COR Biosciences). Membranes were scanned 
using the Li-Cor Odyssey IR scanner. 
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The following antibodies were used: polyclonal rabbit anti-Pum2 1:10,000, rabbit anti-
Rpl7a (both Abcam) 1:1,000, goat anti-Vinculin (Santa Cruz) 1:200, guinea pig anti-
Gabra2 (Synaptic Systems) 1:1,000, mouse anti-Puromycin (PMY) (Millipore) 
1:10,000, anti-β-III-Tubulin (Sigma Aldrich) 1:10,000 and monoclonal rat anti-GAPDH 
(Helmholtz Center Munich Antibody Core Facility) 1:20. 
 
Immunoprecipitation of endogenous Pum2 granules 
Pum2 immunoprecipitation was performed as previously described18,19. In brief, one 
P21 mouse brain was homogenized in brain extraction buffer (25 mM HEPES pH 7.4, 
150 mM KCl, 8% glycerol, 0.1% NP-40, 1 mM DTT supplemented with Complete 
Protease Inhibitor [Roche] and RNase Inhibitor) on ice using an hand-driven douncer. 
Homogenate was spun at 20.000 x g for 15 min at 4°C (S20). S20 lysate was loaded 
on continuous OptiPrep gradients (0% to 30% (v/v)) and spun at 40,000 rpm (SW 41 
rotor, Beckman) for 2.5 h at 4°C. Gradients were fractionated in 900 µL fractions by 
hand. To detect the fate of Pum2, proteins were isolated using methanol-chloroform 
extraction17. Pum2 enriched fractions were pooled and precleared with protein A 
Sepharose beads. For immunoprecipitation, anti-Pum2 or preimmune serum bound 
beads were blocked in brain extraction buffer supplemented with 1.25 mg/mL BSA. 
Precleared lysate was incubated with beads for 1.5 h at 4°C. Upon incubation, beads 
were washed four times in brain extraction buffer. RNA was isolated using TRIzol 
reagent according to manufactures manual. To control for antibody specificity, Pum2GT 
brains15 were used for immunoprecipitation. 
 
XRN1 treatment of total RNA 
2 µg of total RNA was incubated with 1 U of XRN1 for 1.5 h at 37°C. RNA was isolated 
using acidic phenol-chloroform according to the manufacturer’s manual. RNA was 
subsequently reverse transcribed and then used for quantitative RT-PCR. 
 
Quantitative real-time PCR (qRT-PCR) 
RNA was isolated from DIV14 cultured cortical neurons using TRIzol according to the 
manufacturer’s manual. cDNA synthesis and qRT-PCR were performed as 
described20. PPIA was used as reference gene. 
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Neuronal cell culture and transfection 
Neuronal cell culture from rat was performed as previously described21 with slight 
modifications for cortical neurons. For transient transfection of shPum2 and control 
plasmids, DNA calcium phosphate coprecipitation22 was performed. 
 
Immunostaining and image analysis 
Upon fixation with 4% PFA, cells were washed with HBSS and permeabilized in 0.1% 
Triton X100 for 15 min at room temperature (RT) followed by washing in HBSS. Cells 
were immunostained as described20. Antibodies were diluted in 10vol% blocking 
solution (rabbit polyclonal anti-Gabra2, Synaptic Systems, 1:500) and incubated 
overnight at 4°C. Cells were washed in HBSS and incubated with fluorescently labeled 
secondary antibodies (Dianova). Upon washing, coverslips were mounted in 
fluoromount (Sigma Aldrich). Fluorescence microscopy was performed using the 
Observer Z1 microscope (Zeiss) with a 63x planApo oil immersion objective (1.40 NA). 
 
Statistics 
For data analysis and statistics, prism software (version 5 GraphPad, San Diego, CA, 
USA) was used. Data was tested for normal distribution using either the Kolmogorov-
Smirnov or the Shapiro-Wilk normality test. To calculate p-values, unpaired Student’s 
t-test, Mann-Whitney or Kruskal-Wallis test were used, respectively. p< 0.05 was 
considered as statistically significant.
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Results 
 
Pum2 regulates Gabra2 expression in the mouse brain 
 
To get insight into the role of Pum2 into the regulation of neuronal excitability, we 
analyzed our transcriptome dataset from both wildtype (WT) and Pum2 KD (Pum2GT) 
brains14. Interestingly, we observed a twofold increase in the mRNA expression of the 
α2 subunit of the GABAAR (Gabra2) (Fig. 1A). Surprisingly, we did not detect 
alterations in the expression of NMDA, AMPA receptors nor sodium and potassium 
channels (referred to as ‘excitatory’ genes). The GABAAR consists of different 
subunits1. Therefore, we tested all subunits detected in our microarray dataset. 
Strikingly, Gabra2 was selectively upregulated (Fig. 1B). We validated the effect of 
Pum2 on Gabra2 expression by qRT-PCR in newborn (P0), juvenile (P21) and adult 
animals (Supplementary Fig. 1A). Importantly, we did not observe differences in the 
expression of vesicle release components or neuromodulatory receptors 
(Supplementary Fig. 1B). These findings point toward a unique role of Pum2 in 
regulating Gabra2 expression. To get further insight into Gabra2 expression, we 
performed polysome profiling by biochemically separating translationally active from 
dormant ribosomes. Here, we observed a similar upregulation of Gabra2 mRNA in 
translationally active polysomes (Fig. 1C). Complementary, we found Gabra2 protein 
to be starkly upregulated in Pum2GT brain lysates compared to age-matched WT 
controls (Fig. 1D and Supplementary Fig. 1C). Next, we asked whether Gabra2 is a 
Pum2 mRNA target in mouse brain. Supportive for this notion is the observation that 
mRNAs coding for subunits of the GABAAR exhibit a higher number of Pum2 binding 
sites23 compared to transcripts coding for other receptors such as ionotropic glutamate 
or glycine receptors (Supplementary Fig. 1D). To experimentally test this hypothesis, 
we performed immunoprecipitation (IP) with self-made, affinity purified Pum2 
antibodies upon density gradient fractionation as previously described for Stau218,19 
(Supplementary Fig. 1E). Density gradient fraction confirmed that the biochemically 
isolated Pum2 complexes indeed contain RNA as we observed a shift of Pum2 towards 
lighter fractions upon RNase1 treatment (Fig. 1E). In IPs of endogenous Pum2 
complexes from mouse brain, we detected a threefold enrichment of Gabra2 compared 
to Pum2-deficient brain tissue (Fig. 1F). As positive control, we included eIF4E, a 
known Pum2 mRNA target24 that was enriched twofold. Importantly, other GABAAR 
Schieweck et al. Pum2 regulates Gabra2 in neurons 
 
subunits such as Gabra1 or transcripts coding for proteins involved in GABAergic 
inhibition such as Slc12a5 (coding for KCC2) were not enriched. Moreover, we did not 
observe binding of Pum2 to Grin1 coding for the NMDA receptor subunit Grin1 nor to 
the ribosomal RNA 18S rRNA showing the selectivity for Gabra2 in our Pum2 IP. 
Together, these results clearly show that Pum2 regulates Gabra2 expression in the 
mouse brain. 
 
Pum2 regulates translation of Gabra2 in cultured cortical neurons 
 
Next, we aimed at identifying the underlying mechanism of Pum2 mediated 
repression of Gabra2 expression. Pum2 is able to destabilize mRNA through the 
recruitment of the deadenylase complex CCR4-NOT25,26. To test whether depletion of 
Pum2 leads to an increase in mRNA stability, we measured the relative amount of 
uncapped mRNAs exploiting an XRN1 assay27. In brief, XRN1 degrades uncapped 
mRNAs while capped mRNAs remain unaffected. Interestingly, we observed the same 
ratio of uncapped to capped mRNAs for WT and Pum2GT brains (Fig. 2A) indicating 
that Pum2 does not affect Gabra2 stability. To further investigate the impact of Pum2 
on Gabra2 expression, we downregulated Pum2 in cultured cortical neurons using 
either lentivirus transduction or transient transfection of an established shPum2 
plasmid24. Interestingly, Gabra2 mRNA levels were not altered (Fig. 2B). The 
corresponding Gabra2 protein levels, however, were found to be increased in Pum2 
depleted neurons (Fig 2C,D). Importantly, this effect could be rescued by performing 
a double-knock down for Pum2 and Gabra2 (Fig. 2D and Supplementary Fig. 2A-D). 
Together, these results suggest that Pum2 regulates Gabra2 expression at the 
translational level rather than through decreasing RNA stability. To test this hypothesis, 
we exploited polysome profiling coupled with qRT-PCR to determine the amount of 
Gabra2 mRNA in translationally active polysomes. Strikingly, we observed an increase 
in Gabra2 mRNA levels associated with polysomes (Fig. 2E). Of note, the 50% 
increase of Gabra2 mRNA in polysomes mirror the observed increase in Gabra2 
protein levels (Fig. 2C,D). In summary, our data strongly suggest that Pum2 regulates 
translation of Gabra2 in neurons. 
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Gabra2 decreases dendritic branching 
 
To determine the physiological role of Gabra2 upregulation in Pum2 depleted 
neurons, we simultaneously downregulated both Pum2 and Gabra2 using our shRNA 
tandem construct (Fig. 2D). First, we tested whether downregulation of Pum2 has an 
impact on dendritic branching in cortical neurons as shown for hippocampal neurons24. 
Interestingly, we observed that Pum2 depleted neurons exhibited reduced dendritic 
branching (Fig. 3A-C). Next, we ask whether the upregulation of Gabra2 might be 
responsible for this effect. Gabra2 protein binds different proteins in the brain indicating 
an extra-receptor function. Amongst others, it binds ephexin-1 (Eph1)28. Interestingly, 
Eph1 regulates growth cone collapse29,30. Thus, it is tempting to speculate that 
increased expression of Gabra2 might recruit Eph1 to dendrites to cause growth cone 
collapse. To test this hypothesis, we downregulated Pum2 and Gabra2 in cortical 
neurons with our shRNA tandem construct. Interestingly, double knock-down 
completely rescued dendritic branching deficits (Fig. 3A-C). Together, our results 
clearly demonstrate that Gabra2 represses dendritic branching. 
 
Gabra2 inhibits neuronal activity 
 
Dendrites are essential for receiving synaptic input31. Hence, we speculated that 
decreased dendritic branching might inhibit synaptic input of Pum2 depleted neurons. 
To test this hypothesis, we stained against c-Fos, a known marker for neuronal activity, 
as it accumulates in the nucleus upon stimulation32. Strikingly, Gabra2 and Pum2 
depleted cultures showed an higher number of c-Fos positive cells compared to 
shControl and shPum2 alone (Fig. 4A,B). Importantly, this effect was selectively 
detected in cells that surround the transfected pyramidal neuron (visualized in green). 
This finding indicates that postsynaptic neurons exhibit significantly higher neuronal 
activity. Thus, Gabra2 inhibits neuronal activity. This effect might counterbalance 
enhanced excitability in Pum2 depleted neurons (Fig. 4C). 
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Discussion 
 
Pumilio2 controls translation of Gabra2 to regulate neuronal input  
Pum2 is known to repress the expression of sodium channels such as Nav1.613 
thereby inhibiting neuronal excitability. It is generally accepted that this control might 
be the molecular basis for epileptic seizures in Pum2 KD animals. The role of Pum2 in 
neuronal inhibition, however, has not yet been addressed. Here, we show that Pum2 
represses the translation of Gabra2 in cortical neurons. Gabra2 interacts with 
numerous proteins in the brain28. One of its protein interactors is ephexin-1 (Eph1), a 
known growth cone regulator29,30. It is therefore plausible that higher expression of 
Gabra2 leads to enhanced Eph1 mediated growth cone collapse and, in turn, to 
decreased dendritic branching. Consequently, the dendritic input is reduced. Higher 
expression of voltage-gated sodium channels in the absence of Pum2 increase the 
frequency of action potentials13. Thus, it is tempting to speculate that decreased 
synaptic input balances increased sodium channel mediated excitability of Pum2 
depleted neurons. Consequently, double-knock-down of Pum2 and Gabra2 leads to 
enhanced neuronal activity. These findings together strongly suggest that the 
regulation of Gabra2 represents a compensatory mechanism to inhibit neuronal 
activity. We propose that this effect is a rescue mechanism to avoid excitotoxicity in 
neurons. This dual regulator role of Pum2 in regulating mRNA coding for neuronal 
excitation and inhibition might also apply for other RBPs33. Thus, it is tempting to 
speculate that RBPs balance neuronal activity through this mechanism. In summary, 
our study reveals an exciting, yet unexplored mechanism to regulate neuronal 
excitability through a dual role of RBPs in promoting and inhibiting neuronal activity. Of 
note, neurological and neuropsychiatric diseases such as epilepsy or ASD that are 
hallmarked by an imbalanced ratio of excitation and inhibition3,4. Hence, Pum2 might 
also contribute to the pathology of these disorders. Future studies are clearly needed 
to unravel the role of Pum2 in ASD.
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Figure legends 
 
Figure 1 Pum2 binds and regulates Gabra2 in the brain 
A. Volcano plot of transcripts that significantly changed in Pum2 deficient (Pum2GT) 
brains compared to WT. B. Relative abundance of transcripts coding for subunits of 
the GABAA receptor. C. Representative polysome profile of postnuclear brain lysates 
(left) and quantification of Gabra2 mRNA in subpolysomal and polysomal fractions 
from WT and Pum2GT brains (right). D. Representative immunoblot against Gabra2 
from either WT or Pum2GT brain lysates (n=3). Vinculin served as loading control. E. 
OptiPrep density gradient fractionation (0%-30%) of Pum2 RNA complexes. Proteins 
were either stained with Coomassie blue or Pum2 was detected by Western blot. F. 
Quantification of Gabra2, eIF4E, Gabra1, Slc12a5, Grin1 and 18S in eluates from 
Pum2 immunoprecipitates from either WT or Pum2GT brain lysates from 2 independent 
experiments. P-values were calculated using unpaired Student’s t-test, n=2-3 
biological replicates. ** p < 0.01. 
 
Figure 2 Pum2 regulates translation of Gabra2 in cortical neurons 
A. Gabra2 mRNA quantification upon XRN1 treatment of isolated total RNA from WT 
or Pum2GT brain lysates. B. Quantification of Gabra2, Gabra1 and Pum2 mRNA levels 
in total RNA isolated from shControl and shPum2 transduced cortical neurons. C.-D. 
Representative microscopy images of shControl and shPum2 transfected neurons 
(GFP positive) stained against endogenous Gabra2 (C) and quantification of the 
observed staining intensity (D). E. Quantification of Gabra2 mRNA in polysomal 
fractions of either shControl or shPum2 transduced cortical neurons. P-values were 
calculated using unpaired Student’s t-test. * p < 0.05, *** p < 0.001, **** p < 0.0001, ns 
not significant, n=3 biological replicates. Scale bar: 10 µm. 
 
Figure 3 Gabra2 balances activity of Pum2 depleted neurons 
A.-C. Representative microscopy images (A) and Sholl analysis (B,C) of shControl, 
shPum2 and shPum2+shGabra2 transfected neurons. P-values were calculated using 
unpaired Student’s t-test. * p < 0.05, ** p < 0.01, ns not significant, n=3 independent 
cultures. Scale bar: 10 µm. 
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Figure 4 Gabra2 inhibits neuronal activity 
A. Representative microscopy images of shControl, shPum2 and shPum2+shGabra2 
transfected neurons stained against the neuronal activity marker c-Fos. B. 
Quantification of the relative number of cFos positive cells surrounding the transfected 
cell (marked by an asterisk). C. Scheme showing how Gabra2 reduces neuronal 
activity in Pum2 depleted neurons. P-values were calculated using Kruskal-Wallis test. 
* p < 0.05, *** p < 0.001, ns not significant, n=3 independent cultures. Scale bar: 10 
µm.
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Supplementary Figure legends 
 
Supplementary Figure 1 (Related to Figures 1) 
A. Quantification of Gabra2 mRNA in newborn (P0), juvenile (P21) and adult animals 
(3 month). mRNAs coding for KCC2, NKCC1 and eIF4E, respectively, were included 
as controls. B. Relative mRNA expression levels of vesicle release components and 
neuro-modulatory receptors in Pum2GT brains. C. Representative Western blot against 
Gabra2 in three juvenile Pum2GT and WT brains. D. Bioinformatic prediction of the 
Pum2 binding site (UGUANAUA) in the 3’-UTR of transcripts coding for the indicated 
receptors. E. Experimental scheme for the immunoprecipitation of endogenous Pum2 
complexes from mouse brain. P-values were calculated using unpaired Student’s t-
test. * p < 0.05, ns not significant, n=3 biological replicates. 
 
Supplementary Figure 2 (Related to Figures 2) 
A./B. Representative microscopy images showing cortical neurons transfected with 
shControl or shGabra2 stained against endogenous Gabra2 (A) and quantification of 
Gabra2 staining intensity (B). C. Quantification of mRNAs upon Gabra2 KD in cortical 
neurons. D. Quantification of Gabra2 and Pum2 mRNA, respectively in shPum2 or 
shPum2+shGabra2 transfected cells. P-values were calculated using unpaired 
Student’s t-test. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, ns not significant, 
n=3-4 independent cultures. Scale bar: 10 µm. 
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Abstract (113 words) 
The RNA-binding protein Pumilio2 (Pum2) is a known translational regulator in neurons 
and a well-established genetic risk factor for epilepsy. In this study, we aimed at 
identifying synaptic pathways that are functionally regulated by Pum2. Here, we show 
that Pum2 enhances global translation and activates the expression of key 
components of inhibitory synapses, e.g. the GABAA receptor scaffold protein Gephyrin 
(Gphn), a well-known regulator of neuronal inhibition. Consequently, Pum2 depletion 
selectively reduces the amplitude of miniature inhibitory postsynaptic currents 
establishing a role of Pum2 in enhancing synaptic inhibition. As Pum2 controls 
neuronal excitability through voltage-gated sodium channels, it is reasonable to 
assume that Pum2 regulates both excitation and inhibition to balance neuronal activity. 
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Control of neuronal activity is a prerequisite for normal brain function. Dysregulation of 
the balance between excitation (E) and inhibition (I) has been linked to neurological 
and neuropsychiatric diseases such as epilepsy and autism spectrum disorders (ASD) 
(1, 2). The E/I balance is in part mediated through GABAergic inhibition, which is 
conveyed by the activation of γ-aminobutyric acid (GABA) type A receptors (GABAAR) 
(3). The molecular details, however, causing an imbalanced E/I ratio are essentially 
unknown. A reduction of the RNA-binding protein (RBP) Pumilio2 (Pum2) in the brain 
causes epileptic seizures in mice (4, 5) and has been linked to epilepsy in humans (6) 
suggesting that Pum2 might play a role in regulating the E/I balance.  
To address this hypothesis, we investigated the impact of the translation regulator 
Pum2 on neuronal protein expression. First, we evaluated the interaction of Pum2 with 
translationally active polysomes. Differential centrifugation of mouse brain lysates (7) 
led to the preferentially detection of Pum2 complexes in the pellet (P) compared to 
supernatant (S), whereas the RBP Barentsz (Btz) (8) was found exclusively in the 
supernatant (Fig. 1A,B). RNase1 treatment prior to centrifugation released Pum2 into 
the supernatant, whereas EDTA treatment did not, indicating that its association is 
RNA-mediated (Fig. 1B). This is not a general feature of all RBPs as the nuclear 
protein NeuN (Rbfox3) (9) were insensitive to RNase1 treatment. To further investigate 
the interaction of Pum2 with the translation machinery, we performed polysome 
profiling (Fig. 1C). When we separated translationally competent ribosomes from 
translationally silent ribosomes (fig. S1A), we could detect the majority of Pum2 in 
translationally dormant fractions (Fig. 1D) that are enriched for the translation initiation 
factor eIF4E. Together, our results suggest Pum2 regulates mRNA translation 
independently of its association with ribosomes. Moreover, our polysome profiling 
experiments indicate that Pum2 represses translation. Importantly, the mere 
association of RBPs with ribosomes does not allow to deduce its role in translational 
activity as recently shown for FMRP (10), a known Pum2 protein interactor (11). 
We therefore performed polysome profiling (Fig. 2A) of Pum2-depleted versus control 
neurons (Fig. 2B). Interestingly, Pum2 knockdown significantly decreased the ratio 
between polysomes to monosomes, a commonly used index for translational activity 
(Fig. 2C,D). Such a decrease in the polysome to monosome ratio can also be observed 
when comparing Pum2 knock-down (KD) brains (Pum2GT) with the corresponding 
tissue in WT mice (Fig. 2E). This indicates that the effect on translation is Pum2-
dependent and not caused by shRNA expression. Accordingly, we observed a general 
Schieweck et al. Pum2 activates Gephyrin expression 
 
 
 
reduction of newly synthesized proteins (Fig. 2F) by performing puromycylation (PMY) 
assays using a PMY specific antibody (fig. S2A,B). This was not due to a reduction of 
the number of ribosomes or other essential translation factors as the levels of 18S 
rRNA or PABPC1 remained unaffected. In neurons lacking Pum2, we neither observed 
changes in phosphorylation of ribosomal protein S6, known to affect translation (12) 
(fig. S2C,D), nor in the levels of protein ubiquitination ruling out a Pum2-dependent 
effect on protein degradation (fig. S2E). Altogether, these results strongly suggest that 
Pum2 regulates global translation. Neuronal growth has been tightly linked to protein 
synthesis and protein degradation (13, 14). As decreased translation activity has an 
impact on cell size (15), we investigated whether Pum2 depletion in neurons affects 
their morphology. Consistent with its effect on translation, Pum2 depleted neurons 
showed a reduced cell size when compared to shControl transfected cells (fig. S2F,G). 
This seems to be a general effect as the body weight of Pum2GT mice compared to 
age-matched WT animals is significantly reduced (fig. S2H). It is therefore tempting to 
speculate that enhanced Pum2-dependent translation critically contributes to neuronal 
growth. 
Next, we aimed at identifying proteins affected by the Pum2 downregulation. In brief, 
we performed label-free mass spectrometry to determine protein abundance (Fig. 3A). 
Our analysis revealed that Pum2 significantly alters the neuronal proteome (Fig. 
3B,C). In agreement with our results (Fig. 2), we observed a clear bias towards protein 
downregulation in Pum2 KD neurons (Fig. 3D). Most of the dysregulated proteins 
showed a moderate effect at the expression level (Fig. 3D). Importantly, this effect was 
specific for Pum2 as downregulation of Stau2 resulted in an increase in relative protein 
abundance (Fig. 3E). Accordingly, we detected a drop in peptide intensity in Pum2 
depleted neurons compared to control or Stau2 depleted neurons (Fig. 3F). This not 
only confirms our polysome profiling results (Fig. 2C,D) but also further supports the 
notion of reduced general translational activity. Furthermore, we compared the proteins 
dysregulated in Pum2 depleted neurons with published Pum2 targets (11, 16). 
Surprisingly, there is only limited overlap with known Pum2 targets (Fig. 3G) indicating 
that loss of Pum2 has a global effect on mRNA translation and may not be restricted 
to its (direct) target mRNAs. This is in line with the finding that translation repressors 
such as Ago1 (17) and ZBP1 (18) were significantly upregulated while translational 
activators such as Impact (19) and YTHDF3 (19) were significantly downregulated (fig. 
S3). There is a subset of proteins, however, that is significantly downregulated upon 
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Pum2 depletion (Fig. 3B). Gene ontology (GO) analysis revealed the terms ‘forebrain 
development’ and ‘metabolic pathways’ to be significantly enriched. Notably, one of 
the strongest clusters are factors involved in GABAergic synaptic transmission (Fig. 
3C). Importantly, protein synthesis plays an important role in releasing GABA from 
presynaptic terminals (20). Moreover, RBP mediated expression control has been 
suggested to control inhibition of the postsynaptic neuron (21). Together, these 
findings further support the notion that Pum2 plays a role in GABAergic synaptic 
transmission. 
According to our proteomic data, several key regulators of GABAergic transmission 
were found to be downregulated: Gephyrin (Gphn), Vesicular inhibitory amino acid 
transporter (Vgat), Sodium- and chloride-dependent GABA transporter 1 (Gat1) and 
Glutamate decarboxylase 1 (Gad1) (Fig. 4A). Importantly, none of the detected 
proteins known to localize at glutamatergic synapses was affected (Fig. 4B). The four 
regulated proteins selectively contribute to GABAergic transmission, as Gphn is a key 
postsynaptic scaffold protein for the GABAA receptor(22), Vgat transports GABA into 
presynaptic vesicles (23), Gat1 is involved in the reuptake of GABA into presynaptic 
terminals and Gad1 synthesizes GABA(24) (Fig. 4C). We decided to focus on Gphn 
as it is a known Pum2 target (16) and essential for GABAergic transmission (22). Pum2 
KD cortical neurons were stained against Gphn (25). Interestingly, we did not see a 
reduction in somatic Gphn (Fig. 4D,E), but rather in dendrites of those neurons. The 
observed reduction in dendritic Gphn expression parallels those by our proteomic data 
(Fig. 4A). 
Next, we tested whether this Pum2-dependent downregulation of proteins present at 
GABAergic synapses had any functional impact on GABAergic synaptic transmission. 
To this end, we recorded from shPum2- or shControl-treated neurons and analyzed 
spontaneous synaptic activity in these neurons. Strikingly, we observed a reduction in 
the amplitude of miniature inhibitory postsynaptic currents (mIPSCs), but not for 
inhibitory postsynaptic currents (IPSCs) or postsynaptic spontaneous postsynaptic 
currents (PSCs) (Fig. 4F,G). A similar reduction of the amplitude of GABAergic current 
has been reported in Gphn KO brains (26). In contrast, the frequency of mIPSCs, 
IPSCs and PSCs was comparable (Fig. 4F,H). Together, these findings argue for a 
postsynaptic role of Pum2 in GABAergic synaptic transmission. Moreover, we 
observed Gat1 to be downregulated (Fig. 4A,C). Accordingly, we found that the decay 
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time of mIPSCs and IPSCs was significantly prolonged in Pum2-depleted neurons 
(Fig. 4I), similar to Gat1 KO mouse brains (27). 
In conclusion, our results provide strong experimental evidence that Pum2 activates 
expression of proteins independent of its ribosome association. Amongst others, Pum2 
critically enhances abundance of key components of GABAergic synapses and 
crucially contributes to GABAergic transmission. Pum2 had previously been linked to 
neuronal excitation through its impact on voltage-gated sodium channels (28–30). 
Therefore, Pum2 appears to play a dual role in balancing excitability. This novel aspect 
of Pum2 mediated expression control explains in all likelihood the epileptic seizures 
observed in Pum2 depleted brains. Our results provide new insight into the unexpected 
role of the RBP Pum2 in neurological and neuropsychiatric diseases such as epilepsy 
or ASD thereby potentially initiating new therapeutic approaches for the treatment. 
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Figure legends 
 
Figure 1 Pum2 granules co-migrate with translationally dormant mRNAs 
(A) Experimental scheme. (B) Representative Western Blot showing Pum2, Btz and 
neuronal nuclei antigen (NeuN) in pellet and supernatant upon differential 
centrifugation of brain lysates. (C) Scheme of polysome profiling to separate 
translationally active from dormant ribosomes. (D) Representative polysome profile 
(18%-50%) of post-nuclear brain lysate and representative immunoblots for Pum2 
(eIF4E as marker for the translation initiation machinery, Rpl7a for ribosomes, n=3 
biological replicates).  
 
Figure 2 Loss of Pum2 decreases translation in cultured cortical neurons 
(A) Experimental scheme. (B) Representative Pum2 immunoblot from control and 
Pum2 depleted cortical neurons. Vinculin and β-III tubulin were used as loading 
controls. (C) Representative polysome profiles of post-nuclear lysates from Pum2 KD 
or control neurons as well as representative immunoblots for Pum2 (Rpl7a served as 
marker for ribosomes). (D) Polysome to monosome ratios determined by calculating 
the area under the polysome profile curves for cultured cortical neurons. (E) Polysome 
to monosome ratios calculated from polysome profiles of WT and Pum2 depleted 
(Pum2GT) brains. Dots present individual profiles from individual brains. (F) 
Representative puromycin (PMY) immunoblot from control and Pum2 depleted 
neurons (DIV14). GAPDH served as loading control (left). Quantification of total PMY 
intensities from control and Pum2 KD lysates of cultured cortical neurons. P-values 
were calculated using paired (B, D), unpaired Student’s t-test (E) or one sample t-test 
(F).*p < 0.05, ** p < 0.01, n=3-4 biological replicates, Scale bar: 10 µm. 
 
Figure 3 Pum2 promotes translation 
(A) Experimental scheme. (B) Volcano plot of proteins showing differential expression 
in Pum2 KD neurons compared to controls. (C) GO term analysis of significantly up- 
and downregulated proteins in Pum2 depleted neurons. (D-E) Number (left) and 
histogram of relative fold change (right) of significantly up- and downregulated proteins 
in Pum2 (D) and Stau2 (E) KD neurons. (F) Cumulative plot of peptide intensities 
detected in shControl, shStau2 and shPum2 treated cells. (G) Number of significantly 
up- and downregulated proteins in Pum2 depleted neurons (shPum2) that are Pum2 
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mRNA targets identified in two independent studies (1 = Zhang et al., 2 = Zahr et al.). 
P-values were calculated using unpaired Student’s t-test (B) or Mann Whitney test (F). 
*** p < 0.001; ns, not significant, n=4 biological replicates. 
 
Figure 4 Pum2 regulates GABAergic synapses 
Relative abundance of proteins essential for GABAergic (A) and glutamatergic (B) 
transmission in Pum2 depleted neurons. Dots represent biological replicates. (C) 
Cartoon of an inhibitory synapse highlighting proteins that are downregulated in Pum2 
deficient neurons. (D) Representative phase and fluorescence images of shControl 
and shPum2 transfected neurons. Cells were stained against Gphn. (E) Quantification 
of Gphn signal in the cell body (left) and in dendrites (right). Dots represent individual 
neurons. (F-I) Electrophysiological recordings of shControl and shPum2 transduced 
neurons. Representative current traces of IPSCs and mIPSCs (F, left) as well as 
representative averaged trace of IPSCs (grey) and mIPSCs (colored) (F, right). 
Quantification of amplitude, frequency and decay time of mIPSCs (G), IPSCs (H) and 
postsynaptic currents (I). P-values were calculated using unpaired Student’s t-test, *p 
< 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, ns, not significant, n=3 biological 
replicates, Scale bar: 10 µm. 
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Supplementary Materials 
 
Materials and Methods 
 
Animals 
Pum2 gene trap (Pum2GT) and WT mice (background: C57Bl6/J and C57Bl6/JRccHsd) 
were used throughout. All experiments were approved by the institutional committee 
on animal care and performed according to German welfare legislation. 
 
Differential centrifugation and sucrose cushion centrifugation 
One brain hemisphere of postnatal day 21 (P21) mouse (Bl6/J) was homogenized in 
homogenization buffer (HB; 150 mM KCl, 50 mM Hepes pH 7.4, 1x complete protease 
inhibitor [Roche], 5 µL Ribolock [ThermoFisher] per 10 mL HB) on ice using a hand-
driven glass douncer. Homogenate was spun at 16,000 x g for 10 min at 4°C (S16, 
P16). Supernatant S16 was then spun at 100,000 x g for 20 min at 4°C (S100, P100). 
When required, samples were treated with RNase1 prior to centrifugation. P100 pellets 
were volume-even resuspended in RIPA buffer (150 mM NaCl, 50 mM Tris-HCl pH 8, 
0.5% (w/v) sodium deoxycholate, 1vol% NP-40, 0.1% (w/v) SDS, 1x complete protease 
inhibitor [Roche]) at 37°C. All fractions used were methanol/chloroform extracted(31). 
Pum2 and Barentsz (Btz) were detected by Western blotting. 
For sucrose cushion centrifugation, one P21 mouse brain was homogenized in 
polysome lysis buffer (150 mM NaCl, 5 mM MgCl2, 10 mM Tris-HCl pH 7.4, 1vol% NP-
40, 1% (w/v) sodium deoxycholate supplemented with 100 µg/mL cycloheximide, CHX, 
and 2 mM dithiothreitol, DTT) at 4°C as described above. Lysate was spun at 13,000 
x g for 5 min at 4°C. Postnuclear lysate was loaded on 2 mL 20% sucrose cushion 
(20%(w/v) sucrose, 100 mM KCl, 5 mM MgCl2, 20 mM Hepes pH 7.4) and centrifuged 
for 2 h at 100,000 rpm (SW41Ti, Beckman rotor) at 4°C. Pellets were resuspended in 
SDS Laemmli buffer, separated by SDS PAGE and transferred to nitrocellulose by 
Western blotting. 
 
Polysome Profiling 
One P21 mouse brain hemisphere was homogenized in polysome buffer on ice as 
described above. Cultured cortical neurons (5 million cells per condition) were 
transduced with either shControl or shPum2 lentivirus after 10 days in vitro (DIV10) as 
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described (32). Medium was changed the day after and one day prior to lysis. Upon 
four days of shPum2 expression, cells were incubated with 100 µg/mL CHX for 10 min, 
washed 3 times with prewarmed Hank’s Balances Salt Solution (HBSS) supplemented 
with 100 µg/mL CHX and then lysed in polysome buffer. Lysates were spun at 13,000 
x g for 5 min at 4°C. Supernatant was layered onto a sucrose gradient (18% (w/v) to 
50% (w/v) sucrose in 100 mM KCl, 5 mM MgCl2, 20 mM Hepes pH 7.4) and centrifuged 
at 35,000 rpm (SW55Ti, Beckman) for 1.5 h at 4°C. Gradients were fractionated into 
10x 500 µL fractions using an automated fractionator (Piston Fractionator, Biocomp) 
with RNA detection at 254 nm. 150 µL were used for protein extraction using 
methanol/chloroform extraction (31). 
 
Western Blotting and Antibodies 
Lysates were separated by SDS-PAGE. Proteins were transferred to nitrocellulose 
(pore size 0.2 µm). Membranes were incubated in blocking solution (2% (w/v) BSA, 
0.1 vol% Tween 20, 0.1% (w/v) sodium azide in 1xTBS pH 7.5) for at least 1 h. Primary 
antibodies were diluted in blocking solution and incubated overnight at 4°C. 
Membranes were washed in PBS supplemented with 0.2vol% Tween 20. Primary 
antibodies were detected using infrared dye labeled secondary anti-rabbit, anti-goat or 
anti-mouse antibodies (all 1:10,000, Li-COR Biosciences). Membranes were scanned 
using the Licor Odyssey IR scanner. 
The following antibodies were used: polyclonal antibodies: rabbit anti-Pum2 (Abcam) 
1:10,000, self-made rabbit anti-Btz(33) 1:500, rabbit anti-Rpl7a (Abcam) 1:1,000, 
rabbit anti-Rps6 1:1,000, rabbit anti-phospho-Rps6 1:1,000, rabbit anti-PABP1 (all Cell 
Signaling) 1:1,000, goat anti-Vinculin (Santa Cruz) 1:200, mouse anti-Puromycin 
(PMY, Millipore) 1:10,000, anti-β-III-Tubulin (Sigma Aldrich) 1:10,000 and monoclonal 
rat anti-GAPDH (Helmholtz Center Munich Antibody Core Facility) 1:20. 
 
Quantitative real-time PCR (qRT-PCR) 
RNA was isolated from DIV14 cultured cortical neurons using TRIzol according to the 
manufacturer’s manual. cDNA synthesis and qRT-PCR were performed as described 
(34). PPIA was used as reference gene. 
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Neuronal cell culture and transfection 
Neuronal cell culture from rat was performed as described (35) with slight modifications 
for cortical neurons. For transient transfection of shPum2 and control plasmids (36), 
DNA calcium phosphate coprecipitation was performed (37). 
 
Label-free mass spectrometry (LC-MS/MS) 
For proteome analysis, 6 million cortical neurons were transduced with either 
shControl, shPum2 or shStau2 lentivirus as described (32). Proteins were digested 
with trypsin and analyzed by LC-MS as described (38). Data was analyzed by 
Maxquant 1.5.2.8 using default parameters. The String Database was used for Gene 
Ontology (GO) analysis. 
 
Puromycylation of cultured cortical neurons 
Puromycylation was performed as described (39). In brief, cultured cortical neurons 
were incubated with 25 µM PMY for 15 min. Cells were washed 3 times with 
prewarmed HBSS and lysed in Laemmli buffer. 
For immunostaining, cortical cells were plated on coverslips and incubated for 5 or 10 
min with 1 µM PMY. For controls, cells were either preincubated with 100 µg/mL CHX 
for 10 min followed by 10 min 1 µM PMY incubation or left untreated. For surface 
staining, anti-PMY antibody was used at 1:500. 
 
Immunostaining and image analysis 
Upon fixation with 4% PFA, cells were washed with HBSS and permeabilized in 0.1% 
Triton X100 for 15 min at room temperature (RT) followed by washing in HBSS. Cells 
were then incubated in blocking solution (2% FCS, 2% BSA, 0.2% fish gelatin [Sigma], 
in 1x PBS) for at least 30 min at RT. Antibodies were diluted in 10vol% blocking solution 
(mouse monoclonal anti-PMY [Millipore], mouse monoclonal anti-Gphn [Synaptic 
Systems] both 1:500) and incubated overnight at 4°C. Cells were washed in HBSS and 
incubated with fluorescently labeled secondary antibodies (Dianova). Upon washing, 
coverslips were mounted in fluoromount (Sigma Aldrich). Fluorescence microscopy 
was performed using the Observer Z1 microscope (Zeiss) with a 63x planApo oil 
immersion objective (1.40 NA). For distal dendrites, z-stacks were acquired (optimal 
step size 0.26 nm as suggested by the ZEN software, ZEISS). Images were subjected 
to deconvolution using the Zen software using default parameters.  
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Whole-cell patch-clamp recordings 
All electrophysiological recordings were performed blindly. For whole-cell patch-clamp, 
coverslips with cultured cortical neurons were transferred to an organ bath mounted 
on the stage of an upright microscope (BX-RFA-1-5, Olympus, Japan). A single 
coverslip was continuously perfused with artificial cerebro-spinal fluid (ASCF) 
containing (in mM): NaCl (125), KCl (3), NaH2PO4 (1.25), NaHCO3 (25), CaCl2 (2), 
MgCl2 (2) and D-Glucose (25 mM). The ACSF was saturated with 95% O2 / 5% CO2 to 
maintain a pH of 7.4. The osmolarity of the ACSF ranged between 305 to 318 mOsmol. 
The perfusion rate with ACSF was set to 3 mL / min and recordings were performed at 
28°C. Cultured cells were visualized with a Dodt contrast tube (DGC, Scientifica, UK) 
that was attached to the microscope. Successfully transduced neurons were identified 
by RFP expression with the help of a fluorescence lamp (pE-300, CooLED, UK) and 
epifluorescence optics for green fluorescence (filter: ZT473dcrb, Chroma, USA). 
Images were taken and displayed using a software-operated microscope camera 
(Evolve 512 Delta, Teledyne Photometrics, USA). The electrodes for whole cell patch-
clamp recordings were fabricated from borosilicate glass capillaries (OD: 1.5 mm, ID: 
0.86 mm, Hugo Sachs Elektronik-Harvard Apparatus, March-Hugstetten, Germany) 
and filled with a solution composed of (in mM): KCl (139), NaCl (2), EGTA (0.2), 
HEPES (10), Mg-ATP (4), Na-GTP (0.5), and phosphocreatine (10) (pH: 7.25 – 7.30, 
osmolarity: about 290 mOsmol). The electrodes (resistance: 4-5 MW) were connected 
to the headstage of a npi ELC-03XS amplifier (npi, Tamm, Germany). The recorded 
signals were amplified (x20), filtered at 3 kHz (voltage clamp), digitized at a sampling 
rate of 10 kHz and stored on a computer for off-line analysis. Data acquisition was 
performed by means of a CED 1401 Power 3 system in conjunction with the Signal6 
data acquisition software (Cambridge electronic design, Cambridge, England).  
All spontaneous synaptic activity was recorded at a holding potential of -60 mV for 5 
minutes. Inhibitory postsynaptic currents (IPSCs) were recorded in the presence of the 
AMPA receptor blocker 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-
dione (NBQX, 10 µM) and in the presence of the NMDA receptor blocker D-2-amino-
5-phosphonopentanoate (D-AP5, 20 µM). Miniature inhibitory postsynaptic currents 
were recorded in the presence of tetrodotoxin (TTX, 0.5 µM). Data analysis was 
performed using IGOR Pro 6 (WaveMetrics, Lake Oswego, USA) together with the 
NeuroMatic IGOR plugin(40). Spontaneous synaptic events were automatically 
detected using the algorithm provided by the NeuroMatic plugin (version 2.00) for 
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IgorPro. The detection threshold was set to 15 pA. Only monophasic synaptic currents 
were analyzed, and the following parameters were determined: PSC frequency, peak 
amplitude and decay time. 
All chemicals and drugs were obtained from Sigma-Aldrich (Munich, Germany) and 
Biotrend (Cologne, Germany), respectively. All drugs were added to the bathing 
solution.  
 
Statistics 
For data analysis and statistics, prism software (version 5 GraphPad, San Diego, CA, 
USA) was used. Data was tested for normal distribution using either the Kolmogorov-
Smirnov or the Shapiro-Wilk normality test. To calculate p-values, paired, unpaired 
Student’s t-test or Mann-Whitney test were used, respectively. Paired Student’s t-test 
was used for paired, dependent samples to correct for variation in primary neuronal 
cultures. p < 0.05 was considered as statistically significant.
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Supplementary Figure legends 
 
Supplementary Figure 1 (Related to Figures 1) Pum2 does not associate with 
translating polysomes 
Representative polysome profiles of cortical neurons upon incubation with CHX or 
Harringtonine, respectively, including representative Pum2 immunoblots (Rpl7a 
served as marker for ribosomes, n=2 biological replicates). 
 
Supplementary Figure 2 (Related to Figures 2) Pum2 does not affect mTOR 
activity nor Ubiquitin-dependent proteolysis 
(A) Representative immunostainings of cortical neurons upon puromycylation (1 µM 
PMY treatment for 5 or 10 min) and labeling with anti-PMY antibody. Translation 
inhibitor CHX was added prior to PMY for 10 min. (B) PMY signal in cell bodies (>24 
cells were quantified for each condition, two independent cultures). (C) Normalized 
qRT-PCR results for 18S rRNA from total RNA extracted from control and shPum2 
transduced neurons (DIV14). PPIA was used as reference gene. (D) Representative 
immunoblots for Rpl7a, Rps6, p-Rps6 and PABPC1 (left). Quantification of 
immunoblots (right) normalized to Vinculin and β-III Tubulin (n=3). (E) Representative 
immunoblot against Ubiquitin (α-tubulin served as loading control, left) and 
quantification (right). (F/G) Representative phase and fluorescence images of 
shControl and shPum2 transfected mature cortical neurons (F) and quantification of 
cell body size (> 38 cells were measured for each condition, n > 4 cultures, G). (H) 
Body weight of WT and Pum2GT animals (n=11-12). P-values were calculated using 
Mann-Whitney test. ** p< 0.01, **** p < 0.0001; ns, not significant; Scale bar: 10 µm 
 
Supplementary Figure 3 (Related to Figures 3) Pum2 affects expression of key 
translation regulators 
Protein fold change of hand-selected translation regulators Ago1, ZBP1, Impact and 
YTHDF3. Dots represent biological replicates (n=4). 
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